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ABSTRACT
The use of biological catalysts is common in many of today’s industrial processes. 
Interest in enzymes capable of working under harsh industrial conditions has heightened 
over recent years with the identification and characterisation of enzymes from 
extremophilic organisms. In addition, advancements in laboratory techniques suited to 
the modification of proteins mean that it is now possible to design and engineer an 
enzyme to suit specific needs within the laboratory environment.
The aim of this project is to enhance the thermal stability of xylanase A from the 
anaerobic ruminal fungus Neocallimastix patriciarum, whilst retaining its high levels of 
activity at lower temperatures. Xylanase A has a potential application in the animal feed 
industry, and this forms the basis for this project.
Two separate techniques have been applied in order to fulfil the aims of this project 
Using a generated three-dimensional model of the second catalytic domain of xylanase 
A (xylA.cd2), mutations predicted to increase the thermal stability of the enzyme were 
introduced by site-directed mutagenesis. Two cysteine residues were introduced with the 
aim of forming a disulphide bond. The mutant enzyme was as active as the original 
enzyme, yet displayed at least 2.5 times greater stability at the temperatures assayed.
The second approach was to use directed evolution in attempts to increase the thermal 
stability of xylA.cd2. A library of xylA.cd2 random mutants was generated, and after 
initial unsuccessful attempts to screen the mutants for those with greater thermal 
stability a screening system based on 96-well plate format was developed. This screen 
was used to identify 12 mutants retaining high levels of activity after incubation at 65°C. 
The three of these 12 mutants that were characterised in detail all demonstrate 
improvements in thermal stability over the original enzyme while retaining similar 
temperature optima. The most stable mutant of the three characterised demonstrates a 





1.1 RATIONALE AND AIMS OF PROJECT
The rationale behind this project comes from a problem faced by many industrial 
companies. The use of enzymes to aid and improve existing processes is increasingly 
common in today’s industrial market place, and many companies are now seeking to 
acquire enzymes capable of carrying out processes in more demanding situations, for 
example in conditions of extreme pH or temperature. While, through the use of enzymes 
from ‘extremophilic’ organisms, it is possible to find natural enzymes capable of 
working in extreme conditions, there are some applications where enzymes with ‘non- 
natural’ properties would be more suited to the task. This problem forms the basis for 
this project, as outlined by its industrial sponsors. One of their main interests is in the 
use of enzymes as additives in animal feeds. Some of the stages of feed processing 
involve high temperature steps, and the mesophilic enzymes currently added to the feed 
cannot fully withstand these temperatures. As a result much of the added enzyme is 
rendered inactive, and in attempts to overcome this problem higher quantities of the 
enzyme are added to the feed prior to processing, an option that is economically 
unfavourable. There are a couple of obvious solutions to this problem: one would be to 
add the enzyme to the feed after processing, and the other would be to substitute the 
current mesophilic enzyme for a thermophilic one. It is possible to add enzyme to the 
feed following processing, and this is achieved by spraying it over the feed in a liquid 
form. There are disadvantages associated with this option though, and they include non- 
uniform coverage of the feed and the necessity for specialised equipment to carry out 
this process. Substituting the current mesophilic enzyme for a thermophilic one would 
solve the problem of inactivation at high temperatures, but the fact that thermophilic 
enzymes often demonstrate a decreased activity at lower temperatures means that this 
option is not practical as the enzyme additive needs to demonstrate high levels of 
activity at normal, physiological temperatures. An ideal animal feed enzyme additive 
should be both stable at elevated temperatures and highly active at lower temperatures.
l
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The enzyme of interest in this study is a xylanase, and the problems outlined above form 
the basis for the aims of the project. Using a variety of techniques, attempts will be made 
to increase the thermal stability of a mesophilic xylanase whilst retaining its high levels 
of activity at lower temperatures.
1.2 XYLANASE IN INDUSTRY
In 2000 the global industrial enzyme market was estimated to be worth US$2 billion 
(Diversa Corporation), and US demand alone is projected to exceed $2.6 billion by 2004 
(The-infoshop.com). Enzymes including cellulases, xylanases, proteases, lipases, 
amylases, pectinases and phosphatases are widely used in the pulp and paper, textiles, 
detergent, and food and beverage industries. Xylanases in particular, the focus of this 
project, have numerous biotechnological applications. Many industrial processes utilise 
xylanases to enhance and improve existing systems, resulting in more economically 
sound and environmentally friendly processes. Xylanases are already produced on an 
industrial scale and used in bakeries to improve the texture of bread dough, which in 
turn improves the loaf volume, texture and shelf life of the bread (Maat et al., 1992). 
Another area where the use of xylanases, and in particular thermostable xylanases, is 
becoming increasingly common is in the pulp and paper industry. Traditionally, paper 
pulp is bleached using chlorine and hypochlorite. This bleaching process is essentially to 
remove lignin from the pulp, and it is estimated that over 2 x 106 tonnes of chlorine and 
chlorine derivatives are used annually in the United States for this purpose. The 
chlorinated derivatives generated by this process constitute a major environmental 
problem (McDonough, 1992), and public demand and environmental regulations have 
now put restrictions on the use of chlorine in the bleaching process of the pulp and paper 
industry, particularly in Western Europe and North America (Chauvt et al., 1987). 
Recent studies have demonstrated the feasibility of enzymatic treatment as an alternative 
to chlorine bleaching for the removal of lignin from pulp (Viikari et al. 1994). Treatment 
of pulp with xylanase leads to the release of xylan and lignin without unnecessary loss of 
other pulp components. Performing this enzymatic bleaching at elevated temperatures 
opens up the cell wall structure of the pulp and facilitates lignin removal in subsequent 
stages, and it is for this reason that industrial interest for this application concentrates on
2
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thermostable xylanases. Other industrial applications of xylanases include the 
clarification of wine and juices and the extraction of flavours, spices, oils and pigments 
(Biely, 1985). Another major use of xylanases is in the animal feed industry, and the 
remainder of this section shall focus on this application.
1.2.1 Xylanase in the animal feed industry
In today’s animal feed market the use of exogenous enzymes in the diets of non­
ruminant animals is common. Their use has allowed an increase in the utilisation of 
lower quality feedstuffs, along with an improvement in animal performance due to the 
increased absorption of nutrients. Non-ruminant animals such as pigs and poultry lack 
the digestive advantages possessed by ruminant animals. Ruminants have an extensive 
array of microbial enzymes, produced and secreted by rumen inhabitants, that play an 
important role in their digestive process. These enzymes aid in the digestion of fibre and 
other plant cell wall polymers, and allow the animal to obtain nutritional value from 
otherwise indigestible feed. Non-ruminant animals, which are also referred to as 
monogastric, do not have the benefit of such advantageous symbiotic relationships and 
as a result are not capable of releasing the full potential of nutrients from their feed. The 
presence of exogenous enzymes in non-ruminant feed aids the animal in obtaining 
greater nutritional value from the normally indigestible feed fraction.
Common feedstuff ingredients include wheat, barley, oats, rye and maize. These all 
contain anti-nutritional factors (ANFs), that is, they all contain elements that limit 
animal performance by affecting the way in which an animal can obtain nutrients from 
its feed. The most common ANFs are non-starch polysaccharides (NSPs), including 
cellulose, arabinoxylans, p-glucans, galactomannans and pectin, which are primarily 
derived from plant cell walls. Non-ruminants do not possess all the necessary enzymes 
to completely digest the carbohydrate portion of their feed. Whilst they produce 
enzymes such as amylases and disaccharidases to ensure the hydrolysis of starch, 
sucrose and lactose, they lack the enzymes necessary to digest NSPs. NSPs interfere 
with the digestibility, absorption and utilisation of nutrients and the main problem that 
arises as a result of this is increased intestinal digesta viscosity. Increased digesta
3
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viscosity effectively slows down the gastrointestinal passage rate (van der Klis et al., 
1993; Sudendey & Kamphues, 1995) and reduces the diffusion of digestive enzymes, 
and their substrates and products (Bedford & Morgan, 1996; Ellis et al., 1996). These 
factors have a direct impact on animal performance, particularly in poultry, and it is for 
this reason that NSPs are the major target substrates when exogenous enzymes are used 
as animal feed additives.
NSP-degrading enzymes can affect the nutritional value of feedstuffs in several ways. 
By breaking down cell walls they allow digestive enzymes to access normally 
unavailable nutrients. By hydrolysing the actual NSPs they can help to produce 
absorbable nutrients or to yield a more digestible substrate. Finally, by breaking down 
the NSPs they can decrease intestinal viscosity, which has the knock-on effect of 
increasing nutrient uptake. The most common NSP-degrading enzymes used as feed 
additives are xylanases and (3-glucanases.
The enzymes in current commercial use are commonly isolated from the bacterial genera 
Bacillus, or from fungal strains of Aspergillus, Trichoderma, Penicillium or Humicola 
(Official Journal of the European Communities, 1996). A major consideration in the 
selection of appropriate enzymes for use as additives is their stability. The feed pelleting 
process involves subjecting the feed to moist heat (often 70-90°C), followed by 
mechanical pressing. Exogenous enzymes added to feed prior to pelleting are susceptible 
to heat inactivation (Inborr & Bedford, 1994), and whilst this problem can be overcome 
by application of the enzyme post-processing, it is economically desirable to include the 
enzyme before processing. The development of a more thermostable enzyme that retains 
good activity at 37°C in the digestive tract would overcome this problem. Thermal 
stability is not the only factor that requires consideration when selecting appropriate feed 
enzymes: pH and proteolytic stability are also of importance. An enzyme must be 
sufficiently stable to withstand the low pH, proteolytic environment of the stomach. 
These above considerations are all of considerable importance when selecting an 
enzyme that will function well as a feed additive.
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Current research into potential animal feed enzyme additives is focusing on the 
identification of new enzymes, or the development of existing ones, that are more 
suitable for inclusion in animal feeds (by fulfilling the stability criteria discussed above). 
Techniques such as protein engineering and directed evolution have significant potential 
for ‘customising’ existing enzymes, and have already been employed with success in 
other areas of industry. Both of these techniques will be discussed in detail in subsequent 
sections of this chapter.
1.3 XYLAN AND XYLANASE
Plant cell walls have three major polymeric constituents: cellulose, hemicellulose and 
lignin. Xylan, a heteropolysaccharide based on a backbone structure of p-l,4-linked D- 
xylose residues, is the major constituent of hemicellulose and can be found in the cell 
walls of all land plants and in almost all plant parts (Whistler & Richards, 1970). Xylan 
is a heteropolysaccharide as its backbone structure is branched with side chains, the 
most common of which include acetyl and arabinofuranosyl groups, and glucuronic acid 
(Figure 1.1). Xylan chains can also be polymerised, and both the degree of 
polymerisation and the composition of the branched side chains are dependent on their 
biological source. (3-1,4-xylans are mainly found in secondary cell walls, the major 
component of mature cell walls in woody tissue, and are characteristic of hardwoods, 
softwoods and grasses (Timell, 1967). There are differences in the composition of side 
chains between hardwood and softwood xylans, with hardwood xylan being mainly 
acetylated and softwood being substituted with arabinofuranosyl groups. Approximately 
one in ten xylose backbone residues are substituted with a glucuronic acid residue at 
carbon position 2 (C2) in hardwood xylan, and 70% are substituted with acetyl groups at 
C2 or C3 (Puls & Schuseil, 1993). In contrast, softwood xylan is not acetylated, but 
instead 20% of its xylose backbone residues are substituted at C2 with glucuronic acid 
residues and 13% are substituted at C3 with arabinofuranosyl residues (Puls & Schuseil, 
1993). The xylan of grasses contains fewer glucuronic acid residues than hardwood 
xylan but has a large number of arabinofuranosyl residues (Puls & Schuseil, 1993). In 
grass xylan, in addition to the xylose backbone residues being substituted, the 
arabinofuranosyl residues are also branched: 6% are substituted with feruloyl groups and
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3% with p-coumaroyl residues (Coughlan & Hazlewood, 1993; Mueller-Harvey et a l, 
1996).
Given the widespread abundance and complexity of polysaccharides in nature, it is not 
surprising that their degradation entails diverse enzymes with differing specificities and 
modes of action. Glycosyl hydrolases (EC 3.2.1.jc) are the major group of enzymes 
involved in polysaccharide hydrolysis, and they achieve this by breaking the glycosidic 
bond either between carbohydrate molecules, or between a carbohydrate and a non­
carbohydrate moiety. In addition to classification by the International Union of 
Biochemistry (IUB) nomenclature of enzymes, glysosyl hydrolases have also been 
classified into families based on hydrophobic cluster analysis and amino acid sequence 
similarities of enzyme catalytic domains (Henrissat, 1991; Henrissat & Bairoch, 1993). 
This additional classification system, of which there are 85 families to date (Coutinho & 
Henrissat, 1999), is based on the direct relationship between sequence and folding 
similarities, and was designed both to reflect common structural features and to reveal 
evolutionary relationships between enzymes. The classification also provides a 
convenient tool for deriving mechanistic information (Coutinho & Henrissat, 1999) 
about lesser-known enzymes. Xylanases have been classified into glycosyl hydrolase 
families 10 and 11. Members of family 10 include xylanases and cellulases, while family 
11 contains only xylanases. The fact that xylanases catalyse the same reaction, yet can 
be grouped into two distinct families, indicates obvious differences at the amino acid 
sequence level. A major difference between family 10 and 11 xylanases is their three- 
dimensional structure. Family 10 xylanases adopt an 8-fold p/a-barrel structure, whereas 
family 11 xylanases have a P-sandwich structure (2 twisted P-sheets and an a-helix), 
also referred to as a P-jelly roll. The enzymes from both families catalyse the hydrolysis 
of the glycosidic bond via the same mechanism, and this will be discussed in more detail 
later in the subsequent section.
As the major constituent of hemicellulose, xylan is an abundant natural, renewable 
resource, and the enzymes that bring about its degradation play an enormous role in the 
maintenance of carbon flow through the carbon cycle. The hydrolysis of the p-1,4-
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linked D-xylose backbone that is characteristic of xylans involves xylanases (P-l,4-D- 
xylan xylanohydrolase; EC 3.2.1.8) and xylosidases (P-l,4-D-xyloside xylohydrolase; 
EC 3.2.1.37). Generally, the xylanases hydrolyse internal xylosidic bonds on the 
backbone chain, and the P-xylosidases release xylose residues by hydrolysing from the 
ends of xylooligosaccharides formed by the action of the xylanases. Other enzymes are 
necessary for the complete degradation of xylan into its substituent units as xylanases 
and P-xylosidases cannot remove branched side chains. Esterases, arabinofuranosidases 
and glucuronidases are all involved in the degradation of the side chain branches.
Xylanases are produced by a multitude of organisms, including bacteria, algae, fungi, 
protozoa, gastropods and arthropods (Dekker & Richards, 1976). Most of the bacteria 
and fungi secrete xylanases into their extracellular surroundings, allowing them to live 
heterotrophically on the liberated xylose. Ruminal microorganisms in particular are 
known to be powerful producers of xylanolytic enzymes, presumably due to the high 
hemicellulose content of animal feed, and as discussed previously this is of benefit to the 
animal by allowing them to obtain greater nutritional value from their feed.
Glucuronic acid Arabinofuranose Arabinofuranose
Figure 1.1 Generalised structure of a xylan polymer
Adapted from Coughlan & Hazlewood (1993). Ac represents acetyl group.
1.3.1 Mechanism of catalysis
The reaction that brings about hydrolysis of a glycosidic bond is formally a nucleophilic 
substitution at the saturated carbon of the anomeric centre (Sinnott, 1990). Glycosyl 
hydrolases can be classified according to the mechanism by which they hydrolyse 
glycosidic bonds. There are two classes of glycosyl hydrolases: the inverting enzymes 
and the retaining enzymes. These classifications correspond to the stereochemical
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outcome of glycosidic bond hydrolysis, and refer to the overall inversion or retention of 
anomeric configuration during catalysis (Koshland, 1953; Sinnott, 1990). Mutagenesis 
studies and the availability of crystal structures have aided in the elucidation of accurate 
catalytic mechanisms for each class of glycosyl hydrolase. The xylanase of interest in 
this study is a member of glycosyl hydrolase family 11. Family 11 xylanases are known 
to retain the anomeric configuration during catalysis. Retaining enzymes are proposed to 
proceed via a double-displacement mechanism involving the production of a covalent 
glycosyl-enzyme intermediate (Koshland, 1953; Sinnott, 1990). The formation and 
hydrolysis of this covalent intermediate occurs via oxocarbenium ion-like transition 
states, aided by two active site residues. In family 11 xylanases the two active site 
catalytic residues have been identified as glutamic acids: one acts as a nucleophile and 
the other as an acid/base catalyst (Miao et a l , 1994; Torronen et a l , 1994; Wakarchuk et 
al, 1994). The mechanism is summarised in Figure 1.2, and proceeds as follows: the 
first step involves the nucleophile attacking the anomeric carbon, displacing the leaving 
group and forming a covalent glycosyl intermediate, and the acid/base catalyst assisting 
in the formation of the intermediate by protonating the leaving group to allow bond 
cleavage. The second step involves deprotonation of an incoming water molecule, which 
attacks at the anomeric carbon and leads to displacement of the sugar. The distance 
between the two catalytic active site residues is approximately 5.5A (McCarter & 
Withers, 1994), which allows the proton donor to be within hydrogen-bonding distance 
of the glycosidic oxygen and the nucleophile to be close to the anomeric carbon of the 
sugar.
The active site of family 11 xylanases has a cleft structure (Figure 1.3). This ‘open’ 
structure permits the xylan polymer to lie along the cleft, where several of its xylose 
units are bound by interactions with amino acid residues. Aromatic residues within the 
active site cleft are involved in stabilising the xylan backbone chain by packing against 
individual xylose units. Additionally, other residues along the active site cleft help to 
stabilise the xylan by forming hydrogen bonds with substrate hydroxyl groups.
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Figure 1.2 Reaction mechanism of retaining glycosyl hydrolases
Adapted from Davies & Henrissat (1995). Figure represents the stages o f catalysis occurring in 
the active site cleft of retaining glycosly hydrolases. A represents the acid/base catalyst, which 
assists in the formation o f a glycosyl intermediate by protonating the leaving group (RO). B 
represents the nucleophile, which attacks the anomeric carbon and displaces the leaving group 
forming the covalent intermediate. In the second stage o f the reaction an incoming water 




Figure 1.3 The ‘open cleft’ active site structure
Reproduced from Davies & Henrissat (1995). Image is of the three-dimensional structure of 
endoglucanase E2 from Trichoderma reesei. Red shaded areas correspond to the two active site 
catalytic residues.
These substrate binding sites within the active site cleft are known as subsites, and are 
labelled as -2, -1, +1, +2 and +3 (where positive numbers represent the reducing end of 
the substrate chain, and negative numbers the non-reducing end) (Bray & Clarke, 1992; 
Torronen & Rouvinen, 1995). Cleavage of the xylan backbone chain is thought to occur 
between subsites -1 and +1. Subsites -2 and -1 are well characterised by studies on a 
Bacillus circulans xylanase (Wakarchuck et al., 1994) and xylanase II from 
Trichoderma reesei (Havukainen et al., 1996), but characterisation of the reducing end 
subsites is based on modelling studies only.
1.3.2 Xylanase assay methods
There are numerous assay methods available to detect xylanase activity, including 
methods to detect activity on a solid support (for example, activity of a xylanase 
expressed in a microorganism that has been cultured on an agar plate) as well as in 
solution. The most common assay method used to detect xylanase activity in solution is 
the dinitrosalicylic acid (DNS) method, which was originally described by Miller 
(1959). It follows hydrolysis of a xylan substrate by determining the release of reducing
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sugar. An interlaboratory evaluation of the various xylanase assays in use determined 
that when the DNS assay is standardised in terms of substrate and assay procedure it is 
capable of generating reproducible results that facilitate comparison of data between 
different laboratories (Bailey et a l, 1992). The DNS assay reagent comprises 3,5- 
dinitrosalicylic acid, sodium hydroxide, phenol and sodium sulphite and is used to detect 
the presence of free carbonyl groups in reducing sugars following incubation of a xylan 
substrate with a xylanase. Under alkaline conditions the aldehyde group present in 
reducing sugars is oxidised to a carboxyl group, while simultaneously the 3,5- 
dinitrosalicylic acid (DNS) is reduced to 3-amino-5-nitrosalicylic acid (Figure 1.4). 
Sulphite (in the form of sodium sulphite) is included in the reagent to absorb dissolved 
oxygen, as this may interfere with oxidation of the reducing sugar. By including phenol 
in the reagent the sensitivity of the assay can be increased. Xylanase activity is 
determined by comparison to a xylose standard curve, where the enzyme and substrate 
portion of the reaction are substituted for a selection of xylose solutions of known 










Figure 1.4 Mechanism of dinitrosalicylic acid assay
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In situations where simply the presence or absence of xylanase activity needs to be 
determined, for example in determining whether a bacterial colony is expressing an 
active xylanase clone, there are two assay methods that can be used. Both are performed 
as ‘solid-phase’ assays, and involve dyes to highlight areas of substrate hydrolysis. The 
first method uses the dye Congo Red to indicate areas where the xylan substrate remains 
intact (Teather & Wood, 1982). Using the example above, a bacterial colony expressing 
a xylanase clone could be either grown on an agar plate containing a xylan substrate, or 
it could be grown on a regular LB-agar plate and overlaid with an agar containing xylan. 
After a suitable incubation time the agar plate is flooded with a 1% solution of Congo 
Red and unbound dye is washed away with 1M sodium chloride solution. Congo Red 
makes strong interactions with polysaccharides containing (3-1,4-linked glycosidic 
bonds, and as such in areas where xylanase activity has hydrolysed the polymeric xylan 
into smaller units the dye does not bind and so a clearing zone, or ‘halo’, is seen around 
the area of xylanase activity.
An alternative method of detecting xylanase activity is to use a xylan substrate that has 
been tagged with a dye. A common dye in use is Remazol brilliant blue R (RBB), and 
RBB-xylan can be included in the agar plates on which bacterial colonies expressing 
xylanase clones are grown. In a similar way to the Congo Red assay, areas of xylanase 
activity are visible by the clearing zone present around them. Here, as the xylanase 
hydrolyses the polymeric xylan the dye is released and is free to diffuse away from the 
area leaving a clearing zone behind it.
1.3.3 Molecular architecture of xylanases
At the molecular level xylanase proteins are known to comprise individual modules, or 
domains. These domains can be catalytic or non-catalytic and are usually joined together 
by linker sequences that are rich in proline and hydroxy-amino acids. Observed domains 
include catalytic, substrate binding, thermostabilising and docking domains. On the basis 
of structural similarities between domains it has been suggested that xylanases (and 
cellulases) have evolved by domain shuffling, followed by subsequent domain 




The catalytic domains of xylanases are individual modules that comprise the active site. 
As previously discussed, sequence similarity between catalytic domains is a major factor 
in the classification of glycosyl hydrolase enzyme families. Generally, xylanases consist 
of a single catalytic domain only, although there are examples of enzymes that possess 
more than one. Evidence for the ability of catalytic domains to function independently 
comes from deletion studies involving the removal of other, non-catalytic, domains in 
several xylanases (Ferreira et al., 1990). The results of these studies suggest that the 
other domains do not necessarily play an important role in catalysis, as truncated 
enzymes, consisting of the catalytic domain only, retain almost full xylanase activity.
1.3.3.2 Substrate binding domains
Many xylanases are known to contain substrate binding domains in addition to their 
catalytic domains. The most common substrate binding domains identified in glycosyl 
hydrolases in general are cellulose binding domains (CBDs) and there are two 
commonly used explanations to suggest why CBDs are found in polysaccharide 
hydrolases other than cellulases. The first proposes that both the abundance and the 
ordered, invariant chemical structure of cellulose make it an ideal anchor for hydrolysing 
enzymes to attach to the plant cell wall; the second suggests that CBDs help to increase 
the synergism known to exist between plant cell-wall hydrolases by bringing an 
assortment of hydrolysing enzymes into close contact with the plant cell wall (Black et 
al., 1995). Through amino acid sequence similarities, cellulose binding domains have 
been classified into unique families (called CBD families), in a similar way to the 
classification of glycosyl hydrolase catalytic domains (Tomme et al., 1995). In addition 
to the CBDs originally classified there are now known to be xylan-specific binding 
domains (XBDs) and these have been identified in both family 10 and family 11 
xylanases (Simpson e ta l, 1999; Sunna e ta l, 2000a).
1.3.3.3 Thermostab ilising domains
Thermostabilising domains (TSDs) were originally identified in xylanases from 
thermophilic bacteria (Lee et a l, 1993; Fontes et a l, 1995; Winterhalten et al., 1995)
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and their role as thermostabilising domains was inferred by the decrease in enzyme 
stability observed when the domains were removed. TSDs are now also known to be 
present in xylanases from mesophilic organisms (identified by sequence homology to the 
original TSDs), and while the exact reason for conveying thermostability to a mesophilic 
enzyme is uncertain it has been suggested that TSDs may also confer additional stability 
against other detrimental factors including proteolytic attack and extremes of pH (Clarke 
et a l, 1996). Whilst TSDs have been shown to enhance the stability of thermostable 
xylanases their presence is not a prerequisite for thermal stability. There are several 
xylanases isolated from thermophiles that are single domain enzymes consisting of a 
catalytic domain only, and yet their stability at elevated temperatures is equal to, or in 
some cases greater than, those enzymes possessing a TSD (Gibbs et a l, 1995; Saul et 
a l, 1995). Recent studies have shown that some of the previously identified TSDs are 
actually xylan binding domains, and have suggested that the decreased thermal stability 
observed with removal of the domains is due to disruption of structure and exposure of 
previously buried residues, rather than the removal of a domain responsible for 
imparting thermostability (Chamock et a l, 2000; Sunna et a l, 2000b).
1.3.3.4 Cellulosome docking domains
The idea that cellulolytic enzymes can be organised into functional, high molecular mass 
complexes was first proposed in 1983 (Lamed et a l, 1983). These complexes, termed 
cellulosomes, are now known to contain not only cellulolytic enzymes but also 
hemicellulolytic enzymes. In contrast to aerobic organisms, whose enzymes do not 
appear to associate, anaerobic microorganisms often synthesise multienzyme cellulase- 
hemicellulase complexes (Gilbert & Hazlewood, 1993). Early research on the 
cellulosome was carried out on extracts from the anaerobic bacterium Clostridium 
thermocellum, and its cellulosome complex was shown to be composed of 18 individual 
proteins (Hazlewood et a l, 1988). Characterisation of some of these enzymes revealed a 
non-catalytic domain containing a 2 2 -residue repeated sequence that was often present at 
the C-terminus of the protein. During this early cellulosome work an additional 
multifunctional, non-catalytic subunit, originally termed SI, was noted (Lamed et al., 
1983; Bayer et al., 1985). This subunit was thought to be involved in both bringing
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together the other subunits of the cellulosome, and in the attachment of the cellulosome 
to its substrate. Subsequent studies on this subunit from C. thermocellum, now renamed 
scaffoldin, have shown that it has a single cellulose binding domain and nine distinct but 
closely related domains called cohesins (Gemgross et al., 1993). The cohesin domains 
have been shown to interact with the other catalytic subunits of the cellulosome complex 
to form a cohesive multienzyme complex (Yaron et al., 1995). The interaction between 
cohesin domains and catalytically active cellulosome subunits occurs via a domain 
within each individual enzyme that contains the 2 2 -residue repeated sequence described 
above. This domain, now termed a dockerin domain, serves to bond each individual 
enzyme to the scaffoldin protein and hence mediate their integration into the 
cellulosome complex. Dockerin domains have been identified in enzymes from both 
bacterial and fungal sources. A study of fungal cellulosome complexes identified a 
lOOkDa polypeptide that was proposed to be the scaffoldin protein, and determined that 
fungal cellulosome complexes have a mass of about 700kDa (Fanutti et al., 1995). This 
is in comparison to bacterial cellulosomes, which are known to be approximately 2  x 1 0 6 
Da.
1.3.4 Neocallimastix patriciarum Xylanase A
The xylanase of interest in this study is xylanase A from the anaerobic fungus 
Neocallimastix patriciarum. N. patriciarum was originally isolated from the rumen of a 
sheep (Orpin & Munn, 1986) and its ability to degrade xylan was first noted by Williams 
and Orpin in 1987. The first characterisation of a xylanolytic enzyme from N. 
patriciarum came when Gilbert et al. (1992) used rDNA methodology to clone the 
cDNA encoding a xylanase into a plasmid vector and expressed the enzyme in E. coli. 
This enzyme was designated xylanase A, and subsequent studies have revealed a further 
two N. patriciarum xylanase enzymes, which have been designated xylanase B and C 
(Black et al., 1995; Liu et al., 1999).
The original characterisation studies by Gilbert et al. (1992) showed xylanase A to be a 
6 6 kDa protein, encoded by an 1821 base-pair gene. In common with other xylanases, 
xylanase A is a modular enzyme and consists of a signal peptide, a 225-amino acid
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repeated sequence at the N-terminus and a 40-amino acid repeated sequence at the C- 
terminus. As with other modular glycosyl hydrolases, the modules are separated by 
linker sequences rich in proline and hydroxyamino acids. (Figure 1.5). The 225-amino 
acid repeats are highly analogous (91.6% identical and 95.6% similar), and have been 
shown by sequence homology to other known xylanases to be glycosyl hydrolase family 
11 catalytic domains. Xylanase A is one of the few xylanases that contains two distinct 
catalytic domains, and the fact that the DNA encoding these two repeated domains 
demonstrates 92.7% identity suggests that xynA is a result of tandem duplication of an 
ancestral gene. The catalytic domains also show high homology to ruminal xylanases 
from bacterial sources, and Gilbert et a l (1992) concluded that this provides evidence 
for a common evolutionary origin. They proposed that gene transfer may have occurred 
between the rumen prokaryotic and lower eukaryotic organisms either within the rumen 
or prior to their colonisation of the rumen. Characterisation of the duplicated catalytic 
domains by deletion analysis showed that both domains can function independently of 
the other, and that they both cleave xylan only, producing both xylobiose and xylose in 
approximately equal amounts. One important observation made during this study was 
that the plasmid coding for a single catalytic domain expressed 15 times more 
recombinant xylanase protein in E. coli than the plasmid encoding the full-length 
enzyme. This was presumed to be a result of the utilisation of an E. coli translation 
initiation sequence by the plasmid coding for the truncated xylanase A catalytic domain 












Tandem 40 Amino Acid 
C-terminal Repeats
Figure 1.5 Molecular architecture of Neocallimastix patriciarum xylanase A
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While in the original characterisation studies the function of the repeated 40-amino acid 
C-terminal domains remained unknown, they were shown by deletion analysis not to be 
necessary for catalysis. It has since been suggested that these repeated domains, which 
also demonstrate high homology (82.9% identical and 90.8% similar), are involved in 
cellulosome formation. A study by Fannutti et al (1995) on xylanase A and mannanase 
A from the anaerobic fungus Piromyces showed that both these enzymes possess a 40- 
amino acid repeated sequence homologous to that in the N. patriciarum xylanase A. 
They showed that the repeated sequence from both these enzymes bound to a protein 
found within the multi-enzyme cellulose-binding complex of both Piromyces and N. 
patriciarum that they proposed to be the scaffoldin protein. By sequence homology they 
suggested that the 40-amino acid repeats in N. patriciarum xylanase A would also be 
able to bind this proposed scaffoldin protein, and as such they classified the repeats as 
cellulosome docking domains.
1.4 PROTEIN STABILITY
The folded conformation of a protein is the conformation, as dictated by its primary 
sequence, in which the protein is able to carry out its biological function. This specific 
three-dimensional structure is maintained and stabilised by a variety of interactions. The 
most significant stabilising forces are known to be weak, non-covalent ones, although 
covalent disulphide bonds do contribute to protein stability. Entropy is known to be the 
main factor opposing the maintenance of a protein in its folded state, and given that the 
folded, active conformation of a protein is only marginally more thermodynamically 
stable than the unfolded, inactive conformation, these weak interactions play an 
important role in preserving the structure and, as a result, function of the protein.
Non-covalent interactions that contribute to the overall stability of a protein include 
ionic interactions, van der Waals interactions, hydrogen bonding and hydrophobic 
interactions. Ionic interactions, or the formation of an ionic bond, occur as a result of the 
association between two oppositely charged ionic groups within close proximity (up to 6  
A) in a protein molecule. Van der Waals interactions are the associations between 
electrically neutral molecules, and they arise as a result of weak electrostatic attraction
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between two atoms with permanent or induced dipole moments. Hydrogen bonds are 
also electrostatic interactions, and they occur between a weakly acidic donor group and 
an acceptor atom that bears a lone pair of electrons. Within a protein molecule both the 
donor and acceptor groups are usually the highly electronegative nitrogen and oxygen 
atoms, although sulphur atoms can also be involved in hydrogen bonding. In order for a 
hydrogen bond to form, the distance between donor and acceptor groups must be 
approximately 3A. Hydrophobic interactions are the forces that hold non-polar 
molecules together. They play an important role in the stabilisation of a protein’s folded 
conformation, as the interior of a protein is generally a densely packed core of 
hydrophobic amino acid side chains. It has been proposed that this hydrophobic effect is 
the major driving force behind protein folding (Dill, 1990).
These non-covalent interactions are all energetically weak in comparison to covalent 
bonds. The energy required to break a mole of covalent carbon-carbon bonds is about 
350kJ. In comparison, approximately 20kJ/mol is required to disrupt a hydrogen bond, 
40kJ/mol for an ionic bond, 4-8kJ/mol for a hydrophobic interaction and only 4kJ/mol to 
disrupt a van der Waals interaction. Whilst each of these interactions individually 
contribute only a small amount to a protein’s overall stability, they predominate as the 
major stabilising forces because of their number. Generally speaking, the protein 
conformation with the lowest free energy, i.e. the most stable conformation, is the one 
with the maximum number of weak non-covalent interactions. Another reason why these 
weak interactions play an important role in protein stability is that they stabilise any 
polar and charged amino acid side chains within the core of the protein. For example, 
whilst one hydrogen bond makes only a small apparent contribution to the stability of a 
folded protein, the presence of a single hydrogen-bonding group without a partner within 
the hydrophobic core of the protein would be sufficiently destabilising so as to make the 
protein’s conformation thermodynamically untenable.
Disulphide bonds are also known to contribute to protein stability, and these are 
examples of covalent interactions. These linkages occur via oxidation between the thiol 
groups of two cysteine residues. The cytoplasm of a cell is relatively reducing in
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character, and this diminishes the stability of a disulphide bond, which is easily reduced. 
As such almost all proteins containing disulphide bonds are found in extracellular 
locations where the environment is more oxidising. Here the disulphide bonds confer 
additional stability to secreted proteins. As they are covalent linkages a much larger 
input of energy is required to disrupt them (approximately 2 1 0 kJ/mol).
1.4.1 Factors contributing to thermal stability
There are many publications that review the studies performed to date that have 
attempted to answer the question of how enzymes from thermophilic organisms are able 
to maintain their stability at the elevated temperatures (for a recent example, see Vieille 
& Zeikus, 2001). The general opinion is that while certain features have been identified 
as contributing to stability at elevated temperatures in the numerous enzymes studied to 
date, these features are not universal ones that can be applied to any enzyme to 
guarantee an increase in its thermostability. Thermostability seems more to be a result of 
small structural modifications brought about by a few amino acid substitutions, and 
modulation of the forces and interactions discussed in the previous section that come 
together in a unique fashion for each individual enzyme. The fact that thermophilic and 
hyperthermophilic enzymes can be cloned and expressed in a mesophilic host, and that 
the recombinant enzymes usually display stability and activity equal to that of the native 
enzymes, highlight the point that these enzymes possess intrinsic factors which 
predispose them to stability and activity at higher temperatures. Studies into the basis of 
thermostability have been performed on families of enzymes containing both mesophilic 
and thermophilic members, and in some cases psychrophilic members also. They have 
concluded that there are common factors (single factors, or multiple factors in 
combination) within an enzyme family that do contribute to thermostability, but that 
these are often not general factors that apply across different families. An important 
point to consider here is that any differences identified between mesophilic and 
thermophilic proteins must be viewed in a structural context in order to fully appreciate 
their involvement in thermostability (Danson & Hough, 2002).
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Common features that have been identified as contributors to thermal stability include an 
increased number of hydrogen bonds, improved electrostatic interaction through ionic 
bonds and networks, greater hydrophobicity, increased packing or core density through 
smaller cavities, shortening or deletion of loops, increased a-helical content, increased 
polar surface area, increased number of proline residues and decreased occurrence of 
thermolabile amino acid residues such as asparagine, glutamine, methionine and 
cysteine (Sterner & Liebl, 2001; Kumar et al., 2000'b). A number of these factors are 
thought to aid thermostability by reducing the flexibility of the protein. For example, 
loops are flexible regions within the secondary structure of a protein. As such it is 
thought that thermal denaturation may be initiated at these flexible sites. Shortening 
these loops, or making them less flexible by the introduction of stabilising amino acids 
(proline residues, for example), may protect the protein from denaturation at this point.
Interestingly, a recent statistical analysis of homologous mesophilic and thermophilic 
enzymes from 18 families (Kumar et al., 2000b) concluded that the only factors 
responsible for increased thermostability across the whole selection of enzyme families 
were increased numbers of ionic bonds and hydrogen bonds between amino acid side 
chains. They concluded that the mesophilic and thermophilic proteins exhibit similar 
hydrophobicities, compactness, polar surface areas and main-chain and side-chain 
hydrogen bonding. They also did not see any obvious increase in the number of proline 
residues or in deletions that shorten loops. This study strengthens the opinion that 
thermostability cannot be defined in general terms for all thermophilic proteins, and 
demonstrates that while certain factors might contribute to thermostability in one protein 
they will not necessarily have the same effect in the next protein.
1.4.1.1 Examples o f non-covalent interactions involved in thermostabilisation
In the studies performed to date that have attempted to address the question of how
individual enzymes are stabilised at high temperatures, increased numbers of ionic
bonds are frequently identified as important stabilising factors. Studies on glutamate
dehydrogenase by Yip et al. (1995,1998) have identified ion-pair networks as the major
factor responsible for thermostability. Similarly, studies on the enzyme citrate synthase
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have also shown the importance of ion-pair networks in maintaining thermostability. 
Russell et a l (1997) compared the crystal structures of three citrate synthases whose 
optimum growth temperatures span the biological temperature range (37, 55 and 100°C) 
and showed that the number of intersubunit ion-pairs increased with increasing 
temperature. Amott et al. (2000) have further confirmed the involvement of these ion 
pairs in thermal stability by showing that disruption of the intersubunit ion-pair network 
in the citrate synthase whose optimum growth temperature is 100°C leads to a decrease 
in its thermostability.
Increased hydrophobic interactions are another example of non-covalent interactions that 
have been frequently cited as one of the mechanisms involved in stabilisation of proteins 
at high temperatures. As previously mentioned, hydrophobic interactions are generally 
accepted as being the major driving force behind protein folding (Dill, 1990). This fact 
is not due to any strong attraction between non-polar molecules, but rather results from a 
protein aiming to achieve the greatest thermodynamic stability possible by minimising 
the entropy decrease that would occur by ordering water molecules around non-polar, 
hydrophobic molecules. An example of where increased numbers of hydrophobic 
interactions have been cited as the responsible factor in increasing thermostability is the 
work of Haney et al. (1997). By comparing the three-dimensional structures of adenylate 
kinases from mesophilic, thermophilic and hyperthermophilic organisms they have 
identified an increase in the number of aliphatic amino acids, leading to a larger and 
more hydrophobic enzyme core, as the factor responsible for the increased 
thermostability seen in the thermophilic and hyperthermophilic enzymes.
1.4.1.2 Examples o f covalent interactions involved in thermostabilisation
Disulphide bonds are the main covalent interactions that play a role in the stabilisation
of proteins at high temperatures. As already discussed in section 1.4, disulphide bonds
are known to give additional stability to the three-dimensional structure of active
proteins, and in particular to those proteins that are secreted to the extracellular
environment. Despite their stabilising nature they occur in unexpectedly low numbers in
thermostable proteins. Cysteines are one of a number of thermolabile residues that are
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found in decreased numbers in thermophilic proteins, and it may be the reduced 
presence of cysteine monomers that leads to the lower than expected frequency of 
disulphide bonds (Danson & Hough, 2002).
Considering the aims of this project, introducing a disulphide bond may be one way to 
increase the thermal stability of xylanase A from N. patriciarum. The idea of using non­
native disulphide bonds to stabilise protein structure was first studied by Villifranca et 
al (1983) with the enzyme dihydrofolate reductase, and since then has been applied in 
the quest to stabilise many other proteins. Xylanase A is a mesophilic enzyme that, in 
the animal feed industry, is expected to be active at mesophilic temperatures but to be 
stable at the high temperatures experienced during the feed pelleting process. The 
formation of an introduced disulphide bond should be possible as the enzyme will be 
synthesised in a mesophilic host, so the problems outlined above with the instability of 
cysteine residues should not pose a problem. On formation of a disulphide bond it would 
be hoped that the bond would help stabilise the enzyme during its incubation at elevated 
temperatures.
In support of this theory, one study has introduced a single disulphide bond, and a 
combination of two and three bonds, into a xylanase from Bacillus circularise and has 
shown that the mutant enzymes are all more stable than the wild-type enzyme 
(Wakarchuk et a l , 1994). The mutants containing a single disulphide bond confer some 
additional thermostability to the xylanase, but the greatest improvement in stability was 
seen in the mutant with three internal disulphide bonds, where an increase in 
thermostability of 15°C was observed over the wild-type, as measured by residual 
activity.
1.5 ENGINEERING STABILITY
Protein engineering is a process whereby an enzyme’s function or stability can be altered 
by modifying its amino acid sequence. The ability to alter the specific properties of an 
enzyme has attracted a great deal of interest from those industrial companies looking to 
use biological catalysts to improve their existing processes, or to carry out novel ones.
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As already mentioned in section 1.1, there is increasing demand from industrial 
companies for enzymes possessing unusual properties that would enable improvements 
to be made in the efficiency of existing industrial processes. In addition to the properties 
found in enzymes from extremophilic organisms, such as activity at elevated 
temperature or extreme pH, the development of many non-natural properties would also 
be of benefit. Examples include alterations to substrate specificity and enantioselectivity, 
and stability and activity in artificial environments such as organic solvents. Xylanases 
are industrially relevant enzymes, and attempts have already been made to improve 
properties such as thermostability and activity at high pH so that the enzymes are more 
suited for use in the pulp and paper and animal feed industries.
The two key techniques commonly employed to engineer enzymic properties within the 
laboratory are rational design and random mutagenesis. Both methods have 
demonstrated varying degrees of success in their ability to alter the characteristics of 
industrially relevant enzymes. Random mutagenesis, also known as directed evolution, 
is becoming the increasingly popular option as it requires little prior knowledge of the 
enzyme under study. Rational design on the other hand requires detailed knowledge of 
the sequence and three-dimensional structure of a protein in order to accurately predict 
mutations that may result in the required improvement.
1.5.1 Rational design
Rational design, also known as site-directed mutagenesis, is the traditional method of 
protein engineering. It uses knowledge of the sequence and three-dimensional structure 
of a protein to design amino acid substitutions that are predicted to alter a characteristic 
of interest. Site-directed mutagenesis is also a useful tool for investigating the 
relationship between protein structure and function. It has been successfully used in the 
elucidation of enzyme catalytic and binding mechanisms, and has been applied in the 




The chances of designing successful mutations by rational design are greatly increased 
by the availability of crystal structures of homologous enzymes possessing the desired 
trait. Consider thermostability, the characteristic of interest in this project. The chances 
of designing site-specific mutations that may lead to an increase in the thermostability of 
a mesophilic enzyme should be improved by structural knowledge of the naturally 
occurring thermostable homologues of the enzyme. However, as already discussed in 
section 1.4, thermostability is a difficult characteristic to predict accurately as no single 
factor is responsible for imparting stability at high temperatures. This makes the task of 
improving the thermal stability of a mesophilic enzyme by rational design significantly 
more challenging.
A successful example of the use of site-directed mutagenesis to increase the 
thermostability of an enzyme is the work carried out by Van den Berg et al. (1998). 
Based on comparisons with the more thermostable protein thermolysin, they have 
introduced 8  mutations into a thermolysin-like protease from Bacillus 
stearothermophilus, and have shown that the resulting mutant enzyme is 340 times more 
stable than the wild-type enzyme at 100°C. Rational design has also been used to 
successfully change the cofactor specificity of the enzyme isopropylmalate 
dehydrogenase from Thermus thermophilus. In this study, Chen et al. (1996) have used 
crystal structures and molecular modelling to make significant changes in the secondary 
structure of the enzyme in order to alter its cofactor specificity. The mutant enzyme, 
which is four times more active than the wild-type enzyme, contains four amino acid 
substitutions and an a-helix and loop in place of a P-tum. Its cofactor specificity has 
switched from a 100-fold preference for NAD to a 1000-fold preference for NADP.
Disadvantages of the rational design approach to protein engineering include that fact 
that crystal structures are not always known for a given enzyme. Even with structural 
information available the effects of multiple mutations are not easily predictable (Tobin 
et al., 2000). An alternative approach if the crystal structure of an enzyme is not 
available is to produce a model based on the already determined crystal structures of 
other closely related proteins. This will provide a rough estimate of the three­
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dimensional structure of a protein, although modelled structures are generally not as 
reliable as the true crystal structure as even small differences in amino acid sequence can 
have large effects on a protein’s structure and the way in which it folds. Site-directed 
approaches to protein engineering based on a modelled structure can, therefore, be 
considerably less reliable than when the actual crystal structure is used as the basis for 
design.
Another disadvantage of site-directed mutagenesis is that often there is not a 
homologous enzyme displaying the desired characteristics available for comparison. 
Even if a homologue is known, it is not uncommon for two enzymes to strongly 
resemble each other in three-dimensional structure but have considerably different 
amino acid sequences (Arnold, 1998). These problems, coupled with the fact that the 
whole process of designing and introducing mutations and assessing the mutant 
enzyme’s new characteristics is labour-intensive and time-consuming means that efforts 
have been made in recent years to develop an alternative method of engineering the 
properties of an enzyme.
1.5.2 Random mutagenesis
Random mutagenesis is emerging as a powerful tool with which to ‘redesign’ enzymes 
for use as biocatalysts in industrial applications. The main advantage of random 
mutagenesis over rational design is the fact that it requires no structural knowledge of 
the enzyme of interest in order to bring about improvements in a specific property. 
Previously, random mutations could be introduced into a gene using chemical mutagens 
such as formic acid, hydrazine or sodium nitrite (for example see Arase et al., 1993). 
However, these methods are not ideal in exploring all potential mutations as they cannot 
generate all possible base substitutions (Fromant et a l , 1995). Over the last decade two 
alternative methods have been developed for the introduction of random mutations into 
gene sequences: directed evolution and DNA shuffling. These have replaced chemical 
mutagenesis to become the popular techniques with which to improve specific enzymic 
properties, and both involve stages of mutagenesis followed by screening to identify 




The technique of random mutagenesis by directed evolution uses the theory of natural 
evolution to generate enzymes with improvements in specific properties. Natural 
evolution has shown that proteins are highly adaptable and are able to evolve in order to 
function in ever-changing environments. Generally, directed evolution involves the 
generation of a library of randomly mutated genes, followed by screening to identify 
those genes encoding enzymes displaying improvements in the desired property. The 
gene(s) encoding the improved enzymes are then subjected to further rounds of 
mutagenesis and screening in order to accumulate beneficial mutations (Kuchner & 
Arnold, 1997). Nature is able to evolve new proteins by randomly walking from a good 
starting point, and this system forms the basis for directed evolution experiments. By 
starting with an enzyme close, but not ideal, to what is required, it is possible to evolve it 
by accumulating small changes such that it retains its initial characteristics (for example, 
the ability to degrade xylan) but acquires new ones (such as increased stability at high 
temperature) (Arnold, 1996). Directed evolution uses the polymerase chain reaction to 
enzymatically introduce random mutations into a gene (Fromant et al., 1995). This is 
achieved by using a polymerase lacking proofreading ability and by using unequal 
concentrations of the four deoxynucleoside triphosphates, and is also known as error- 
prone PCR. The screening process is the equivalent of natural selection, providing a 
selective pressure such that only mutants able to cope with this pressure are chosen for 
further rounds of mutation.
The main advantage of directed evolution over rational design is the lack of structural 
information required about the enzyme of interest. It is not necessary to know the crystal 
structure of the protein and how this relates to its function, nor is it necessary to have 
information about related enzymes from the same family in order to successfully 
improve a function of the enzyme. One limitation to the success of directed evolution 
experiments is the precision of the screening system. In order to identify a few improved 
mutant enzymes from the many thousands produced by error-prone PCR the screen must 
be sensitive to the properties of interest, reproducible with low inherent variability and 
efficient enough to screen many mutants quickly and effectively. Although the
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mutational frequency can be controlled by the error-prone PCR conditions used, 
beneficial mutations are rare, with the majority being deleterious (Arnold et a l , 2001). 
This means that devising a screen capable of detecting the small functional changes 
expected from one or two amino acid substitutions can prove difficult. Despite the 
challenges of designing an accurate, reliable screen, directed evolution has proved 
successful in engineering numerous enzymic properties, including substrate specificity, 
enantioselectivity and thermostability (with and without an associated decrease in 
activity at lower temperatures) (See Table 1.1 for further examples). With the recent 
emergence of high-throughput screening processes, the application of directed evolution 
should soon be extended to many more industrial enzymes, and as such should increase 
the feasibility for creating new enzymic functions as well as improving existing ones 
(Georgiu & DeWitt, 1999).
There have been many attempts to use directed evolution to improve the thermostability 
of an enzyme. Successful examples include the work Gonzalez-Blasco et al (2000). In 
this study they have used a single round of error-prone PCR and screening to isolate a 
mutant of p-glucosidase from Paenibacillus polymyxa that displays a half-life at 65°C of 
12 minutes. This is in comparison to the wild-type enzyme, which displays no detectable 
activity at 55°C.
ALTERED PROPERTY TARGET ENZYME
Increased thermostability p-Nitrobenzyl esterase 1
Increased activity in organic solvents Subtilisin E 2
Altered substrate specificity p-Galactosidase3
Increased enantioselectivity Lipases4
Increased catalytic activity Cytochrome P4 5 0 5
Table 1.1 Examples of enzyme properties improved by directed evolution
Adapted from Aflholter & Arnold, 1999. 1Giver et al., 1998; 2You & Arnold, 1996; 3Zhang et 




The technique of DNA shuffling was first introduced by Stemmer in 1994 (Stemmer, 
1994a). Rather than a method of introducing random point mutations into a gene, it is a 
method for homologous recombination of genes by random fragmentation and PCR- 
mediated reassembly. Like random mutagenesis by error-prone PCR, DNA shuffling is 
based on the evolutionary principle of mutation and natural selection (screening being 
the laboratory equivalent of natural selection). DNA shuffling requires homologous 
sequences that are separated by regions of variability. By shuffling together closely 
related genes it should be possible to combine the phenotypes of the similar enzymes in 
order to produce mutants displaying properties from all ‘parent’ sequences. An 
advantage of the DNA shuffling approach is that by backcrossing mutants with excess 
wild-type DNA it is possible to remove neutral mutations that do not cause functional 
changes (Stemmer, 1994b).
In recent years DNA shuffling has been used in conjunction with directed evolution by 
error-prone PCR in order to increase its power as a protein engineering tool. It is, 
however, a useful technique in its own right and there are examples where it has been 
successfully used to alter or improve enzyme function. One such example is the work of 
Zhang et al. (1997), where E. coli p-galactosidase has been evolved into an efficient p- 
fucosidase through seven rounds of shuffling and screening. The final mutant 
demonstrated 1 0 0 0 -fold increase in specificity for o-nitrophenyl fucopyranoside over its 
previously preferred substrate o-nitrophenyl galactopyranoside.
When coupling the two directed evolution techniques together, DNA shuffling is 
typically used after error-prone PCR and screening in order to recombine improved 
mutants identified from the random mutagenesis stage. By combining the adaptive 
mutations introduced by random mutagenesis, the DNA shuffling step allows additional 
enhancements to be made to the property of interest, and provides a more improved 
mutant with which to begin the whole process of directed evolution and screening again.
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An example of the power of combining both error-prone PCR and recombination is the 
work of Zhao and Arnold (1999). They have used directed evolution to effectively 
convert subtilisin E from Bacillus subtilis into its thermophilic homologue thermitase, 
from Thermoactinomyces vulgaris. The mutant enzyme was over 200 times more stable 
at 65°C than the wild-type enzyme, and it displayed an increase of 17°C in its 
temperature optimum. While subtilisin E and thermitase differ at 157 amino acid 
positions (subtilisin E is 381 amino acids and thermitase is 279 amino acids), it only 
took eight amino acid substitutions introduced by directed evolution and recombination 
to turn one enzyme into a functional equivalent of the other. Of the eight substitutions, 
which are all situated on the surface of the enzyme, only two are found in thermitase. 
The remaining substitutions include some known stabilising mutations in addition to 
mutations not previously reported as being thermostabilising. Most of the substitutions 
are located in loops connecting regions of secondary structure and are thought to 
increase thermostability by reducing the entropy of these flexible loops. One substitution 
is thought to increase thermostability by the improvement of a hydrogen bond. The 
mechanisms of thermostabilisation of four of the eight mutations are still under 
investigation.
Giver et al. (1998) have also successfully used a combination of error-prone PCR and 
recombination by DNA shuffling to improve the thermostability of /?-nitrobenzyl 
esterase from Bacillus subtilis. Over six generations of random mutagenesis, 
recombination and screening they have increased the melting temperature of the esterase 
by more than 14°C to 66.5°C. Of importance in this example is the fact that the 
thermostability of the enzyme has been improved without compromising its catalytic 
activity at lower temperatures. It has often been thought that thermostability comes at a 
cost of decreased activity at lower temperatures (Shoichet et a l, 1995).This study by 
Giver et al. (1998) has shown that by designing the screen to select for both properties it 
is possible to improve thermal stability whilst retaining low temperature activity. These 
results are encouraging when the aims of this project are considered.
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1.5.3 Successful examples of protein engineering in xylanases
Considering that the aims of this project are to increase the thermostability of xylanase 
A from Neocallimastix patriciarum, it is encouraging to find examples in the literature 
where various protein engineering techniques have been successfully applied to improve 
characteristics of other xylanases.
Attempts to engineer xylanases by rational design have succeeded in increasing both 
catalytic activity and thermostability. By targeting conserved residues within the enzyme 
Moreau et al (1994) increased both the catalytic activity and thermostability of xylanase 
A from Streptomyces lividans. Georis et al. (2000) have modelled the structures of the 
thermostable xylanase A from Thermomonospora fusca and the mesophilic xylanase 1 
from Streptomyces sp. S3 8 , and then introduced some of the features identified as 
contributing to the higher thermostability of xylanase A into xylanase 1. They have 
shown that the introduction of an additional aromatic interaction can increase both the 
thermostability and thermophilicity of xylanase 1 (i.e. they have increased both the 
enzyme’s stability and activity at higher temperatures). Another successful site-directed 
mutagenesis study has stabilised a xylanase from Bacillus circulans by the introduction 
of both intra- and inter-molecular disulphide bonds (Wakarchuk et al., 1994).
There are also successful examples of the use of random mutagenesis to improve 
thermal stability, catalytic activity and alkalophilicity of xylanases. Arase et al. (1993) 
used chemically induced random mutagenesis to improve the thermostability of xylanase 
A from Bacillus pumilus. DNA shuffling was used by Shibuya et al. (2000) to improve 
both the thermostability and hydrolytic activity of xylanase B from Streptomyces 
lividans. Here the stability of xylanase B has been improved by shuffling together its 
gene with the gene encoding xylanse A from Thermomonospora fusca, a naturally 
thermostable enzyme with a temperature optimum of 75°C. The best mutant produced in 
this study demonstrated a temperature optimum the same as T. fusca xylanase A, and 
additionally produced 40% more reducing sugar at this temperature than xylanase A. A 
recent study by Chen et al. (2001) has used directed evolution by error-prone PCR to 
improve the activity of a catalytic domain from a Neocallimastix patriciarum xylanase
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in alkaline conditions. They identified eight amino acid substitutions in six mutants that 
lead to an increased activity at pH 8.5 (where the wild-type enzyme does not 
demonstrate any activity), and introduced seven of these mutations into the enzyme by 
site-directed mutagenesis. The resulting enzyme was more thermostable at 60°C and 
more alkaline tolerant at pH 10 than the wild-type xylanase.
1.5.4 Alternatives to protein engineering
An alternative approach to protein engineering in order to obtain industrially relevant 
enzymes is to look to nature and screen for the required catalytic activity. It is estimated 
that less than 1 % of microorganisms from extremophilic environments can be cultured at 
present (Hugenholtz & Pace, 1996). The remaining 99% represents a largely unexploited 
resource, and efforts to selectively culture these currently ‘unculturable’ organisms 
based on required catalytic activity will surely lead to the discovery of many more 
industrially useful catalysts (Danson & Hough, 1998). Ito et a l (1998) have adopted 
this approach to isolate enzymes for use in laundry and dishwasher detergents. Detergent 
enzymes need to function under alkaline conditions, and Iko et al. have isolated a 
number of alkaliphilic Bacillus strains that secrete useful detergent enzymes such as 
cellulases, proteases and a-amylases.
1.6 OBJECTIVES
The objectives of this project are essentially two-fold. The first is to increase the thermal 
stability of the second catalytic domain of xylanase A (xylA.cd2) from Neocallimastix 
patriciarum; the second is to retain its high levels of activity at lower temperatures. Two 
individual methods will be utilised in attempts to fulfil these objectives. The first method 
will be to design and introduce site-specific mutations that are predicted to increase the 
thermal stability of xylA.cd2. This will be achieved by comparing a structural model of 
the protein to the published crystal structures of thermostable family 11 xylanases. The 
second method will be to apply directed evolution techniques to the xylanase A second 
catalytic domain, in order to produce a library of random xylA.cd2 mutants. Using a 
suitable screening system the library will be screened in order to identify those mutants
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that retain activity at lower temperatures but also demonstrate an increased stability at 
elevated temperatures.
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Chapter 2 
MATERIALS AND METHODS
2.1 MOLECULAR BIOLOGY MATERIALS AND METHODS
2.1.1 Materials
SeaKem® LE agarose was purchased from FMC Bioproducts, Rockland, ME, USA and 
lkb DNA molecular weight marker was purchased from GibcoBRL Life Technologies, 
Paisley, UK. E. coli JM109 competent cells were obtained from Promega, Madison, WI, 
USA. IPTG and X-Gal were purchased from Calbiochem-Novabiochem Corporation, La 
Jolla, CA, USA. PCR Primers were synthesised by MWG-Biotech GmbH, Ebersberg, 
Germany. pUC18 plasmid vector, BamHI digested pUC18, M l3 sequencing and reverse 
primers and deoxynucleoside triphosphates (dNTP’s) were all purchased from 
Amersham Pharmacia Biotech, Uppsala, Sweden. QIAprep Spin Miniprep Kit, 
QIAquick PCR Purification Kit and QIAEX II Gel Extraction KIT were all obtained 
from Qiagen Ltd, Hilden, Germany. Rapid DNA ligation kit was purchased from 
Boehringer-Mannheim, Mannheim, Germany. Vent DNA polymerase, restriction 
endonucleases and reaction buffers were supplied by New England Biolabs, Hitchin, 
Hertfordshire, UK. All other reagents used in the molecular biology methods were 
supplied by Sigma, Poole, Dorset, UK.
2.1.2 Agarose gel electrophoresis
DNA was analysed by agarose gel electrophoresis. 1% (w/v) agarose gels (agarose 
dissolved in TAE buffer (40mM Tris-acetate, ImM EDTA, pH 8.3) by heating) 
containing 0.5pg/ml ethidium bromide were placed in an electrophoresis tank and 
covered with TAE buffer. DNA samples were loaded with the appropriate volume of 6 x 
loading buffer (40% (w/v) sucrose, 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene 
cyanol) and electrophoresed at a constant voltage of 80 V until the xylene cyanol dye 
front was 1cm from the end of the gel. DNA, visible by the presence of ethidium 
bromide, was visualised under UV transillumination and estimation of the size of DNA
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fragments was by comparison to the lkb DNA molecular weight marker run 
simultaneously on the gel.
2.1.3 Polymerase chain reaction
Amplification of the xylanase A second catalytic domain from the full-length gene was 
carried out by PCR using primers designed to the flanking region of the catalytic 
domain. Full details of all primers can be found in the Appendix. For expression of 
xylA.cd2 from the plasmid vector pUC18 both forward and reverse primers were 
designed with a BamHl restriction site to aid cloning of the PCR product into pUC18 
commercially digested with BamHl. The reverse primer was also required to 
incorporate a stop codon. A total of 20pmol of each primer was used in a reaction. Vent 
DNA polymerase was used in a total reaction volume of lOOpl. Final concentrations in 
the reaction mixture were as follows: 0.2mM of each deoxynucleoside triphosphate 
(dATP, dCTP, dGTP, dTTP), 2mM MgC^ and 1U Vent DNA polymerase. 
Approximately lpg of template DNA was added and the reaction was incubated in 
buffer supplied by the manufacturer. The final reaction mixture was overlaid with 20pl 
mineral oil to prevent evaporation. A ‘hot-start’ PCR technique was used, where the 
reaction mixture is heated to 96°C for 5 minutes prior to the addition of the polymerase. 
The following conditions were then repeated for 30 cycles before a final 10 minutes 
extension at 72°C:
96°C denaturation step 1 min 15 s
55°C annealing step 1 min 30 s
72°C extension step 2 min
A Cetus DNA thermal cycler (Perkin-Elmer, Norwalk, CT, USA) was used to perform 
the reactions. 1 0 pi of each PCR reaction was run on a 1% agarose gel, as previously 
described in section 2.1.2, to visualise the product. Products were purified as described 
in section 2.1.4.2.
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2.1.4 Purification of PCR products
2.1.4.1 Gel purification
PCR products were purified by running on an agarose gel and using the QIAEX II Gel 
Extraction Kit according to the manufacturer’s instructions. Products were resuspended 
in a final volume of 30jul distilled water.
2.1.4.2 Column purification
PCR products were purified using the QIAquick PCR Purification Kit according to the 
manufacturer’s instructions and were resuspended in a final volume of 50pl elution 
buffer (lOmM Tris-Cl, pH8.5, supplied with kit).
2.1.5 Restriction digestion of DNA
Plasmid DNA and PCR products were digested by restriction endonucleases in a 
reaction volume of 20pl. Commonly approximately 2pg of plasmid DNA, prepared as 
described in section 2.1.8, or lOOng of PCR product were incubated with 10 or 20 units 
of enzyme (according to the manufacturer’s instructions) in the buffer supplied. The 
reaction was allowed to proceed for 3 hours at 37°C. BSA (lOOpg/ml) was included in 
some reactions according to the manufacturer’s instructions. Where the products of a 
digestion were to be used for cloning, the reaction was further incubated at 65°C for 20 
minutes to inactivate the remaining enzyme.
2.1.6 Ligation
PCR products were ligated into the appropriately digested plasmid vector using the 
Rapid DNA Ligation kit in a total volume of 20 j l x 1. An insert to vector ratio of 3 to 1 was 
commonly used. Reactions were carried out according to the manufacturer’s 
instructions.
2.1.7 Transformation of DNA into E. coli - heat shock method
Ligated DNA was transformed into E. coli strain JM109 as follows: 3pi of ligation 
reaction was added to 40pl of competent E. coli cells on ice and the mixture was mixed
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gently before incubating on ice for 20 minutes. The cells were then heat shocked at 42°C 
for 1 minute before being returned to ice for a further 2 minutes. 1ml of LB broth (lOg/L 
bacto-tryptone, lOg/L sodium chloride, 5g/L yeast extract) was added to the cells and 
this mixture was incubated at 37°C for 1 hour with shaking. Cells were then spread onto 
LB agar plates (LB broth with 15g/L agar) supplemented with 100 jug/ml ampicillin, to 
select for cells that have been transformed with the ligated plasmid DNA, and incubated 
overnight at 37°C.
2.1.8 Preparation of plasmid DNA
E. coli strain JM109 transformed with the plasmid of interest was cultured overnight at 
37°C in 5ml of LB broth supplemented with 100pg/ml ampicillin. Plasmid DNA was 
prepared using the QIAprep Spin Miniprep Kit according to the manufacturer’s 
instructions and eluted in 50jul elution buffer (lOmM Tris-Cl, pH8.5, supplied with kit).
2.1.9 DNA sequencing
DNA sequencing was performed on an ABI Prism™ 377 automated sequencer (PE 
Applied Biosystems, Fostercity, CA, USA) using the Big Dye™ Terminator Cycle 
Sequencing Ready Reaction Kit (PE Applied Biosystems). Sequences were analysed 
using the Wisconsin Package, version 8.0 (Genetics Computer Group, Madison, WI, 
USA).
2.2 PROTEIN MATERIALS AND METHODS
2.2.1 Materials
Acrylamide/bis-acrylamide mixture (Ultrapure protogel™) was purchased from National 
Diagnostics, Atlanta, GA, USA. APS, SDS broad range markers and Bio-Rad Protein 
Assay reagent were obtained from Bio-Rad, Hercules, CA, USA. Bovine serum albumin 
standard (2mg/ml) was supplied by Pierce, Rockford, IL, USA. HiTrapQ High 
Performance 5ml anion exchange columns were supplied by Amersham Pharmacia 
Biotech, Uppsala, Sweden. TEMED (N, N, N’, N’-tetramethylethylenediamine) and 
RBB-xylan (4-O-methyl-D-glucurono-D-xylan-remazol brilliant blue R) were purchased 
from Sigma, St. Louis, MO, USA. Amicon YM-30 Centriplus® centrifugal filter devices
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and 0.22jiim syringe driven filter units were purchased from Millipore, Bedford, MA, 
USA. All other chemicals and reagents were supplied by either Fisons, Loughborough, 
Leicestershire, UK or Sigma, Poole, Dorset, UK.
2.2.2 Bradford protein estimation assay
Protein concentration was determined using the Bio-Rad Protein Assay, which is 
essentially as described by Bradford (1974). In brief, samples of unknown protein 
concentration were diluted accordingly in 0.9% NaCl solution and incubated with 900pl 
Bio-Rad Protein Assay reagent for 15 minutes at room temperature. The absorbance of 
the samples was measured at 595nm and protein concentration was determined by 
comparison to a standard curve generated using samples containing known 
concentrations of bovine serum albumin.
2.2.3 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed according to the method of Laemmli (1970) using an Atto 
Corporation Mini-Atto System. A 12.5% running gel solution (5ml Ultrapure protogel™ 
(30% (v/v) acrylamide/0.8 % (v/v) bis-acrylamide), 3ml running gel buffer (1.5M Tris, 
0.4% (w/v) SDS, pH 8.9), 4ml (IH2O) was polymerised by the addition of 50 pi of 10 % 
APS and 12.5pl TEMED. A stacking gel (0.9ml Ultrapure protogel™, 2.4ml stacking 
gel buffer (0.48M Tris, 0.4% (w/v) SDS, pH 6 .8 ), 3.6ml dH20, 50pl 10% (w/v) APS, 
1  O j l i I  TEMED) was poured on top of the polymerised running gel, and wells were 
formed for loading the samples. The gel was placed in an electrophoresis tank and 
submerged in tank buffer (0.052M Tris, 0.1% (w/v) SDS, 0.4% (w/v) glycine). Protein 
samples were loaded on to the gel in an equal volume of 2x loading buffer (0.125M Tris, 
4% (w/v) SDS, 20% (w/v) sucrose, 0.08% (w/v) bromophenol blue, 10 (v/v) p- 
mercaptoethanol) and were electrophoresed at 10mA through the stacking gel and 20mA 
through the running gel. After electrophoresis the gel was stained for 20 minutes with 
Coomassie staining solution (0.25% (w/v) Coomassie blue R, 45.4% (v/v) methanol, 
9.2% (v/v) acetic acid) and destained overnight with destain solution (5% (v/v) 
methanol, 7.5% (v/v) acetic acid). The molecular weight of proteins visible as bands 
after the gel had been stained was determined by comparison to standards of known
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molecular weight that were run simultaneously on the gel. (broad range markers were 
commonly used: rabbit muscle myosin (200kDa), E. coli (3-galactosidase (116.25kDa), 
rabbit muscle phosphorylase B (97.4kDa), bovine serum albumin (66.2 kDa), hen egg 
white ovalbumin (45kDa), bovine carbonic anhydrase (31 kDa), soybean trypsin inhibitor 
(21.5kDa), hen egg white lysozyme (14.4kDa), bovine pancreas aprotinin (6.5kDa)).
2.2.4 Zymogram analysis
Xylanase-active protein bands were identified using a novel Zymogram technique. The 
method is essentially as described for performing SDS-PAGE, with the inclusion of 
RBB-xylan in the running gel. RBB-Xylan was dissolved in the water component of the 
running gel at 0.1%, and the gel was then prepared as described in section 2.2.3. 4pg of 
purified protein, or lOpg of cell extract proteins, were loaded onto the gel and run as 
previously described. After electrophoresis the gel was incubated overnight in 25% (v/v) 
isopropanol with gentle shaking to renature the proteins. The gel was then washed four 
times for 30 minutes at 4°C with 0.1M sodium acetate buffer (pH 5.5). It was then 
incubated at 37°C in pre-warmed PC buffer (phosphate-citrate buffer, pH 6.5) with 
lOOjug/jLxl BSA until clearing zones became visible. The proteins were then stained with 
Coomassie staining solution and destained as described above.
2.2.5 Purification of XylA.cd2
XylA.cd2 was purified from E. coli JM109 harbouring the pUC18.cd2 plasmid vector. 
JM109 cells were grown in 5ml LB broth supplemented with lOOpg/ml ampicillin 
overnight at 37°C. This culture was then used to inoculate 250ml LB-ampicillin broth 
(2.5ml of overnight culture into 250ml LB-ampicillin broth), which was incubated at 
37°C for 16 hours. The cell extract was then prepared as outlined below.
2.2.5.1 Preparation o f cell extract
Cell extract was prepared by harvesting the cells by centrifugation at 1250g for 10 
minutes at 4°C, and resuspending the cell pellet in 1/25 of the original culture volume of 
20mM Tris-HCl, pH 8.0. Cells were disrupted by sonication with 4 x 30 second bursts,
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at 8-10 microns, peak to peak (3mm probe, 150 watt Ultrasonic Disintegrator, MSE 
Scientific Instruments, Crawley, Sussex, UK) with cooling on ice between ultrasonic 
bursts. Disrupted cells were centrifuged for 20 minutes at 8000g at 4°C to give the 
supernatant as the cell extract and the pellet as the cell debris. The debris was 
resuspended in 1/50 the original culture volume of 20mM Tris-HCl, pH 8.0. Both cell 
extract and debris were stored at 4°C until further use.
2.2.5.2 Anion exchange chromatography
Separation of XylA.cd2 from the cell extract proteins was achieved using reverse anion 
exchange chromatography. A HiTrap Q High Performance 5ml anion exchange column 
was equilibrated with 20mM Tris-HCl, pH 8.0, and cell extract was applied to the 
column using an FPLC System (Amersham Pharmacia Biotech, Uppsala, Sweden). 
XylA.cd2 protein was washed through the column with equilibration buffer and 
collected in the unbound fraction. The bound protein was collected by washing the 
column with elution buffer (equilibration buffer containing 1M NaCl).
2.2.5.3 Concentration ofpurified protein
Purified protein was concentrated in an Amicon YM30 Centriplus® centrifugal filter 
device, (molecular weight cut-off 30kDa) by centrifuging at 3000g in a swing-out bucket 
rotor at 4°C until reduced to a suitable volume.
2.3 ASSAY MATERIALS AND METHODS
2.3.1 Materials
Tris was supplied by BDH, Poole, Dorset, UK. Oat spelt xylan was purchased from 
Fluka Chemie AG, Buchs, Switzerland. Congo Red, 3,5-dinitrosalicylic acid, phenol and 
D(+)xylose, were purchased from Sigma, Poole, Dorset, UK. All other chemicals and 
reagents were supplied by either Fisons, Loughborough, Leicestershire, UK or Sigma, 
Poole, Dorset, UK.
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2.3.2 Dinitrosalicylic acid (DNS) assay
Xylanase activity was determined using a modification of the DNS assay, originally 
described by Miller (1959). lOOjul of enzyme sample (diluted if necessary in PC buffer 
with lmg/ml BSA) was incubated with 400jnl of 0.2% soluble xylan (in 50mM Tris, 
pH8.0) (see section 2.3.2.1 for production of soluble xylan) at 37°C for 15 minutes. The 
reaction was terminated by the addition of 500pl DNS reagent (1% (w/v) DNS, 0.2% 
phenol (v/v), 1% (w/v) sodium hydroxide, 0.002% (w/v) glucose and 0.05% (w/v) 
sodium sulphite). The samples were heated to 100°C for 20 minutes before being placed 
on ice for 10 minutes and centrifuged at 12,000g for 5 minutes. The absorbance of the 
samples was measured at 575nm against a blank sample (IOOjliI of PC buffer used in 
place of the 100pi sample). The amount of xylanase activity in the samples was 
determined by comparison to a standard curve, generated using standard solutions of 
D(+)xylose in PC buffer with lmg/ml BSA. The standard xylose solutions were in a 
total volume of 500pl, and after addition of 500pl of DNS reagent were treated as 
described above. The calculated amount of xylanase activity was expressed as pmoles of 
xylose equivalents produced per minute per mg enzyme.
2.3.2.1 Preparation o f soluble xylan
Soluble xylan used in the DNS assay was prepared as follows: 20g of oat spelt xylan 
were resuspended in 200ml distilled water and the pH was adjusted with 1M NaOH to 
pH 10.0. After stirring at room temperature for 1 hour the pH was adjusted with 1M 
acetic acid to pH 7.0. After centrifugation at 20,000g for 10 minutes the supernatant was 
removed and freeze-dried until no liquid remained. The dried soluble xylan fraction was 
resuspended as a 0.2% solution in 50mM Tris, pH 8.0 when required for the xylanase 
assay.
2.3.3 Congo Red overlay assay
Xylanase activity was determined for the XylA.cd2 in E. coli JM109 by the Congo Red 
overlay assay, essentially as described by Teather & Wood (1982): JM109 cells 
harbouring the pUC18.cd2 plasmid vector were grown overnight on LB-ampicillin agar
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plates then overlayed with 7ml xylan agar (0.25% (w/v) oat spelt xylan, 1.5% (w/v) agar 
in PC buffer, pH6.5). After incubation for 2 hours at 37°C the top agar was stained with 
1% Congo Red solution for 10 minutes, then destained by washing three times with 
10ml 1M NaCl, each wash being for 15 minutes. Cells that were xylanase active had a 
visible clearing zone, or orange ‘halo’, around them.
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Chapter 3 
CLONING, EXPRESSION, PURIFICATION AND 
CHARACTERISATION OF RECOMBINANT N. PA TRICIARUM 
XYLANASE A SECOND CATALYTIC DOMAIN
3.1 INTRODUCTION
It is known from previous studies (Gilbert et al, 1992) that E. coli harbouring a clone 
coding for only the second xylanase A catalytic domain from N. patriciarum expresses 
15 times more protein than E. coli expressing the full-length enzyme. These previous 
studies are the basis for the initial aims of this project, which are to clone, express, 
purify and characterise the isolated second catalytic domain from xylanase A.
This chapter will describe the cloning of the second catalytic domain of Neocallimastix 
patriciarum xylanase A from the full-length gene into the plasmid vector pUC18, the 
expression of this xylA.cd2 clone in E. coli strain JM109 and the purification to near 
homogeneity of the recombinant protein by anion exchange chromatography. It will then 
go on to describe characterisation of the recombinant xylA.cd2 with respect to its 
specific activity, temperature optimum for enzymic activity and thermal stability.
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3.2 MATERIALS AND METHODS
All methods used in this chapter not outlined below can be found in chapter 2.
3.2.1 Materials
Neocallimastix patriciarum xylanase A full-length gene was kindly supplied as a 
pBluescript clone by Dr Geoff Hazlewood. All other materials used in this section are as 
outlined in chapter 2, sections 2.1.1,2.2.1 and 2.3.1.
3.2.2 PCR amplification of the xylA.cd2 fragment and ligation into pUC18
As described in section 2.1.3, the second catalytic domain was amplified from the full- 
length gene by PCR using primers 1 and 2, designed to the flanking regions either side 
of the catalytic domain. Full details of all primers can be found in the Appendix. Both 
forward and reverse primers contained a BamHl restriction site, and the purified PCR 
product was digested with BamHl, as described in section 2.1.5, before being ligated 
into BamHl commercially digested pUC18 plasmid vector using the Rapid DNA 
Ligation Kit (section 2.1.6). This construct is known as pUC18.cd2.
3.2.3 Expression of recombinant xylA.cd2 in E. coli
pUC18.cd2 was transformed into E. coli strain JM109 using the heat shock method 
(section 2.1.7). The Congo Red overlay assay was employed to identify which clones 
had the xylA.cd2 insert ligated in the correct orientation in the pUC18 plasmid. Once 
this was determined, and the xylA.cd2 insert had been sequenced to ensure that no errors 
had been introduced during the PCR reaction, the xylA.cd2 protein was expressed from 
a 250ml culture of LB supplemented with 100pg/ml ampicillin as described in section 
2.2.5.
3.2.4 Purification of recombinant xylA.cd2 from E. coli
E. coli cells harbouring the pUC18.cd2 plasmid were harvested after approximately 16 
hours of growth. The cells were disrupted by sonication and a cell extract was prepared 
as described in section 2.2.5.1. The cell extract was applied to a HiTrap Q High
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Performance 5ml anion exchange column equilibrated with 20mM Tris-HCl, pH8.0, and 
the xylA.cd2 protein was collected in the unbound fraction.
3.2.5 Determination of specific activity
The DNS assay was performed as outlined in section 2.3.2 to determine the specific 
activity of the purified xylA.cd2 protein. In order to determine a suitable dilution of the 
enzyme to ensure that the initial rate of reaction was being measured, standard assays 
were performed using varying dilutions of xylA.cd2 from 1/250 to 1/10,000. Protein 
concentration was determined as described in section 2.2.2.
3.2.6 Determination of temperature optimum for activity
The temperature optimum for activity of the purified xylA.cd2 protein was determined 
using the DNS assay essentially as described in section 2.3.2, the only difference in 
method being that the enzyme sample and substrate were incubated together for 15 
minutes at various temperatures, rather than just at 37°C. A 1/5000 dilution of the 
enzyme was used in these reactions, and the temperatures studied were 18, 30, 40, 45, 
50, 55, 58, 60, 62, 65, 70 and 80°C.
3.2.7 Thermal inactivation of xylA.cd2
The stability of purified xylA.cd2 protein at elevated temperatures was determined by 
thermal inactivation studies. The appropriate amount of PC buffer with lmg/ml BSA 
was pre-heated to 58, 60, 62 or 64°C and using an initial 1/50 dilution of xylA.cd2, 
which was stored on ice, an appropriate volume was added to the heated buffer to give a 
final dilution of 1/5000. At various times 100pl aliquots were taken out of the heated 
enzyme solution and quickly placed into a pre-chilled tube in an ice/water bath. To 
determine the activity of the enzyme prior to heating, a separate 1/5000 dilution was 
made using the initial 1/50 dilution, and this was stored on ice until all the other samples 
had been collected. Xylanase activity was then determined in all the samples using the 
DNS assay, as described in section 2.3.2.
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3.3 RESULTS
3.3.1 Construction of the pUC18.cd2 clone
Primers were designed to the flanking regions of the second catalytic domain, both of 
which contained the necessary coding sequence to ensure the introduction of a BamHl 
restriction site. In addition the reverse primer was also designed to incorporate a stop 
codon. The sequence of primers 1 and 2 can be found in the Appendix. Figure 3.1 shows 
the full xylanase A gene sequence.
1 TTTTATTATA TCAATCTCTA ATTTATTTTT TTAGGAAAAA AATAAAAAAA
51 TAAATATAAT AAATATTAGA GAGTAATATT TAAAAACAAA GAAATTTAAA
101 AACGTTTATT TAGTTATTTT TTTTACTGGT TAAAAAAAAA ATAAAAAACA
15 1 AAATTAATAA AGATATTTTT GAAAAATATT GAATTAGAAA AAAAATGAGA
2 0 1 ACTATTAAAT TCTTTTTCGC AGTAGCTATT GCAACTGTTG CTAAGGCCCA
2 5 1 ATGGGGTGGA GGTGGTGCCT CTGCTGGTCA AAGATTAACC GTCGGTAATG
3 0 1 GTCAAACCCA ACATAAGGGT GTAGCTGATG GTTACAGTTA TGAAATCTGG
3 5 1 TTAGATAACA CCGGTGGTAG TGGTTCTATG ACTCTCGGTA GTGGTGCAAC
4 0 1 CTTCAAGGCT GAATGGAATG CATCTGTTAA CCGTGGTAAC TTCCTTGCCC
4 5 1 GTCGTGGTCT TGACTTCGGT TCTCAAAAGA AGGCAACCGA TTACAGCTAC
50 1 ATTGGATTGG ATTATACTGC AACTTACAGA CAAACTGGTA GCGCAAGTGG
5 5 1 TAACTCCCGT CTCTGTGTAT ACGGTTGGTT CCAAAACCGT GGAGTTCAAG
601 GTGTTCCATT GGTAGAATAC TACATCATTG AAGATTGGGT TGACTGGGTC
651 TCAGATGCAC AAGGTAGAAT GGTAACCATT GATGGAGCTC AATATAAGAT
7 0 1 TTTCCAAATG GATCACACTG GTCCAACTAT CAATGGTGGT AGTGAAACCT
7 5 1 TTAAGCAATA CTTCAGTGTC CGTCAACAAA AGAGAACTTC TGGTCATATT
80 1 ACTGTCTCAG ATCACTTTAA GGAATGGGCC AAACAAGGTT GGGGTATTGG
85 1 TAACCTTTAT GAAGTTGCTT TGAACGCCGA AGGTTGGCAA AGTAGTGGTA
90 1 TAGCTGATGT CACCAAGTTA GATGTTTACA CAACCCAAAA AGGTTCTAAT
95 1 CCTGCCCCTA CCTCCACTGG TACTGTTCCA AGCAGTTCTG CTGGTGGAAG
1 0 0 1 TACTGcbAAT GGTAAAAAGT T T A C T G T C G G T A A T G G A C A A A A C C A A C A T A
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1 0 5 1 A G G G T G T C A A C G A T G G T T T C A G T T A T G A A A T C T G G T T A G A T A A C A C T G G T
1 1 0 1 G G T A A C G G T T C T A T G A C T C T C G G T A G T G G T G C A A C T T T C A A G G C T G A A T G
1 1 5 1 G A A T G C A G C T G T T A A C C G T G G T A A C T T C C T T G C C C G T C G T G G T C T T G A C T
1 2 0 1 T C G G T T C T C A A A A G A A G G C A A C C G A T T A C G A C T A C A T T G G A T T A G A T T A T
1 2 5 1 G C T G C T A C T T A C A A A C A A A C T G C C A G T G C A  A G T G G T A A C T C C C G T C T C T G
1 3 0 1 T G T A T A C G G A T G G T T C C A A A A C C G T G G A C T T A A T G G C G T T C C T T T A G T A G
1 3 5 1 A A T A C T A C A T C A T T G A A G A T T G G G T T G A C T G G G T T C C A G A T G C A C A A G G A
1 4 0 1 A A A A T G G T A A C C A T T G A T G G A G C T C A A T A T a a g a t t t t c c A A A T G G A T C A
1 4 5 1 C A C T G G T C C A A C T A T C A A T G G T G G T A G T G A  A A C C T T T A A G C A A T A C T T C A
1 5 0 1 G T G T C C G T C A A C A A A A G A G A A C T T C T G G T C A T A T T A C T G T C T C A G A T C A C
1 5 5 1 T T T A A G G A A T G G G C C A A A C A A G G T T G G G G T A T T G G T A A C C T T T A T G A A G T
1 6 0 1 G G C T T T G A A C G C C G A A G G T T G G C A A A G T A G T G G T G T T G C T G A T G T C A C C T
1 6 5 1 T A T  T A G A T G T T T A C A C A A C T
< - - - - - - - - - - - - - - - -
C C A A A G G G T T C T A G T C C A G C CACCTCTGCC
1 7 0 1 g c t c c t c g t K CTACTACCCG TACTACTACT CGTACCAAGT CTCTTCCAAC
1 7 5 1 CAATTACAAT AAGTGTTCTG CTAGAATTAC TGCTCAAGGT TACAAGTGTT
1 8 0 1 GTAGCGATCC AAATTGTGTT GTTTACTACA CTGATGAGGA TGGTACCTGG
1 8 5 1 GGTGTTGAAA ACAACGACTG GTGTGGTTGT GGTGTTGAAC AATGTTCTTC
1 9 0 1 CAAGATCACT TCTCAAGGTT ACAAGTGTTG TAGCGATCCA AATTGCGTTG
1 9 5 1 TTTTCTACAC TGATGACGAT GGTAAATGGG GTGTTGAAAA CAACGACTGG
2 0 0 1 TGTGGTTGTG g t t t c t a a g c AGTAAAATAC TAATTAATAA AAAATTAAAG
2 0 5 1 AATTATGAAA AATTTAAATT TAAAAATTTA AAAGAATTAT GAAAAATTTA
2 1 0 1 AATTTAAAAA TTTAAAAAAA ACTAATTTAG TAAAAAATTA AAGAATTATT
2 1 5 1 GAAAATTTTA AATGTAAAAA TTTAAAAAAT ACAAATTTGT AAAAAAAAAT
2 2 0 1 GAAAGAATTA TGAAAAATTA AAATGTAAAA GTTTAAAAAA TACAAATTTG
2 2 5 1 TAAGAAAAAT AAAGAATTAT AAAAAAAATA AAGAATTATG AAAAACCCAA
2 3 0 1 ATGTAAAGAA AAAAAAAAAA AAAAAAAAAA AAAAAAAA
Figure 3.1 N. patriciarum xylanase A gene sequence
I— ► Indicates start o f xylanase A coding region. * over bold text indicates stop codon. 
Second catalytic domain coding region is highlighted in bold text. Large arrows indicate position 
of primers used to amplify second catalytic domain.
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3.3.1.1 PCR amplification o f xylanase A second catalytic domain 
A PCR fragment of the expected size, 703bp, was produced (Figure 3.2) (675bp
xylA.cd2 coding region, plus primer extensions of lObp (5s) and 18bp (3’)). After
digestion with BamHl, the PCR fragment was ligated into pre-digested pUC18 plasmid
vector and the resulting clones were transformed into E. coli strain JM109 cells.
Successful transformants were selected for by growth on LB-agar plates containing
100]ug/ml ampicillin, and successful ligation of the xylA.cd2 insert into each plasmid
was confirmed by restriction digest of plasmid prepared from single colonies. Digestion
with BamHl gives two bands when run on an agarose gel: one corresponding to the
insert and the other corresponding to the plasmid (Figure 3.3)
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Figure 3.2 Identification of xyIA.cd2 PCR product by agarose gel electrophoresis
Lane 1, lkb DNA molecular weight markers; lane 2, 703bp PCR product.
Figure 3.3 BamHl digested pUC18.cd2, to confirm the cloning of xylA.cd2 insert into 
pUC18 plasmid
Lane 1, lkb DNA molecular weight markers; lane 2, undigested pUC18.cd2 (supercoiled & 
relaxed circle); lane 3, BamHl digested pUC18.cd2 (~700bp insert band & 2.7kb plasmid band).
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3.3.1.2 Identification o f clones with correctly oriented xylA.cd2 insert
To determine that the PCR fragment had ligated into the pUC18 vector in the correct
orientation, E. coli cells containing the plasmid clones were subjected to the Congo Red
overlay assay. Those cells that contained the plasmid with insert ligated in the correct
orientation showed a clearing zone around them, while the ones containing the plasmid
with insert ligated in the reverse orientation showed no visible clearing zones, indicating
no xylanase activity (Figure 3.4).
Figure 3.4 Congo Red assay confirming xylanase activity of pUC18.cd2 clones
These clones are all displaying xylanase activity (note the yellow halos around the individual 
streaks).
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3.3.1.3 Sequencing o f the PCR insert
Sequencing of the PCR insert was performed using the Ml 3 universal sequencing and 
reverse primers. One sequencing reaction from each direction allowed the full insert 
sequence to be obtained. Comparison of this sequence to the published full-length gene 
sequence confirmed that no errors had been introduced during the PCR reaction. The 
xylA.cd2 sequence can be seen in Figure 3.5. As the xylA.cd2 insert is cloned into 
pUC18 in frame with the lacZ promoter there are a few upstream amino acid residues 
preceding the sequence shown in Figure 3.5. These a r e M I T N S S S V P G D P .
3.3.2 XylA.cd2 purification
Recombinant xylA.cd2 was expressed in E. coli strain JM109 cells from a pUC18.cd2 
clone. A summary of the purification results can be seen in Table 3.1.
Approximately 2.3g (wet weight) of cells were harvested from a 250ml culture of 
JM109 cells harbouring the pUC18.cd2 plasmid after 16 hours of growth. After 
resuspension and lysis by sonication the cell extract contained approximately 35.4mg of 
protein, and demonstrated a specific xylanase activity of 20 lOU/mg.
The cell extract was applied to a HiTrap Q High Performance 5ml anion exchange 
column and the xylA.cd2 protein was washed through in the unbound fraction. Although 
quite dilute - the unbound fraction was eluted in approximately 18ml as compared to the 
3ml of cell extract applied to the column -  the unbound fraction showed very high 
xylanase activity. The total amount of protein in the fraction was approximately 5.7mg, 
and the xylanase specific activity was calculated as 10,400U/mg.
SDS-PAGE analysis (Figure 3.6) showed the xylA.cd2 within the unbound fraction to be 
over 90% pure (estimated visually). Zymogram analysis of the various purification 
stages showed a clearing zone around a band at approximately 27kDa, indicating that 
this is the molecular weight of the recombinant xylA.cd2 protein (Figure 3.7).
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AAGTTTACTGTCGGTAATGGACAAAACCAACATAAGGGTGTCAACGATGGTTTCAGTTAT
TTCAAATGACAGCCATTACCTGTTTTGGTTGTATTCCCACAGTTGCTACCAAAGTCAATA
K F T V G N G Q N Q H K G V N D  G F S Y
GAAATCTGGTTAGATAACACTGGTGGTAACGGTTCTATGACTCTCGGTAGTGGTGCAACT
CTTTAGACCAATCTATTGTGACCACCATTGCCAAGATACTGAGAGCCATCACCACGTTGA
E I W L D N T G G N G S M T L G S G A T
TTCAAGGCTGAATGGAATGCAGCTGTTAACCGTGGTAACTTCCTTGCCCGTCGTGGTCTT
AAGTTCCGACTTACCTTACGTCGACAATTGGCACCATTGAAGGAACGGGCAGCACCAGAA
F K A E W N A A V N R G N F L A R R G L
GAC TTCGGTTCT CAAAAGAAGGCAACC GAT T ACGAC T ACAT T GGAT T AGAT TAT GC T GC T
CTGAAGCCAAGAGTTTTCTTCCGTTGGCTAATGCTGATGTAACCTAATCTAATACGACGA
D F G S Q K K A T D Y D Y I G L D Y A A
ACTTACAAACAAACTGCCAGTGCAAGTGGTAACTCCCGTCTCTGTGTATACGGATGGTTC
TGAATGT T TGT T TGACGGTCACGT TCACCATTGAGGGCAGAGACACATATGCCTACCAAG
T Y K Q T A S A S G N S R L C V Y G W F
CAAAACCGTGGACTTAATGGCGTTCCTTTAGTAGAATACTACATCATTGAAGATTGGGTT
GTTTTGGCACCTGAATTACCGCAAGGAAATCATCTTATGATGTAGTAACTTCTAACCCAA
Q N R G L N G V P L V E Y Y  I  I E D W V
GACTGGGTTCCAGATGCACAAGGAAAAATGGTAACCATTGATGGAGCTCAATATAAGATT
CTGACCCAAGGTCTACGTGTTCCTTTTTACCATTGGTAACTACCTCGAGTTATATTCTAA
D W V P D A Q G K M V T  I  D G A Q Y K  I
T T C CAAAT GGAT CACAC T GG T C CAAC TAT CAAT GG T GGT AGT GAAAC C T T T AAGC AAT AC
AAGGTTTACCTAGTGTGACCAGGTTGATAGTTACCACCATCACTTTGGAAATTCGTTATG
F Q M D H T G P T I N G G S E T F K Q Y
TTCAGTGTCCGTCAACAAAAGAGAACTTCTGGTCATATTACTGTCTCAGATCACTTTAAG
AAG T C AC AG GC AG TTGTTTTCTCTT GAAGAC C AG TAT AAT GACAGAG T C TAG T GAAAT T C
F S V R Q Q K R T S G H I T V S D H F K
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GAATGGGCCAAACAAGGTTGGGGTATTGGTAACCTTTATGAAGTTGCTTTGAACGCCGAA
CTTACCCGGTTTGTTCCAACCCCATAACCATTGGAAATACTTCAACGAAACTTGCGGCTT
E W A K Q G W G  I  G N L Y E V A L N A E
GGTTGGCAAAGTAGTGGTGTTGCTGATGTCACCTTATTAGATGTTTACACAACTCCAAAG
CCAACCGTTTCATCACCACAACGACTACAGTGGAATAATCTACAAATGTGTTGAGGTTTC
G W Q S S G V A D V T L L D V Y T T P K
GGTTCTAGTCCAGCCTAG
6 6 1 . ----------------- +---------------- 678
CCAAGATCAGGTCGGATC
G S S P A *
Figure 3.5 Sequence of xylA.cd2
The translated amino acid sequence is shown below the gene sequence using the single letter 
amino acid codes.
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Cell extract 35.4 71,000 2010 100 1
HiTrap Q anion 
exchange unbound 
fraction
5.7 59,700 10,400 84 5.17
Table 3.1 Summary of purification of xylA.cd2 from E. coli strain JM109
Samples after each step were analysed for xylanase activity using the DNS assay and for protein 
concentration using the Bio-Rad protein estimation assay. Yield is expressed relative to the total 
amount of enzyme activity present in the cell extract. Purification factor is expressed relative to 
the specific activity of the enzyme in the cell extract. *One unit of enzyme activity is defined as 
that which releases 1 jimol product (expressed as xylose equivalents) per minute.
1 2 3 4 5 6
200.0 — ►
116 2  p,
97.4 *
66 . 2 — ►
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Figure 3.6 SDS-PAGE analysis of the purification stages of xylA.cd2
Lane 1, SDS-PAGE Broad range markers; lane 2, Total cells; lane 3, Cell extract; lane 4, Cell 
debris; lane 5, HiTrap Q anion exchange unbound fraction; lane 6, HiTrap Q anion exchange 
total bound protein.
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Figure 3.7 Zymogram of purification stages of xylA.cd2
Clearing zones indicate areas of xylanase activity. Lane 1, SDS-PAGE Broad range markers; 
lane 2, Total cells; lane 3, Cell extract; lane 4, Cell debris; lane 5, HiTrap Q anion exchange 
unbound fraction; lane 6, HiTrap Q anion exchange total bound protein.
3.3.3 XylA.cd2 characterisation
3.3.3.1 Determination o f appropriate enzyme dilution and specific activity
When performing characterisation studies on an enzyme it is important to ensure that the
initial rate of reaction is being measured. If over the time course of an assay the reaction
reaches near-completion then a false representation of the enzymes characteristics will
be obtained. In order to determine the correct dilution of xylA.cd2 to use in the studies
of its activity with temperature and thermal stability, and also to determine its specific
activity, a series of standard assays were carried out using varying volumes of a 1/250
dilution of xylA.cd2. It was determined that a 1/5000 dilution of the purified xylA.cd2
would be an appropriate dilution to use in order to ensure initial rates were being
measured. Figure 3.8 graphically represents these results. The purified xylA.cd2 enzyme
demonstrated a specific activity of 10,400 units per mg of protein.
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3.3.3.2 Temperature optimum for activity
XylA.cd2 was assayed at various temperatures from 18°C to 80°C, and these results are 
shown in Figure 3.9. Blank reactions (with lOOpl PC buffer in place of the IOOjj.1 
enzyme dilution) were carried out at each temperature to account for any degradation of 
the soluble xylan substrate at the higher temperatures, although no significant increase in 
absorbance of the blank samples was observed. The maximum activity of the purified 
xylA.cd2 was observed at 55°C.
3.3.3.3 Thermal Inactivation
Temperatures just above the observed optimum were chosen to study the thermal 
stability of purified xylA.cd2. These results are represented graphically in Figure 3.10 
and show that purified xylA.cd2 has a half-life of approximately 15 minutes at 58°C, 
reducing to a half-life of less than 1 minute at 64°C. An Arrhenius plot can be 
constructed, according to the Arrhenius equation (Equation 3.1), by plotting In (k) 
against 1/T for each temperature studied. The slope of this straight-line plot gives -E a/R, 
which can be used to determine the activation energy for the inactivation process of 
purified xylA.cd2 (Figure 3.11).
k = Ae'Ea/RT Equation 3.1
Where A is the pre-exponential factor
R is the universal gas constant (8.314 J* K'1 mol’1)
T is the absolute temperature (K)
Ea is the activation energy for the reaction (kJ/mol)
From the Arrhenius plot Ea is calculated as 478kJ/mol.
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Figure 3.8 XylA.cd2 activity against volume of a 1/250 enzyme dilution
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Figure 3.9 Temperature activity curve for xylA.cd2
Activities are expressed as a percentage of activity at 55°C, as this was the temperature at which 
the maximum activity was observed. Each point represents the mean of 4 assays.
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Figure 3.10c Figure 3.10d
Figure 3.10 Thermal inactivation of xylA.cd2
Data are shown as In (% activity) against incubation time (% activity being calculated as a 
percent of maximum activity, seen at time 0). Lines of best fit, calculated by linear regression, 
are shown.
Figure 3.10a Thermal inactivation of xylA.cd2 at 58°C
Figure 3.10b Thermal inactivation of xylA.cd2 at 60°C
Figure 3.10c Thermal inactivation of xylA.cd2 at 62°C
Figure 3.10d Thermal inactivation of xylA.cd2 at 64°C
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Figure 3.11 Arrhenius plot for xylA.cd2 thermal inactivation data
Data from Figure 3.10 are represented as an Arrhenius plot, according to the Arrhenius equation 
(Equation 3.1). Linear regression has been used to calculate a line of best fit through the data.
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3.4 DISCUSSION
3.4.1 Cloning and expression
The second catalytic domain of Neocallimastix patriciarum xylanase A has been cloned 
into the plasmid vector pUC18 and expressed in E. coli strain JM109. pUC18 is a high 
copy number plasmid that is recommended for use in error-prone PCR experiments 
(described in Chapter 6). As the xylA.cd2 does not have its own translation initiation 
sequence it has been cloned in frame with the lacZ promoter of pUC18 to enable 
translation to occur via this promoter and start codon. As a result the expressed xylA.cd2 
will have 12 additional residues, coded for by the first few bases of the lacZ gene, at its 
N-terminus. These preceding amino acids could influence both the activity and stability 
properties of the xylA.cd2 enzyme, although definite conclusions about their precise 
effects cannot be drawn without a comparison to an expressed xylA.cd2 lacking these 
additional residues.
3.4.2 Recombinant xylA.cd2 purification
The purification of recombinant xylA.cd2 from cell extract was achieved in a one step 
procedure by anion exchange chromatography. An 84% yield, constituting 19% of the 
total protein, was obtained. The expressed protein was estimated by SDS-PAGE analysis 
to be over 90% pure. This level of purity is more than sufficient for the characterisation 
studies carried out.
Interestingly, the anion exchange chromatography worked as a ‘negative’ purification 
step; that is, it enabled purification of xylA.cd2 from the remaining cell extract proteins 
by eliminating it from the column unbound, while the majority of the remaining proteins 
stayed bound to the anion exchange matrix. This would suggest that xylA.cd2 should 
actually bind to a cation exchange matrix, with the remaining proteins eluting unbound. 
If this were the case then it may serve to increase the purity of the protein by switching 
to a cation exchanger, as controlling the elution of xylA.cd2 from the matrix may also 
lead to further separation from the few contaminating proteins, and as such increase its 
purity.
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The specific activity of purified recombinant xylA.cd2 is almost twice that of purified 
full-length xylanase A (10,400U/mg compared with 5980U/mg (Gilbert et al, 1992)). 
This factor is of obvious advantage when the industrial application of xylA.cd2 is 
considered. An enzyme having twice the specific activity of another would convert its 
substrate to product at twice the rate. Alternatively, only half the amount of xylA.cd2 
would be necessary to complete the equivalent conversion of substrate to product. Either 
of these points could be considered economically advantageous.
3.4.3 Temperature activity and thermal stability
Performing DNS assays on purified xylA.cd2 over a range of temperatures has shown 
that the optimum temperature for activity, i.e. the temperature at which maximum 
activity is seen, is 55°C. Beyond this temperature inactivation is rapid, with over 50% of 
activity lost with an increase of just 5°C over the 15 minute time-course of the assay. 
Assaying xylA.cd2 for activity at varying temperatures measures both reversible and 
irreversible denaturation, and this rapid loss of activity may be due to a combination of 
both these effects.
The thermal inactivation studies measure the effects of irreversible denaturation only, 
and they confirm the observation from the temperature activity profile that rapid 
inactivation is seen above the temperature optimum. At 58°C the half-life of xylA.cd2 is 
approximately 15 minutes, but this reduces rapidly with only relatively small increases 
in temperature. At 60°C the half-life is reduced by over half to 6 minutes, and by 62°C it 
is reduced again by over half to approximately 2 minutes. At 64°C the inactivation is so 
rapid that it becomes difficult to measure accurately using this method of study, but it 
can be estimated as less than one minute. XylA.cd2 is not expected to display any 
exceptional thermostability, as its biological source is a mesophilic organism. The aim 
of this project is to increase the thermostability of xylA.cd2 whilst retaining its activity 
at lower temperatures. Successful attempts to increase the thermostability of proteins 
have often achieved an increase in stability at the cost of a decrease in activity at lower 
temperatures, i.e. the temperature activity profile of the protein has been shifted to the 
right. In order to fulfil the aims of this project it will be necessary to broaden the peak of 
the temperature activity profile (or even increase the peak to higher temperatures) and
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increase the half-life of xylA.cd2 at higher temperatures, but retain the activity at sub- 
optimal temperatures.
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Chapter 4 
STRUCTURAL STUDIES OF NEOCALLIMASTIXPA TRICIARUM 
XYLANASE A SECOND CATALYTIC DOMAIN
4.1 INTRODUCTION
Site-directed mutagenesis is a powerful tool for exploring the role of specific amino acid 
residues, or the interaction of multiple residues, within a protein. Three-dimensional 
crystal structures greatly enhance the chances of accurately predicting the effect a 
change in residue would have on the overall protein structure, and as such are important 
tools in the design of site-directed mutagenesis experiments. In cases where the crystal 
structure of a protein is not available it is possible to design a model of the protein of 
interest using known structures of homologous proteins. This model can then be used in 
the same way to design site-specific mutations.
The crystal structure of Neocallimastix patriciarum xylanase A is not known. For the 
purpose of this project a model had been designed using the crystal structures of closely 
homologous family 11 xylanases present in the Protein Data Bank. Sequence alignment 
of xylanases similar to the second catalytic domain of N. patriciarum xylanase A shows 
that xylanase II (PDB code 1ENX) from Trichoderma reesei is most closely matched, 
and this was used as the primary template for constructing the model. Some additions 
and deletions of residues in N. patriciarum xylA.cd2 were found to correspond more 
closely to xylanase 1 (PDB code 1UKR) from Aspergillus niger, so this was used as a 
secondary template.
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4.2 METHODS
4.2.1 Sequence manipulation
Manipulation of related xylanase sequences in order to produce an alignment and 
consensus sequence was performed using the Wisconsin Package, version 8.0 (Genetics 
Computer Group, Madison WI, USA). The N. patriciarum xylA.cd2 sequence was 
manually manipulated to ensure that conserved residues (e.g. catalytic residues, large 
aromatic residues) aligned with those present in the other sequences. Care was also 
taken to ensure that the location of any conserved residues in the thermostable xylanases 
used in the alignment, for which an involvement in maintaining the stability of the 
enzyme has been suggested, were mapped onto the xylA.cd2 sequence.
4.2.2 Molecular modelling
The three-dimensional structure of the template was visualized using the O graphics 
program. Beginning at the N-terminus of the template each amino acid residue was 
mutated, replacing the template residue with that of the N. patriciarum sequence. 
Residues present in the template but absent from xylA.cd2 were deleted, and residues 
present in xylA.cd2 but absent from the template were added and their structures 
modelled using the O program database: O has a database of well-refined structures and 
this can be searched to find the 20 loops that best fit the conformation of the inserted 
stretch of residues. Each conformation is given a value reflecting its likelihood, and the 
final choice of conformation is left to the user.
4.2.3 Preliminary analysis of side-chain positions
As the O graphics program does not account for the various possible amino acid side- 
chain conformations when the initial mutations from template to model are made, it is 
necessary to examine the model and alter any unfavourable side-chain conformations. 
This was done manually using O’s database of commonly found conformations for each 
amino acid side-chain.
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4.2.4 Detailed analysis of the structural model
The PROCHECK program suite (Laskowski et al., 1993) was used to obtain a more 
detailed analysis of the structural model. The conformation of the main chain atoms of a 
protein is determined by the § (phi) and (p (psi) angles of each amino acid. Rotation 
around the C«-N bond and Ca-C bond gives the <|> and <p angles of rotation, respectively. 
PROCHECK compares the model to well-refined structures of a similar resolution and 
checks for ‘unusual’ backbone atom conformations. In order to ensure that unusual 
conformations are in fact unusual, and not a characteristic of the protein, the template 
structure is also submitted as a check. PROCHECK displays the pairs of <|> and <p angles 
for each amino acid in a Ramachandran plot, making unfavourable main chain 
conformations easy to identify.
The model was also submitted to the Verify 3D website (Luthy et al., 1992). This 
program analyses individual residues, giving each one a score based on a comparison of 
its actual environment as opposed to its ideal environment. For example, a hydrophobic 
residue on the external surface of the protein would rate a very low score. Very low or 
negative scores generally indicate serious errors in the structural model
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4.3 RESULTS
4.3.1 Sequence homology
The sequence data and crystal structure coordinates of template candidates were 
obtained from the Protein Data Base. Eight homologues of the N. patriciarum xylA.cd2 
were aligned manually alongside the xylA.cd2 sequence and the most similar sequence 
was found to be that of xylanase II from Trichoderma reesei (Figure 4.1 shows 
alignment of N. patriciarum xylA.cd2 sequence with template sequences and 
thermostable sequences only). N. patriciarum xylA.cd2 was found to have two large 
insertions not found in any of the other eight xylanases (residues 89-95 and 130-135 as 
numbered in Figure 4.1). These insertions corresponded to loop regions in the template 
structure and were modelled as extensions of these existing loops, as large insertions 
positioned in a secondary structural element are predicted to severely disrupt the 
function of the enzyme. The shape and orientation of the inserted loops were predicted 
from conformations suggested by the O graphics program. Care was taken to ensure that 
the loops did not clash with any pre-existing structure.
4.3.2 Model analysis
The first Ramachandran plot produced (not shown) showed 80.7% of residues in most 
favoured regions, and a further 14.2% in allowed regions. This left seven residues in 
generously allowed regions and two in disallowed regions. These latter two regions are 
unsatisfactory and as such the <|> and (p bond angles of these residues were progressively 
altered until the residues moved into acceptable regions of the plot. Figure 4.2 shows the 
final Ramachandran plot with all residues in acceptable regions, 82.9% of which are in 
the most favoured region. Figure 4.3 shows the final model of N. patriciarum xylA.cd2.
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lpvx PSSGSTDLGT VSiDGSTYTL GQSTRYNAPS IDGTQ.TFNQ YWSVRQDKRS
lyna PSSGATDLGT VeIdGSIYRL GKTTRVNAPS IDGTQ.TFDQ YWSVRQDKRT
2 0 1  2 5 0
xylA SGH...ITVS |HFKEWAKQG WGIGNLYE.V ALNAEGWQSS GVADVTLLDV
lukr SG...TVTVA NHFNFWAQHG FGN.SDFNYQ VMAVEAWSGA GSASVTISS.
lenx SG...SVNTA NHFNAWAQQG LTL.GTMDYQ IVAVEGYFSS GSASITVS..
lpvx SG...TVQTG |HFDAWASAG LNVTGDHYYQ IVATEGYFSS GYARITVADV
lyna SG...TVQTG IhFDAWARAG LNVNGDHYYQ IVATEGYFSS GYARITVADV






Figure 4.1 Sequence alignment of N. patriciarum xylA.cd2 with template and 
thermostable xylanases only
xylA, xylanase A from Neocallimastix patriciarum; lukr, xylanase 1 from Aspergillus niger; 
lenx, xylanase II from Trichoderma reesei; lpvx, xylanase from Paecilomyces varioti Banier; 
lyna, xylanase from Thermomyces lanuginosus. Residues in yellow represent the catalytic 
residues; red represents the cysteines involved in disulphide bond formation in the two 
thermostable enzymes (with the corresponding xylA.cd2 residues highlighted also); green 
represents the aromatic residue (possible target for increasing thermostability); blue represents 
the two residues involved in defining the active site cleft entrance size (possible targets for 
increasing substrate specificity).
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Figure 4.2 Final Ramachandran plot for xylA.cd2 model
Plot created using the PROCHECK program. All residues are positioned in allowed regions of 
the plot.
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Figure 4.3 Final model of Neocallimastix patriciarum xylanase A second catalytic 
domain
Blue highlights the N-terminus, red highlights the C-terminus.
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4.4 FEATURES OF MODEL
Producing models of a protein structure allows visualisation of what the protein may 
look like. It cannot, however, be expected to produce an exact image of the actual 
protein. Although the actual crystal structure of another homologous enzyme is used as a 
template, it can only be used as a guide to suggest what structure the unknown protein 
may adopt. Sequence variations between the two proteins, including insertions and 
deletions, will obviously affect the way in which the modelled protein will fold. By 
using the crystal structure of an enzyme as homologous as possible as a template, the 
chances of predicting a reasonably accurate model are increased.
4.4.1 Conserved sequences and their functional properties
4.4.1.1 Structural features
The three-dimensional structure of family 11 xylanase catalytic domains is unique to 
family 11 xylanases, with family 10 xylanases showing a completely different fold in 
their structure. The family 11 catalytic domain is a single domain composed mainly of 
two curved (3-sheets. Its appearance has been likened to a right hand, with four ‘fingers’ 
and an opposing ‘thumb’ held in a grasping position around a cylindrical active site 
cleft. A long cord joins the thumb to one of the fingers. The structure of a protein is 
determined by its amino acid residues, and the interaction of these residues with each 
other. Proline and glycine residues are particularly important in determining the general 
structure of a protein as these can allow the amino acid chain to ‘bend’ into otherwise 
difficult conformations according to their own conformation. Glycines at positions 59, 
135 and 206, along with Pro 148, have all been identified as important residues for 
allowing the backbone chain to twist and form hairpin bends in other xylanase 
structures, and these are conserved in this model.
4.4.1.2 Binding activity
During catalysis the xylanase holds the polysaccharide xylan chain in position in the 
active site cleft, similar to a hand grasping a bar or rope. Through sequence homology 
with the template enzyme and other family 11 xylanases it can be proposed that the
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model residues Trp 24, Tyr 97, Tyr 114, His 145 and Trp 202 all interact with the xylan 
substrate by either forming hydrogen bonds or by packing against the sugar rings of the 
substrate. The hydrogen bonding causes conformational changes within the protein 
structure, for example Pro 114 converts from cis to trans, which enables the ‘fingers’ of 
the enzyme to curl around the polysaccharide chain.
4.4.1.3 Catalytic activity
Family 11 xylanases have two conserved catalytic residues, both of which are glutamic 
acids. They are situated on opposite sides of the active site cleft and are involved in a 
catalytic mechanism thought to be similar to that of lysozyme. One glutamate acts as an 
acid'base catalyst while the other acts as a nucleophile to stabilise the reaction 
intermediate. The sequence alignment has shown that these two glutamic acids are 
located at positions 112 and 200 in the N. patriciarum xylA.cd2 (highlighted in yellow 
in Figure 4.1). Glu 200 is the acid/base catalyst, and conformation of it and its 
environment is thought to be determined by Asn 53, Leu 55 and Tyr 97. Glu 112 is the 
nucleophile, and its surrounding residues (Tyr 114, Glu 159 and Tyr 193) are thought to 
form a hydrogen bond network that is capable of fine-tuning the properties of this 
residue.
4.4.2 Non-conserved sequences
The major difference between N. patriciarum xylA.cd2 and other family 11 xylanases of 
similar sequence (and presumably structure) is the insertion of four sections of amino 
acid residues. The major insertions were modelled into the structure as loops, as 
insertion into a (3-sheet or a-helix was predicted to cause major disruptions within the 
structure and as a result would be likely to disrupt the activity of the enzyme. Their 
positions and conformations are however an estimation, and can only be accurately 
determined by actual structure determination. It could be predicted that these residues 
may in some way interact with the first catalytic domain of the N. patriciarum xylanase 
A, and are missing from other family 11 xylanases as these are single catalytic domain 
enzymes. Again this can only be verified by obtaining the actual crystal structure of the 
full-length xylanase A protein.
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4.5 IMPROVEMENT OF THERMOSTABILITY
To date there are crystal structures available for four family 11 xylanases isolated from 
thermophilic organisms: one from Paecilomyces varioti Bainier (Kumar et al, 2000a), 
and one from Thermomyces lanuginosus (formerly Humicola lanuginose) (Gruber et al, 
1998), both of which are from thermophilic fungi, one from Dictyoglomus 
thermophilum, which is a thermophilic bacterium (McCarthy et a l , 2000), and one from 
Bacillus strain D3 (Harris et a l, 1997). All these enzymes have structural variations that 
are not seen in the structures of mesophilic family 11 xylanases, and which are therefore 
thought to confer thermostability. A comparison of the N. patriciarum xylA.cd2 
sequence data and the structural data from these thermophilic enzymes has allowed 
suggestions to be made for improvements to the enzyme that may lead to an increase in 
its thermostability.
4.5.1 Disulphide bonds
Both the P. varioti (PDB code 1PVX) and T. lanuginosus (PDB code 1YNA) xylanases 
have a disulphide bond between residues Cys 110 and Cys 154 that connects the C- 
terminus of a P-strand (B9) with the N-terminus of an a-helix (residues highlighted in 
red in Figure 4.1). This bond is situated in the ‘hinge’ region of the enzyme, i.e. the 
point at which a conformational change occurs on binding of the polysaccharide 
substrate into the active site cleft. It is thought that the presence of a disulphide bond 
makes this hinge region more compact and thus more stable in the thermophilic 
enzymes.
Attempts have already been made to enhance the thermostability of a mesophilic 
xylanase by the introduction of a disulphide bond equivalent to the one seen in the 
thermostable enzymes. Wakarchuk et a l (1994) have introduced a disulphide bond into 
a Bacillus circulans xylanase and have shown that on its own it does confer an increase 
in stability. This suggests that a similar increase in stability may be achieved by 
introducing the equivalent disulphide bond into N. patriciarum xylA.cd2. Sequence 
alignment shows that the residues equivalent to Cys 110 and Cys 154 in xylA.cd2 are lie 
133 and Asp 177. Mutation of these residues by site-directed mutagenesis should result
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in the introduction of a disulphide bond on expression of the protein, which would 
hopefully lead to an increase in its thermostability. Figure 4.4 shows the xylA.cd2 model 
structure, and indicates the location of the residues that could be mutated to introduce a 
disulphide bond.
Figure 4.4 Model structure of N. patriciarum xylA.cd2
Pink spheres indicate location of 2 residues that could be mutated to cysteine residues in 
attempts to introduce a disulphide bond.
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4.5.2 Ionic interactions
Ionic interactions can occur between oppositely charged pairs of residues, and are 
frequently cited as having positive effects on protein stability at elevated temperatures 
(Yip et al., 1995; Russell et al., 1997; Vetriani et a l , 1998). This is confirmed in the 
case of 1PVX and 1YNA, the two thermostable xylanases discussed above. Both studies 
on these enzymes have calculated the number of ionic interactions between charged 
residues in the xylanase, and have compared them to the number of ionic interactions 
seen in similar family 11 xylanases from mesophilic organisms. 1YNA from T. 
lanuginosus, which is optimally active at 70°C, has 25 ion pairs and 1PVX from P. 
varioti, which is optimally active around 60°C, has 17 ion pairs (an ion pair was 
proposed where the distance between two oppositely charged residues was below 8A). 
These values can be put into context when compared with a mesophilic xylanase, for 
example xylanase I from Trichoderma reesei, which has 13 ion pairs. From the modelled 
structure of N. patriciarum xylA.cd2 it can be predicted that it also has 13 ion pairs. The 
studies on 1YNA and 1PVX showed that both the enzymes had an increase in the 
number of ionic interactions around the disulphide bond/hinge region when compared to 
mesophilic family 11 xylanases. It was suggested that these interactions, along with the 
presence of the disulphide bond, were responsible for stabilising the structure at this 
point and as a result stabilising the enzyme as a whole. Although the studies of 1YNA 
and 1PVX could not conclusively determine whether any of the other additional ion pair 
interactions were having a direct effect on thermostability, it was proposed that the 
general stabilisation of the enzymes as a whole through increased numbers of ion pairs 
went some way to explain the enhanced stability seen. Another possible way to increase 
the stability of xylA.cd2 would be to incorporate more ionic interactions, in particular 
around the introduced disulphide bond, through the introduction of charged residues in 
positions equivalent to those in the two thermostable xylanases.
4.5.3 Aromatic residues
The study of the Bacillus strain D3 family 11 xylanase proposed that a major factor in 
the enhanced stability seen over its mesophilic counterpart was the presence of surface 
aromatic residues. The equivalent mesophilic xylanase (from Bacillus circulans) only
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has three of its 29 aromatic amino acids on the surface, where the thermostable D3 
xylanase has eight additional aromatic residues and they are all situated on the surface of 
the protein. The study proposes that these additional surface aromatic amino acids are 
positioned in clusters and form ‘sticky patches’ on the surface of the protein. These are 
thought to facilitate aggregation of protein molecules when the aromatic clusters from 
neighbouring proteins ‘stick’ together, and this aggregation is proposed to confer extra 
stability on the enzyme molecules at elevated temperatures.
The N. patriciarum xylA.cd2 model indicates that it has three aromatic residues that may 
be possible candidates for the formation of a surface aromatic cluster. Two of these 
however are situated on an extended loop and so their conformations are not as reliable. 
The third, Tyr 82, is located on the surface of the protein away from the active site cleft 
on the ‘wrist’ of the structure (residue highlighted in green in Figure 4.1). Site-directed 
mutagenesis could again be employed to substitute neighbouring residues for aromatic 
ones in an attempt to increase the thermostability of the molecule by improving its 
protein-protein aggregation.
4.5.4 Other engineering possibilities
Xylan is a very diverse polysaccharide that can have numerous side-chain substituents 
bound to its xylose backbone, and its constitution depends on its biological source. One 
of the reasons why only particular types of xylan are permitted into the active site cleft 
of particular xylanases must be the volume of the cleft, and the size of the entrance to it. 
A great deal of industrial interest would be attracted if a xylanase could be engineered to 
have broad range specificity. This may be possible by altering the residues that limit the 
size of the substrate. In 1PVX from P. varioti the closest residues along the active site 
cleft are Pro 126, which is situated at the tip of the ‘thumb’, and Trp 18, which is 
situated at the end of (3-strand 2 (highlighted in blue in Figure 4.1). These two residues 
are 6A apart. The sequence alignment shows that the equivalent residues in xylA.cd2 are 
Pro 148 and Trp 24, and these are the closest residues along the active site cleft. If 
mutations could be made that would increase the gap between these two residues then
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the specificity of xylA.cd2 may be altered and this in turn may lead to the production of 
a xylanase with wider ranging specificity.
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4.6 CONCLUSIONS
The aim of this section of work was to design a model of the N. patriciarum xylA.cd2, 
and to use this model to suggest site-specific mutations that may lead to an increase in 
the thermostability of the enzyme. Comparison of the sequence data and modelled 
structure of xylA.cd2 to the known crystal structures of other family 11 xylanases has 
allowed three main suggestions to be made about possible targets for increasing 
thermostability: introducing a disulphide bond, increasing the number of ion pair 
interactions, and formation of a surface aromatic cluster. Of these three suggestions the 
most straightforward to introduce by site-directed mutagenesis is a disulphide bond, as 
this requires only the mutation of two residues. In addition, the disulphide bond is a 
feature visible in the thermostable enzymes and is already proven to increase 
thermostability. Ionic interactions would be more difficult to introduce accurately, as 
although a trend of increasing numbers of ion pairs is seen when mesophilic and 
thermophilic enzymes are compared, the actual location of ion pairs is difficult to predict 
(it is thought that increased numbers of ion pairs generally lead to overall stabilisation of 
the enzyme, rather than specific interactions in a particular location). Introduction of a 
surface aromatic cluster would involve the introduction of a number of aromatic residues 
to interact with the existing Tyr 82. Aromatic residues have large, bulky side-chains and 
their introduction may cause disruption to the core structure of the enzyme, leading to a 
loss of activity.
The final decision was to introduce a sulphide bond into N. patriciarum xylA.cd2, and 
this work is described in detail in chapter 5.
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Chapter 5
CONSTRUCTION AND CHARACTERISATION OF A SITE- 
DIRECTED MUTANT OF THE SECOND CATALYTIC DOMAIN 
OF N. PA TR1CIARUM XYLANASE A
5.1 INTRODUCTION
Using structural information obtained from a model of N. patriciarum xylA.cd2, and by 
making comparisons of this model to known structures of thermostable xylanases, it has 
been proposed that the introduction of a disulphide bond may lead to an increase in the 
thermostability of the xylA.cd2 enzyme (Chapter 4). The aim of this section of work is 
to introduce into xylA.cd2 an equivalent disulphide bond to that found in thermostable 
xylanases. This will be achieved using site-directed mutagenesis to mutate residues 133 
and 177 of the xylA.cd2 enzyme into cysteine residues (positions equivalent to those in 
the thermostable enzymes).
This chapter will describe the construction of this disulphide bond mutant by site- 
directed mutagenesis using the megaprimer PCR technique, the cloning of this mutant 
enzyme into the plasmid vector pUC18 and its expression and purification from E. coli 
strain JM109. It will then go on to describe the characterisation of the xylA.cd2 mutant 
enzyme with respect to its specific activity, temperature optimum for enzymic activity 
and thermal stability. Conclusions shall be drawn on the success of introducing a 
disulphide bond as a means of increasing thermostability by comparing the 
characteristics of this xylA.cd2 mutant enzyme with those of the recombinant xylA.cd2 
(described in Chapter 3).
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5.2 MATERIALS AND METHODS
All methods used in this chapter not outlined below can be found in chapter 2.
5.2.1 Materials
DTNB was purchased from Sigma, Poole, Dorset, UK. All other materials used in this 
section are as outlined in chapter 2, sections 2.1.1,2.2.1 and 2.3.1.
5.2.2 Construction of disulphide bond mutant xylA.cd2
A three-step PCR process using mutagenic primers was used to construct the xylA.cd2 
site-directed mutant. The technique, also referred to as Mega-primer PCR, uses the 
product from the first round of PCR as a primer in the second round, and then the 
product from the second round of PCR as a primer in the final round (Figure 5.1). Full 
details of all primers can be found in the Appendix. The site-directed mutagenesis 
involved the introduction of two separate mutations within the xylA.cd2 coding 
sequence, to convert two existing codons into cysteine codons. The first reaction (Figure 
5. la) used the full-length xylanase A gene as a template, with primer 2 and a mutagenic 
forward primer (primer 3, see Figure 5.1) containing the first of the base mutations to be 
introduced. This reaction gave a product of 179bp, which was run on a 2.0% agarose gel 
and purified as described in section 2.1.4.1. This purified product, named megaprimer 1, 
was then used as the reverse primer in the second round reaction (Figure 5.1b), along 
with the same full-length xylanase A gene template and a second mutagenic forward 
primer (primer 4, see Figure 5.1), containing the second of the two base mutations to be 
introduced. This second reaction gave a product of 310bp, which contained both of the 
introduced base changes. It was purified again as described in section 2.1.4.1 by running 
on a 1.8% agarose gel, and used in the final reaction (Figure 5.1c) as the reverse primer 
(megaprimer 2) along with primer 1 and the full-length xylanase A template. The 
product of this reaction gave the full coding sequence for xylA.cd2 containing both the 
introduced mutations.
The reactions were carried out essentially as described in section 2.1.3. The only 
variation was that for the second round reaction the annealing time was extended to 2
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minutes, and for the third round reaction the annealing time was extended again to 4 
minutes.
Cloning of this PCR fragment containing the two mutations into pUC18 was as 
described for xylA.cd2 in section 3.2.2. The product was digested with BamHI (section 
2.1.6) and ligated into BamHI-digested pUC18 plasmid vector using the Rapid DNA 
Ligation Kit (section 2.1.7). This construct is known as pUC18.mutant.cd2.
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Primer 3
I
P r i m e r  2
1 7 9 b p  p r o d u c t  




P r i m e r  4
3 ’
C)
P r i m e r  1
5 ’
M e g a p r i m e r  1
I
3 1 0 b p  p r o d u c t  c o n t a i n i n g  
b o t h  m u t a t i o n s  
-  MEGAPRIMER 2
M e g a p r i m e r  2
i
F i n a l  p r o d u c t  =
XYLA.CD2 CODING REGION WITH BOTH 
INTRODUCED MUTATIONS
Figure 5.1 Schematic diagram representing the PCR strategy for construction of the 
site-directed xylA.cd2 mutant
Blue and red stars indicate location of the mutations.
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5.2.3 Expression of recombinant mutant xylA.cd2 in E. coli 
pUC18.mutant.cd2 was transformed into E. coli strain JM109 using the heat shock 
method (section 2.1.7). As for xylA.cd2 (section 3.2.3), the Congo Red overlay assay 
was employed to identify which clones had the mutant xylA.cd2 insert ligated in the 
correct orientation in the pUC18 plasmid. Once this was determined, the mutant 
xylA.cd2 insert was sequenced to ensure that the mutations had been successfully 
introduced into the coding sequence, and that no other errors had been introduced during 
the PCR reactions.
The mutant xylA.cd2 protein was expressed from a 250ml culture of LB supplemented 
with lOOjug/ml ampicillin as described in section 2.2.5.
5.2.4 Purification of mutant xylA.cd2 from E. coli
The mutant xylA.cd2 protein was purified in the same way as the original xylA.cd2. E. 
coli cells harbouring the pUC18.mutant.cd2 plasmid were harvested after approximately 
16 hours of growth. The cells were disrupted by sonication and a cell extract was 
prepared as described in section 2.2.5.1. The cell extract was applied to a HiTrap Q High 
Performance 5ml anion exchange column equilibrated with 20mM Tris-HCl, pH8.0, and 
the mutant xylA.cd2 protein was collected in the unbound fraction.
5.2.5 Identification of disulphide bond
In order to confirm that a disulphide bond has actually formed between the introduced 
cysteine residues 5, 5 ’-dithiobis-(2-nitrobenzoic acid) (DTNB) can be used as a reagent 
to react with free thiol groups. DTNB will react with exposed thiol groups within a 
protein to form a mixed disulphide and 5-thio-2-nitrobenzoate (TNB), a coloured 
product that can be detected by measuring the absorbance of a reaction mixture at 
412nm (Figure 5.2). In order to detect all cysteine residues within the xylA.cd2 protein, 
the DTNB assay must be performed in the presence of 6M guanidine to ensure complete 
unfolding of the protein.
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Figure 5.2 Schematic diagram demonstrating the reaction of DTNB with a protein 
thiol group
The DTNB assay was performed to infer the presence of a disulphide bond within the 
mutant xylA.cd2 protein. The assay was performed on both the original and mutant 
xylA.cd2 proteins, in order for a comparison to be made between the two. Both purified 
proteins were firstly concentrated approximately 25 fold, then the appropriate amount of 
each was added to a 1ml cuvette along with the other reagents to give a final protein 
concentration of 0.25mg/ml (which equates to a O.OlmM solution). The total reaction 
was performed in a final volume of 1ml. Table 5.1 shows the reagents used and their 
amounts.
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(27pl of 9.12mg/ml stock)
~250ug 
(38pl of 6.6mg/ml stock)
6M Guanidine 750jul 750pl
lOmM DTNB lOpl lOpl
20mM Tris-HCL, pH8.0 213pl 202pl 1
Table 5.1 Reagents and amounts used in DTNB assay 
Assays were performed in a 1ml plastic cuvette.
After thorough mixing and incubation at room temperature for 5 minutes the absorbance 
of both samples was read at 412nm.
5.2.6 Characterisation of mutant xylA.cd2
The mutant xylA.cd2 protein was characterised in the same way as the original xylA.cd2 
protein. Its specific activity was determined as outlined in section 3.2.5, with DNS 
assays being performed using varying dilutions of the mutant xylA.cd2 to determine a 
suitable dilution of the enzyme to ensure that the initial rate of reaction was being 
measured. Its temperature optimum for activity was determined as described in section 
3.2.6, and its thermal stability was determined by thermal inactivation studies as 
described in section 3.2.7.
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5.3 RESULTS
5.3.1 Construction of mutant xylA.cd2 clone
The xylA.cd2 coding sequence was altered by site-directed mutagenesis, using 
mutagenic primers to introduce base changes into the sequence that will cause amino- 
acid changes in the expressed protein. The first set of mutations was required at bases 
1413 and 1414 (numbering corresponds to base positions in the full-length xylanase A 
gene). These are the first two bases of the triplet ATT, coding for amino acid residue He 
133. These two bases were mutated to give a triplet code in the mutant coding sequence 
of TGT, which codes for cysteine. The second set of mutations was required at bases 
1545 and 1546. These are the first two bases of the triplet GAT, coding for amino acid 
residue Asp 177. Again, these two bases were mutated to give TGT, which is the triplet 
code for cysteine. The sequence of the mutagenic primers 3 and 4 can be found in the 
Appendix.
5.3.1.1 PCR amplification and introduction o f site-directed mutations
The mutant xylA.cd2 coding sequence was created in a three-step PCR procedure. All
reactions used the full-length xylanase A gene as a template, the only variable aspect 
being the combination of primers used. The first PCR reaction introduced the first set of 
mutations, and its 179bp product (Figure 5.3) was purified and used as a primer 
(megaprimer 1) in the second reaction. The second PCR reaction introduced the second 
of the two sets of mutations, and created a product of 310bp (Figure 5.4), which was 
purified and used as a primer (megaprimer 2) in the third reaction. The third PCR 
reaction amplified the full coding sequence for the second catalytic domain, and using 
megaprimer 2 as the reverse primer ensured that both sets of mutations were included in 
the final product. As for the amplification of the original xylA.cd2 (section 3.3.1.1) the 
final product (Figure 5.5) was 703bp.
The PCR fragment was digested with BamHI and ligated into pre-digested pUC18 
plasmid vector. The resulting clones were transformed into E. coli strain JM109 cells, 
and successful transformants were selected for by growth on LB-agar plates containing 
lOOpg/ml ampicillin. As with the original xylA.cd2 clone, successful ligation of the
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mutant xylA.cd2 insert into each plasmid was confirmed by restriction digest of plasmid 
prepared from single colonies. Digestion with BamHI gives two bands of the expected 
sizes when run on an agarose gel (Figure 5.6).
1 2
Figure 5.3 Identification of PCR reaction 1 product (megaprimer 1) by agarose gel 
electrophoresis
Lane 1, lkb DNA molecular weight markers; lane 2, 179bp PCR product.
1 2
Figure 5.4 Identification of PCR reaction 2 product (megaprimer 2) by agarose gel 
electrophoresis
Lane 1, lkb DNA molecular weight markers; lane 2, 310bp PCR product.
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1 2
lk b ----- ►
^------  703bp
0.5kb----- ►
Figure 5.5 Identification of final mutant xylA.cd2 PCR product by agarose gel 
electrophoresis
Lane 1, lkb DNA molecular weight markers; lane 2, 703bp PCR product.
1 2 3
5kb  ►
3 k b  ►
2kb ►
1.6kb----- ►
lk b  ►
0.5kb----- ►
Figure 5.6 BamHI digested pUC18.mutant.cd2, to confirm the cloning of mutant 
xylA.cd2 insert into pUC18 plasmid
Lane 1, lkb DNA molecular weight markers; lane 2, undigested pUC18.mutant.cd2 (supercoiled 
& relaxed circle); lane 3, BamHI digested mutant pUC18.cd2 (~700bp insert band & 2.7kb 
plasmid band).
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5.3.1.2 Identification o f  clones with correctly oriented mutant insert
The Congo Red overlay assay was used to determine whether E. coli cells were
harbouring pUC18 plasmid clones with the mutant xylA.cd2 PCR insert ligated in the
correct orientation. Those cells that contained the plasmid with insert ligated in the
correct orientation showed a clearing zone around them, while the ones containing the
plasmid with insert ligated in the reverse orientation showed no visible clearing zones,
indicating no xylanase activity (Figure 5.7).
Figure 5.7 Congo Red assay confirming xylanase activity of pUC18.mutant.cd2 clones
Not all clones are displaying xylanase activity (note the yellow halos around individual streaks 
that are xylanase active).
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5.3.1.3 Sequencing o f the mutant xylA.cd2 PCR insert
Sequencing of the mutant xyl.cd2 PCR insert was performed using the M13 universal 
sequencing and reverse primers. The sequence obtained showed that the specific 
mutations had been introduced into the coding sequence, and that no other sequence 
errors had been introduced during the PCR amplification. Figure 5.8 shows the mutant 
xylA.cd2 sequence.
5.3.2 Mutant xylA.cd2 purification
Mutant xylA.cd2 protein was expressed in E. coli strain JM109 cells from a 
pUC18.mutant.cd2 clone, and purified in the same way as the original xylA.cd2 protein. 
Table 5.2 summarises the purification results.
Approximately 2.2g (wet weight) were harvested from a 250ml culture of JM109 cells 
harbouring the pUC18.mutant.cd2 plasmid after 16 hours of growth. After resuspension 
and lysis by sonication the cell extract contained approximately 37mg of protein, and 
demonstrated a specific xylanase activity of 1970U/mg.
The cell extract was applied to a HiTrap Q High Performance 5ml anion exchange 
column and the mutant xylA.cd2 protein was washed through in the unbound fraction. 
The unbound fraction was eluted in approximately 19ml and again, as with the original 
xylA.cd2, it showed very high xylanase activity despite being quite dilute (the amount of 
cell extract applied to the column was approximately 3ml). The total amount of protein 
in the fraction was approximately 5.1 mg, and the xylanase specific activity was 
calculated as 10,600U/mg.
SDS-PAGE analysis (Figure 5.9) showed the mutant xylA.cd2 within the unbound 
fraction to be over 90% pure (estimated visually). Zymogram analysis of the various 
purification stages showed a clearing zone around a band at approximately 27kDa, 
indicating that this is the molecular weight of the recombinant xylA.cd2 protein (Figure 
5.10).
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AAGTTTACTGTCGGTAATGGACAAAACCAACATAAGGGTGTCAACGATGGTTTCAGTTAT
TTCAAATGACAGCCATTACCTGTTTTGGTTGTATTCCCACAGTTGCTACCAAAGTCAATA
K F T V G N G Q N Q H K G V N D G F S Y
GAAATCTGGTTAGATAACACTGGTGGTAACGGTTCTATGACTCTCGGTAGTGGTGCAACT
C T T TAGAC CAAT C TAT TGT GAC CAC CAT T GC CAAGAT AC T GAGAGCCAT CAC CAC GT T GA
E I W L D N T G G N G S M T L G S G A T
TTCAAGGCTGAATGGAATGCAGCTGTTAACCGTGGTAACTTCCTTGCCCGTCGTGGTCTT
AAGTTCCGACTTACCTTACGTCGACAATTGGCACCATTGAAGGAACGGGCAGCACCAGAA
F K A E W N A A V N R G N F L A R R G L
GAC TTCGGTTCT CAAAAGAAGG C AAC C GAT T AC GAC T AC AT T GGAT TAG AT TATGCTGCT
CTGAAGCCAAGAGT T T TCT TCCGT TGGCTAATGCTGATGTAACC TAATCTAATACGACGA
D F G S Q K K A T D Y D Y I G L D Y A A
ACTTACAAACAAACTGCCAGTGCAAGTGGTAACTCCCGTCTCTGTGTATACGGATGGTTC
TGAATGTTTGTTTGACGGTCACGTTCACCATTGAGGGCAGAGACACATATGCCTACCAAG
T Y K Q T A S A S G N S R L C V Y G W F
CAAAACCGTGGACTTAATGGCGTTCCTTTAGTAGAATACTACATCATTGAAGATTGGGTT
GTTTTGGCACCTGAATTACCGCAAGGAAATCATCTTATGATGTAGTAACTTCTAACCCAA
Q N R G L N G V P L V E Y Y  I  I E D W V
GACTGGGTTCCAGATGCACAAGGAAAAATGGTAACCTGTGATGGAGCTCAATATAAGATT
CTGACCCAAGGTCTACGTGTTCCTTTTTACCATTGGTAACTACCTCGAGTTATATTCTAA
d w v p d a q g k m v t | d g a q y k i  
T T C CAAAT GGAT CAC AC T GG T C CAAC TAT CAAT GG T GG TAG T GAAAC C T T TAAGC AAT AC 
AAGGTTTACCTAGTGTGACCAGGTTGATAGTTACCACCATCACTTTGGAAATTCGTTATG 
F Q M D H T G P T  I N G G S E T F K Q Y  
TTCAGTGTCCGTCAACAAAAGAGAACTTCTGGTCATATTACTGTCTCATGTCACTTTAAG 
AAG T CAC AG GCAG TTGTTTTCTCTT GAAGAC CAG TAT AAT GAC AGAG T C TAG T GAAAT T C
f s v r q q k r t s g h i t v s | h f k
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GAATGGGCCAAACAAGGTTGGGGTATTGGTAACCTTTATGAAGTTGCTTTGAACGCCGAA
CTTACCCGGTTTGTTCCAACCCCATAACCATTGGAAATACTTCAACGAAACTTGCGGCTT
E W A K Q G W G I G N L Y E V A L N A E
GGTTGGCAAAGTAGTGGTGTTGCTGATGTCACCTTATTAGATGTTTACACAACTCCAAAG
CCAACCGTTTCATCACCACAACGACTACAGTGGAATAATCTACAAATGTGTTGAGGTTTC
G W Q S S G V A D V T L L D V Y T T P K
GGTTCTAGTCCAGCCTAG
6 6 1  ------------------ + ----------------- 678
CCAAGATCAGGTCGGATC
G S S P A *
Figure 5.8 Sequence of mutant xylA.cd2
The translated amino acid sequence is shown below the gene sequence using the single letter 
amino acid codes. The base changes introduced by PCR are highlighted in bold text, and the 
introduced cysteine residues are highlighted in red.
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Cell extract 36.9 72,800 1970 100 1
HiTrap Q anion 
exchange unbound 
fraction
5.1 54,300 10,600 75 5.38
Table 5.2 Summary of purification of mutant xylA.cd2 from EL coli strain JM109
Samples after each step were analysed for xylanase activity using the DNS assay and for protein 
concentration using the Bio-Rad protein estimation assay. Yield is expressed relative to the total 
amount of enzyme activity present in the cell extract. Purification factor is expressed relative to 
the specific activity of the enzyme in the cell extract. *One unit of enzyme activity is defined as 
that which releases 1 jimol product (expressed as xylose equivalents) per minute.








Figure 5.9 SDS-PAGE analysis of the purification stages of mutant xylA.cd2
Lane 1, SDS-PAGE Broad range markers; lane 2, Total cells; lane 3, Cell extract; lane 4, Cell 
debris; lane 5, HiTrap Q anion exchange unbound fraction; lane 6, HiTrap Q anion exchange 
total bound protein.
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Figure 5.10 Zymogram of purification stages of mutant xylA.cd2
Clearing zones indicate areas of xylanase activity. Lane 1, SDS-PAGE Broad range markers; 
lane 2, Total cells; lane 3, Cell extract; lane 4, Cell debris; lane 5, HiTrap Q anion exchange 
unbound fraction; lane 6, HiTrap Q anion exchange total bound protein.
5.3.3 Mutant xylA.cd2 characterisation
5.3.3.1 Identification o f  disulphide bond
The DTNB assay was used to determine the number of free thiol groups in both the 
original and mutant xylA.cd2 proteins, as a means of deducing whether the two 
introduced cysteine residues have actually formed a disulphide bond. The absorbance 
values gained from the reactions with both original and mutant proteins were almost 
equal, and using the reasoning set out below this result suggests that both proteins 
contain an equal number of free thiol groups:
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• A=scl, (where A = absorbance, 8  = molar absorption coefficient, c = concentration 
of protein and 1 = pathlength), therefore concentration = A/el
• For original xylA.cd2, 0.0ImM protein + excess DTNB —► AA412 = 0.155
• So, concentration of SH groups = 0.155/13,600 x 1 M
= 0.0114mM SH groups
• Therefore number of SH groups per xyl A. cd2 molecule = 0.0114/0.01
= 1.14
• For mutant xylA.cd2,0.OlmM protein + excess DTNB —► AA412 = 0.162
• So, concentration of SH groups = 0.162/13,600 x 1 M
= 0.0119mM SH groups
• Therefore number of SH groups per mutant xylA.cd2 molecule = 0.0119/0.01
= 1.19
These calculations suggest that both original and mutant xyl.cd2 proteins contain the 
same number of free thiol groups.
5.3.3.2 Determination o f appropriate enzyme dilution and specific activity
Standard DNS assays were performed on the purified mutant xylA.cd2 enzyme to
determine an appropriate dilution to use in the studies of its activity with temperature 
and thermal stability, and also to determine its specific activity. A series of assays were 
carried out using varying volumes of a 1/250 dilution of the mutant xylA.cd2, and it was 
determined that a 1/5000 dilution would be an appropriate dilution to use to ensure that 
initial rates were being measured. Figure 5.11 graphically represents these results. The 
purified mutant xylA.cd2  enzyme demonstrated a specific activity of 10,600 units per 
mg of protein.
5.3.3.3 Temperature optimum for activity
As for the original xylA.cd2 enzyme, the mutant xylA.cd2 was assayed at various 
temperatures from 18°C to 80°C, and these results are shown in Figure 5.12. Blank
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reactions (with lOOpl PC buffer in place of the lOOpl enzyme dilution) were carried out 
at each temperature to account for any degradation of the soluble xylan substrate at the 
higher temperatures, although no significant increase in absorbance of the blank samples 
was observed. The maximum activity of the purified xylA.cd2 was observed at 55°C.
5.3.3.4 Thermal inactivation
The same temperatures as used to study the original xylA.cd2 enzyme were used to 
study the thermal stability of the mutant enzyme, so that a direct comparison between 
the two could be made. These results are represented graphically in Figure 5.13 and 
show that the purified mutant enzyme has a half-life of just less than one hour at 58°C, 
which reduces to 1.2 minutes at 64°C. Figure 5.14 shows the Arrhenius plot of these 
data (plotted according to equation 3.1), and allows the activation energy for the 
inactivation process (Ea) of the mutant xylA.cd2 to be calculated as 624kJ/mol.




Volume (nl) o f  1/250 enzyme dilution
Figure 5.11 Mutant xylA.cd2 activity against volume of a 1/250 enzyme dilution
Each point represents the mean of duplicate assays.
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Figure 5.12 Temperature activity curve for xylA.cd2
Activities are expressed as a percentage of activity at 55°C, as this was the temperature at which 
maximum activity was observed. Each point represents the mean of 4 assays.
95






















•S  2 . 0  -
1 2  3 4
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Figure 5.13d
Figure 5.13 Thermal inactivation of mutant xylA.cd2
Data are shown as In (% activity) against incubation time (% activity being calculated as a 
percent of maximum activity, seen at time 0). Lines of best fit, calculated by linear regression, 
are shown.
Figure 5.13a Thermal inactivation of mutant xylA.cd2 at 58°C
Figure 5.13b Thermal inactivation of mutant xylA.cd2 at 60°C
Figure 5.13c Thermal inactivation of mutant xylA.cd2 at 62°C
Figure 5.13d Thermal inactivation of mutant xylA.cd2 at 64°C
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1/Temperature (K)
0.00296 0.00297 0.00298 0.00299 0.00300 0.00301 0.00302 0.00303
-0.5 -
-4.5 -
Figure 5.14 Arrhenius plot for mutant xylA.cd2 thermal inactivation data
Data from Figure 5.13 are represented as an Arrhenius plot, according to the Arrhenius equation 
(Equation 3.1). Linear regression has been used to calculate a line of best fit through the data.
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5.3 DISCUSSION
5.3.1 Construction of a site-directed mutant xylA.cd2 enzyme and confirmation of 
the introduction of a disulphide bond
This chapter has described the construction of a disulphide bond mutant of N. 
patriciarum xylA.cd2. Site-directed mutagenesis has been used to introduce the 
necessary base changes into the xylA.cd2 coding sequence by PCR such that in the 
translated protein amino acid residues 133 and 177 have been mutated from an 
isoleucine and an aspartic acid to cysteine residues.
The DTNB assay has been used as a means to ‘deduce’ that a disulphide bond has 
indeed been formed in the mutant protein between the two introduced cys residues. 
DTNB can be used to quantitatively determine the number of free thiol groups in a 
protein. The original xylA.cd2 protein has only one cys residue, whereas the mutant 
xylA.cd2 has three. Of these three it was hoped that two would have formed a disulphide 
bond, thus leaving only one free thiol group in the mutant protein. Unfolding both the 
original and mutant xylA.cd2 proteins with 6M guanidine and incubating them in excess 
lOmM DTNB gave almost the same absorbance reading when measured at 412nm. As 
both proteins were present in the reaction mixture in equal molar amounts, this suggests 
that they both have the same number of free thiol groups in them, and as such it could be 
predicted from these data that the two cysteine residues introduced into the mutant have 
formed a disulphide bond.
Mutant xylA.cd2 was expressed and purified in the same way as the original xylA.cd2. 
A slightly lower yield of 75% was obtained for the mutant protein, which constituted 
18% of the total protein. SDS-PAGE analysis showed the purified mutant xylA.cd2 to be 
over 90% pure. Its specific activity, measured to be 10,600U/mg, is almost identical to 
that of the original xylA.cd2 (10,400U/mg). This indicates that the introduction of a 
disulphide bond has not altered the three-dimensional structure of the mutant enzyme in 
a way that may have caused a conformational change in or near the active site. This can 
be proposed as any change in the enzymes structure that affects its active site would be
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reflected in its catalytic efficiency, and as a result a decrease in specific activity would 
be expected.
5.3.2 Comparison of mutant to original xylA.cd2 enzyme
Assaying the mutant xylA.cd2 over a range of temperatures had shown that its optimum 
temperature for activity is 55°C. When these data are compared with that of the original 
xylA.cd2 it can be seen that both enzymes have a very similar temperature activity 
profile. Figure 5.15 shows both profiles on the same axes, and it can clearly be seen that 
both profiles share the same optimum temperature. Closer inspection shows that the 
mutant enzyme has a greater percentage maximum activity when assayed at 58°C, in 
comparison to the original enzyme over the same incubation time. This trend is also 
visible at 60°C, but beyond this point both profiles follow the same path, with percent 
maximum activity values being almost identical. The overall aims of the project are to 
increase the stability of xylA.cd2 without affecting its activity at lower temperatures. 
This comparison of temperature activity between the mutant and wild-type enzymes 
suggests that the introduction of a disulphide bond has had no real effect on the overall 
activity of xylA.cd2 at any temperature. However, this does not indicate that the stability 
of the enzyme at elevated temperatures remains unaffected.
Comparison of the thermal inactivation rates for the two enzymes reveals that there is a 
notable difference between them. At all temperatures studied the mutant is more than 
twice as stable as the original enzyme. At 58°C, which is only 3 degrees above the 
optimum temperature for activity, the mutant has a half-life 3.5 fold higher than the 
original xylA.cd2. This increase in half-life remains at least 2.5 fold higher for all the 
other temperatures studied. Figure 5.16 shows a graphical comparison of the thermal 
inactivation data for both original and mutant xylA.cd2, and Figure 5.17 shows a 
comparison of the thermal inactivation data represented as an Arrhenius plot. The 
activation energy (Ea) for the inactivation process for the mutant enzyme has been 
calculated as 624kJ/mol. This is larger than the Ea for the original xylA.cd2 (which is 
calculated as 478kJ/mol) and supports the observation that the mutant enzyme is more
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stable than the original. Table 5.3 summarises the comparison of data obtained for the 










Figure 5.15 Comparison of temperature activity profiles for original and mutant 
xylA.cd2
Activities are expressed as a percentage of activity at 55°C, as this demonstrated to be the 
temperature at which the maximum activity was observed. Black line represents original 
xylA.cd2; red line represents mutant xylA.cd2. Each point represents the mean of 4 assays.
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Figure 5.16c Figure 5.16d
Figure 5.16 Comparison of thermal inactivation data from original & mutant xylA.cd2
Data are shown as In (% activity) against incubation time (% activity being calculated as a 
percent of maximum activity, seen at time 0). Black line represents original xylA.cd2; red line 
represents mutant xylA.cd2. Lines of best fit, calculated by linear regression, are shown.
Figure 5.16a Thermal inactivation at 58°C
Figure 5.16b Thermal inactivation at 60°C
Figure 5.16c Thermal inactivation at 62°C
Figure 5.16d Thermal inactivation at 64°C
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Figure 5.17 Comparison of Arrhenius plots for original and mutant xylA.cd2 thermal 
inactivation data
Data from Figure 5.16 are represented as an Arrhenius plot, according to the Arrhenius equation 
(Equation 3.1). Black line represents original xylA.cd2; red line represents mutant xylA.cd2. 
Linear regression has been used to calculate a line of best fit through the data.
ORIGINAL XYLA.CD2 MUTANT XYLA.CD2
Temperature Optimum 55°C 55°C
Ti/2at58°C 16 min 56 min
Ti/2at 60°C 5.75 min 17 min
Ty2at 62°C 1.9 min 4.7 min
T1/2at 64°C 0.5 min 1.2 min
Ea for inactivation 478 kJ/mol 624 kJ/mol
Table 5.3 Comparison of temperature optimum and thermal stability data for 
original and mutant xylA.cd2 enzymes
T1/2 represents half-life; Ea represents activation energy for the inactivation process.
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5.4 CONCLUSIONS
This chapter has described attempts to increase the thermal stability of N. patriciarum 
xylA.cd2 by constructing a site-directed mutant enzyme with an equivalent disulphide 
bond to that found in thermostable xylanases. Characterisation of the mutant enzyme and 
comparison to data obtained from the original xylA.cd2 enzyme show that while the 
mutant does not demonstrate a detectable increase in its temperature optimum for 
activity, it is notably more stable than the original enzyme at temperatures above 55°C. 
A DTNB assay has been used to deduce that the two introduced cysteine residues have 
actually formed a disulphide bond, and the fact that the mutant enzyme has an almost 
identical specific activity to the original xylA.cd2 suggests that the substitution of 
residues and introduction of a disulphide bond have not compromised the structure of 
the enzyme in a way that leads to a decrease in activity.
These results support the idea that thermal stability is not caused simply by a single 
change within the structure of a protein. It is often suggested that thermophilic enzymes 
demonstrate an increased stability over their mesophilic counterparts by a combination 
of effects, for example increased numbers of ion pairs and hydrogen bonds, decreased 
flexibility, increased compactness, and this seems to be the case here. While the 
introduction of a disulphide bond does appear to have contributed to an increase in 
stability of the xylA.cd2 enzyme, it has not ‘transformed’ the enzyme from mesophilic 
to thermophilic. It is, however, a good basis for improvement, and in conjunction with 
other thermostabilising features may facilitate a greater stability in the xylA.cd2 enzyme.
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Chapter 6
CONSTRUCTION OF A RANDOM MUTANT LIBRARY AND
INITIAL SCREENING
6.1 INTRODUCTION
Directed evolution is a powerful tool that is being increasingly employed over rational 
design approaches to generate enzymes demonstrating new or improved properties. 
Evolution in a laboratory situation can be used to explore non-natural enzymic functions 
in addition to improving existing properties. From an industrial point of view directed 
evolution presents the opportunity to modify and improve important biocatalysts, and 
this is the basis behind this section of work.
As previously described, the industrial application of the second catalytic domain of N. 
patriciarum xylanase A is as an animal feed additive. In keeping with the aims of this 
project, which are to improve the thermal stability of xylA.cd2 whilst retaining its 
activity at lower temperatures, directed evolution has been utilised in attempts to 
generate mutant forms of the enzyme that display increased thermostability. Successful 
improvements of any property using directed evolution are usually achieved by a 
process of mutation and screening that is repeated several times. Screening for the 
desired property in a library of random mutants is, therefore, of considerable importance 
as it may be required to identify only small improvements at each individual stage. The 
screen described in this chapter studies the thermal stability of the mutant xylA.cd2 
enzymes in situ, within the E. coli cells transformed with the random mutant library.
The basis of directed evolution is to introduce random errors into the coding sequence of 
the enzyme of interest using an error-prone PCR technique. Error-prone PCR is similar 
to standard PCR (as described in section 2.1.3), the main difference being the 
concentration of MgCh and deoxynucleoside triphosphates used in the reaction. By 
varying these concentrations the DNA polymerase is forced into making errors by 
misincorporating bases when copying the DNA template. Taq DNA polymerase is used
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in place of the usual Vent polymerase as the former has a reduced proof-reading ability, 
and as such will be more prone to making errors when copying the template.
This chapter will describe the generation of a random mutant library of xylA.cd2 clones, 
and the initial agar plate-based screening method employed to identify positive mutants. 
It will also describe the characterisation of four mutants identified from the screen that 
demonstrate potential improvements in stability. Conclusions about the success of the 
random mutagenesis method and screening process are drawn by comparing the 
characteristics of the four mutant enzymes to those of the original xvlA.cd2 enzyme.
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6.2 MATERIALS AND METHODS
All methods used in this chapter not outlined below can be found in Chapter 2.
6.2.1 Materials
Taq DNA polymerase and 5-bromo-4-chloro-3-indoyl-|3-D-galactopyranoside (X-gal) 
were purchased from Sigma, Poole, Dorset, UK. Electroporation competent Epicurian 
Coli® cells were purchased from Stratagene, La Jolla CA, USA (Genotype: el4- (McrA) 
A(mcrCB-hsd SMR-mrr)171 endl supE44 thi-1 gyrA96 relAl lac recB recj sbcC 
umuC::Tn5 (kanr) uvr C [F'proAB lacIqZA (Ml5 Tn 10 (Tetr)J). All other materials 
used in this section are as outlined in Chapter 2, sections 2.1.1,2.2.1 and 2.3.1.
6.2.2 Random mutagenesis technique: Error-prone PCR
Random mutations were introduced into the xylA.cd2 coding sequence by error-prone 
PCR (EP-PCR). Reactions were carried out using pUC18.cd2 as the template DNA. The 
cd2 insert was amplified by Taq DNA polymerase using primers 5 and 6, designed to a 
region of the pUC18 vector flanking the poly-cloning site. Full details of all primers can 
be found in the Appendix. A total of 45pmol of each primer was used in all reactions. 
Three separate rounds of EP-PCR were performed. In each round 4 separate reactions 
were carried out: one control reaction (using non-error inducing conditions) and 3 
reactions using a 1/1000, 1/10,000 and 1/100,000 dilution of the template DNA 
respectively. Each reaction used 5 jul of the diluted template DNA. In the first round the 
template DNA was pUC18.cd2. In the subsequent rounds the product from the previous 
round that used the most dilute template to achieve a product was used as the template. 
Table 6.1 summarises the concentrations of deoxynucleoside triphosphates and MgCL 
used in the control and error-prone reactions.
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Table 6.1 Summary of concentrations of deoxynucleoside triphosphates and MgCl2 
used in EP-PCR reactions
5U Taq DNA polymerase were used in each reaction, which was incubated in buffer 
supplied by the manufacturer. The final reaction mixture was overlaid with 20pl mineral 
oil to prevent evaporation. A ‘hot-start’ PCR technique was used, where the reaction 
mixture is heated to 96°C for 5 minutes prior to the addition of the polymerase. The 
following conditions were then repeated for 30 cycles before a final 10 minutes 
extension at 72°C:
94°C denaturation step 1 min
55°C annealing step 1 min
72°C extension step 2 min 30 s
IOjj.1 of each reaction was run on a 1% agarose gel, as described in section 2.1.2, to 
check the products and choose the most appropriate one to use as the template in the 
next round of EP-PCR. The third round products were purified by phenol/chloroform 
extraction as follows: lOOpl of a 1:1 phenol:chloroform solution was added to the PCR 
reaction and vortexed vigorously before centrifugation at 12,000g for 1 min. The DNA 
in the top layer was precipitated by the addition of lOpl of 3M ammonium sulphate 
solution. IOOjliI of isopropanol was then added and the solution incubated at -20°C for 30
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minutes before centrifugation again at 12,000g for 15 minutes. The supernatant was 
removed and the pellet resuspended in 20pl distilled water.
6.2.3 Construction of the random mutant library and transformation into E. coli 
The purified products of the EP-PCR reactions were digested with both Hindin and 
EcoRI, as described in section 2.1.5, before being ligated into Hindlll and EcoRI 
digested pUC18 plasmid vector using the Rapid DNA Ligation Kit (section 2.1.6). The 
product of this ligation reaction is a random mutant libraiy of xylA.cd2 in pUC18. The 
random mutant library was transformed into Epicurian Coli® electroporation competent 
cells by electroporation, as follows: 3pi of DNA from the random mutant library was 
added to 30pl of electroporation competent Epicurian Coli® in a pre-chilled 0.2mm 
electroporation cell on ice. The cells were electroporated using a Biorad Gene Pulser™ 
at 1.7kV with a 1ms pulse, immediately after which 1ml of LB broth, pre-incubated to 
37°C, was added to the cells. After incubation at 37°C for 1 hour the cells were spread 
onto LB-agar plates supplemented with lOOpg/ml ampicillin and 40pg/ml X-gal and 
incubated overnight at 37°C. For analysis of library size and estimation of the number of 
xylanase active clones, varying volumes of the transformed cells were spread onto LB- 
agar plates supplemented with lOOpg/ml ampicillin, 40pg/ml X-gal and 500pg/ml RBB- 
xylan.
6.2.4 Agar plate screen: Heat inactivation and RBB-xylan overlay assay 
Thermal stability of the randomly mutated enzymes was assessed by performing a heat 
inactivation step on the E. coli cells transformed with the random mutant library. The 
transformants were grown overnight at 37°C on LB-agar plates supplemented with 
lOOpg/ml ampicillin. The resulting colonies were incubated for 30 minutes at 85°C 
before being immediately transferred to -20°C for 10 minutes. Once cooled down the 
plates were overlaid with 7ml xylan blue agar (500pg/ml xylan blue, 2% (w/v) agar in 
20mM tris-HCl, pH 7.5) and incubated at 37°C until clearing zones became visible in 
the xylan-blue agar around the colonies (approximately 2 hours). Plasmid was prepared 
from colonies retaining xylanase activity after this heat inactivation step, and was
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retransformed into Epicurian Coli®. The resulting transformants were streaked out onto 
a fresh LB-agar plate with ampicillin and grown overnight at 37°C before being 
subjected to a more stringent screening process.
6.2.5 Further characterisation of improved mutants
Mutants identified from the initial screen as retaining activity after the heat inactivation 
step were subjected to a longer incubation at 85°C. The potentially improved mutants 
were streaked out onto fresh LB-agar plates, as described above, alongside cells 
containing the original pUC18.cd2 construct. The resulting colonies were incubated at 
85°C for 45 minutes, before being chilled at -20°C and assayed for residual activity by 
the RBB-xylan agar overlay assay, as described in section 6.2.4. Plasmid was prepared 
from cultures of each mutant still retaining activity after this extended heat inactivation, 
as described in section 2.1.8, and the mutant xylA.cd2 insert was sequenced to identify 
any mutations in the coding sequence.
6.2.6 Expression and partial purification of mutant xylA.cd2 enzymes
The mutant xylA.cd2 proteins were expressed from 50ml cultures of LB supplemented 
with lOOpg/ml ampicillin as described in section 2.2.5. Epicurian Coli® cells harbouring 
the mutant plasmid clones were harvested after approximately 16 hours of growth. The 
cells were disrupted by sonication and a cell extract was prepared as described in section 
2.2.5.1.
6.2.7 Characterisation of mutant xylA.cd2 enzymes
The unfractionated preparations of mutant xylA.cd2 enzymes, along with a similar 
preparation of the original xylA.cd2 enzyme for comparison (transformed into Epicurian 
Coli® cells and prepared as described above), were characterised in the same way as the 
original xylA.cd2 protein (Chapter 3). Their specific activities were determined as 
outlined in section 3.2.5. Temperature optimum for activity was determined for all the 
enzymes as described in section 3.2.6, and their thermal stability at 60°C was 
determined by a thermal inactivation study as described in section 3.2.7.
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6.3 RESULTS
6.3.1 Construction of the random mutant library
The xylA.cd2 insert was amplified from pUC18.cd2 using primers designed to a region 
of the pUC18 vector flanking the poly-cloning site. The sequence of primers 5 and 6, 
which were a kind gift from Dr Simon Andrews, can be found in the Appendix.
6.3.1.1 Amplification o f xylA. cd2 by EP-PCR
The first round of EP-PCR resulted in a product with all of the template dilutions used 
(Figure 6.1a). The product from the 1/100,000 diluted template reaction was used as the 
template for the second round of EP-PCR. The second round reactions also resulted in a 
product being formed with all of the template dilutions used (Figure 6.1b). As for the 
second round reactions, the 1/100,000 diluted template reaction product was used as the 
template for the third round of EP-PCR. This time a significant product was formed only 
with the 1/1000 template dilution (Figure 6. lc). This third round product was purified by 
phenol/chloroform extraction, digested with Hindlll and EcoRI and directionally cloned 
into similarly digested pUC18 plasmid vector. After transformation into 
electrocompetent Epicurian Coli® cells, successful transformants were selected for by 
growth on LB-agar plates containing lOOpg/ml ampicillin.
6.3.1.2 Estimation o f library size and number o f active clones
Plating varying volumes of the transformed Epicurian Coli® cells onto LB-agar plates 
containing ampicillin, X-gal and RBB-xylan allowed an estimation of the size of the 
library and the proportion of xylanase-active clones. X-gal allows blue/white screening, 
indicating clones that do not/do contain an insertion in the poly-cloning region of the 
pUC18 plasmid, and RBB-xylan allows clones to be assessed for xylanase activity, with 
colonies expressing active mutant xyl.cd2 displaying a clearing zone around them. These 
methods of assessment showed that of the white colonies, i.e. the ones with a xylA.cd2 
insert, in the random mutant library, approximately 50% were xylanase-active. The total 
size of the library, estimated by dividing the number of colonies on a plate by the
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volume spread onto the plate, and multiplying by the total volume of the library, is 
approximately 60,000 clones.
6.3.2 Selection criteria for agar plate screen
The original xylA.cd2 enzyme was used to set selection criteria by which the random 
mutant enzymes could be assessed, using the method described in section 6.2.4. After 
determining that 85°C was a suitable temperature for the heat inactivation step, the 
original xylA.cd2, transformed into Epicurian Coli® cells, was subjected to inactivation 
at 85°C for 15, 30 and 45 minutes. After 30 minutes the majority of colonies did not 
show any remaining xylanase activity on the RBB-xylan agar. After 45 minutes all 
xylA.cd2 activity had been inactivated, as judged by the complete lack of clearing zones 
around colonies on the RBB-xylan agar. From these results it was decided to initially 
incubate the cells transformed with the random mutant library at 85°C for 30 minutes, 
then choose the colonies with a large visible halo around them and assay for remaining 
activity after 45 minutes at 85°C using the RBB-xylan agar overlay assay.
6.3.3 Identification of stable mutants
Using the initial agar plate screen (section 6.2.4) approximately 3500 colonies were 
screened and 24 mutants were identified as having large halos, indicating strong residual 
activity, after 30 minutes at 85°C. Plasmid was prepared from these 24 colonies, 
retransformed into Epicurian Coli® cells and subjected to a longer inactivation at 85°C. 
The original xylA.cd2 enzyme was incubated alongside the mutants for comparison. The 
results of this secondary heat inactivation step identified 4 mutants that still retained 
xylanase activity after 45 minutes, whereas the remaining 20 mutants, along with the 
original xylA.cd2, had no clearing zone around them, indicating no residual activity. 
These 4 mutants were identified as mutants 3, 4, 5 and 12, and were designated as such 
for further study.
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Figure 6.1 Identification of EP-PCR products by agarose gel electrophoresis 
6.1a First round reaction products
Lane 1, lkb DNA molecular weight markers; lane 2, 1/1000 diluted template product; lane 3, 
1/10,000 diluted template product; lane 4, 1/100,000 diluted template product; lane 5, control 
reaction product (non-error inducing conditions); lane 6, lkb DNA molecular weight markers.
6.1b Second round reaction products
Lanes as 6. la  lanes 1-5.
6.1c Third round reaction products
Lane 1, 1/1000 diluted template product; lane 2, 1/10,000 diluted template product; lane 3, 
1/100,000 diluted template product; lane 4, control reaction product, lane 5, lkb DNA molecular 
weight markers.
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6.3.4 Sequencing of mutants 3 ,4 ,5  & 12
The inserts of the 4 mutant plasmid clones were sequenced using the M l3 universal 
sequencing and reverse primers. One sequencing reaction from each direction allowed 
the full insert sequence to be obtained. Comparison of the mutant sequences to that of 
the original identified PCR-introduced mutations in the inserts for mutants 3, 4 and 12, 
and these are summarised in Table 6.2. No sequence mutations were identified in the 
xylA.cd2 coding region for mutant 5.
6.3.5 Characterisation of mutants 3 ,4 ,5  & 12
In order to further characterise the 4 isolated mutant enzymes, they were each expressed 
from a 50ml culture and partially purified by preparing a cell extract. A cell extract from 
a culture expressing the original xylA.cd2 was also prepared, and was assayed alongside 
the 4 mutants so that a comparison could be made between them.
6.3.5.1 Specific activities
The specific activities of the partially purified mutants and original xylA.cd2 were 
determined by carrying out a series of standard assays using dilutions of the cell extracts 
from 1/250 to 1/10,000. It was determined that a 1/4000 dilution of all the partially 
purified enzymes would be an appropriate dilution to use in order to ensure initial rates 
were being measured in further assays (data not shown). Table 6.3 summarises the 
specific activities.
6.3.5.2 Temperature optima for activity
The partially purified enzymes were assayed at various temperatures from 19°C to 80°C, 
and these results are shown in Figure 6.2. For ease of comparison the activity has been 
converted to specific activity, and the activity profiles for each of the 5 enzymes have 
been plotted on the same graph. Blank reactions (with 100pl PC buffer in place of the 
IOOjliI enzyme dilution) were carried out at each temperature to account for any 
degradation of the soluble xylan substrate at the higher temperatures, although no
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significant increase in absorbance of the blank samples was observed. The maximum 
activity of the original xylA.cd2 and the mutant enzymes was observed at 55°C.
6.3.5.3 Thermal stability at 60 °C
Using the information already obtained about the thermal characteristics of the original 
xylA.cd2 (Chapter 3), 60°C was chosen as a suitable temperature at which to study the 
thermal stability of the partially purified mutants. Each mutant enzyme was heat 
inactivated over 15 minutes at 60°C, and Figure 6.3 graphically represents these results. 
Table 6.4 summarises the half-lives of each of the 4 mutant enzymes, in comparison to 













3 136 A G Asn Asp
4 652 A G Thr Ala
12 88 A G Asn Asp
Table 6.2 Summary of mutations identified in the xylA.cd2 coding region of the 4 random 
mutant clones
♦The ‘location o f mutation’ column refers to the base number o f the mutation within the 
xylA.cd2 coding region, where the full region is 675 bases.
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Figure 6.2 Temperature activity curves for original and 4 mutant xylA.cd2 enzymes
Activities are expressed as specific activity for each individual temperature. Each point 
represents the mean of duplicate assays. Blue line represents original xylA.cd2; green line 
represents mutant 3; red line represents mutant 4; purple line represents mutant 5; yellow line 
represents mutant 12.
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Figure 6.3 Thermal inactivation at 60°C of original and 4 mutant xylA.cd2 enzymes
Data are shown as In (% activity) against incubation time (% activity being calculated as a 
percent of maximum activity, seen at time 0). Lines of best fit, calculated by linear regression, 
are shown. Blue line represents original xylA.cd2; green line represents mutant 3; red line 
represents mutant 4; purple line represents mutant 5; yellow line represents mutant 12.






Table 6.4 Comparison of half-lives at 60°C of original and mutant xylA.cd2 enzymes
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6.4 DISCUSSION
6.4.1 Random mutant library construction
Error-prone PCR has been used to generate random mutants of the xylA.cd2 coding 
sequence, and these mutants have been cloned into pUC18 plasmid vector in order to 
produce a random mutant library where, in theory, each individual clone contains a 
slightly different xylA.cd2 insert. By using a DNA polymerase with reduced proof­
reading ability along with ‘abnormal’ concentrations of MgCE and deoxynucleoside 
triphosphates, and by diluting the template as much as possible to still achieve a product, 
it is possible to force the polymerase into making mistakes when it is copying the 
template DNA. As a result bases are misincorporated into the DNA product, and thus 
mutations are introduced into the coding sequence. Performing three rounds of EP-PCR, 
and using serial dilutions of the template, ensures that enough extension has been 
performed by the polymerase to be certain that mutations have been incorporated into 
the sequence. The conditions used in the production of this xylA.cd2 random mutant 
library, which were optimised by Dr Simon Andrews at the University of Newcastle, 
should result in the introduction of mutations that will equate to one or two amino acid 
substitutions per mutant enzyme.
6.4.2 Library screening and identification of improved mutants
Using the agar plate-based screen described in sections 6.2.4 and 6.2.5, 3500 random 
mutant clones were screened, and from these 24 were identified as having strong 
residual activity after the first heat inactivation step. These 24 were not the only mutants 
to display activity after the heat step, but the clearing zones around these colonies were 
clearly visible early after they had been overlaid with RBB-xylan. For ease of handling 
24 mutants were chosen initially, and of these 24 four seemed to show improvements in 
stability after the second heat inactivation step.
Mutants 3, 4, 5 and 12 were identified from the secondary screen as being more stable 
than the original xylA.cd2. On sequencing the inserts of these four mutants it became 
apparent that while 3, 4 and 12 do have introduced errors in their sequence, mutant 5 
does not. Mutants 3 and 12 share the same amino acid substitution, although not in the
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same position within the enzyme; they both have a residue substituted from an 
asparagine to an aspartic acid. These substitutions could be considered 
‘thermostabilising’ as the amide side chain of asparagine can undergo deamidation at 
higher temperatures, so changing it to a residue with a more stable side chain should 
help to improve the stability of the protein. Additionally, the peptide bond between 
asparagine and other amino acids is more prone to cleavage at elevated temps so 
removing this factor may also help to improve stability. Mutant 4 has a threonine to 
alanine substitution, and it is difficult to predict how, if at all, this substitution may lend 
itself to increasing thermostability. It is also difficult to suggest why mutant 5 appears 
more stable than the original xylA.cd2 when there are no apparent mutations in its 
sequence. One possible suggestion could be that a mutation outside the xylA.cd2 coding 
region, for example in the few lacZ residues expressed on the N-terminal of the 
xylA.cd2 protein, has lead to either an increase in stability, which would explain the 
results obtained, or an increase in expression of the enzyme. The latter may explain the 
observed results if an increase in expression meant that more enzyme was present inside 
the colonies containing the mutant 5 clone. More enzyme may mean that over the same 
heat incubation time as the other mutants not all the enzyme was inactivated. Or 
alternatively, the cells may lyse on heating and colonies expressing more enzyme may 
release it onto the agar, causing an artificially high clearing zone of activity when the 
plates are overlaid with RBB-xylan.
6.4.3 Expression and partial purification of improved mutants
In order to characterise mutants 3,4, 5 and 12 in more detail these mutant enzymes were 
partially purified and their temperature activity profiles and thermal stability at 60°C 
were studied. As these are only partially purified enzymes, and the characterisation data 
available for the original xylA.cd2 is on pure protein, a cell extract was also prepared 
from a culture of the original enzyme, and this was studied in parallel to the mutants so 
that a true comparison between them could be made. As for the original xylA.cd2, these 
mutants are cloned in frame with the lacZ promoter of pUC18 and as a result the 
expressed protein has the extra few amino acids at the N-terminus. A mutation in these 
residues could be the reason for the apparent increase in stability seen in mutant 5, as
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discussed above, although the sequence observed was only definite for the actual 
xylA.cd2 coding region so mutations in these residues could not be determined with 
certainty.
6.4.4 Comparison of improved mutants to original xylA.cd2
Before the EP-PCR library was screened for mutant xylA.cd2 enzymes displaying an 
improvement in thermostability, the agar plate-based screening method, outlined in 
section 6.2.4, was used to set selection criteria by which the mutants could be assessed. 
The original xylA.cd2 enzyme was put through the screen, and its characteristics were 
used to set the criteria that promising mutants must exceed in order to be considered 
improved in their thermal stability.
All four mutants demonstrate the same optimum temperature for activity as the original 
xylA.cd2 (55°C). In addition, the thermal stability data suggest that none of the mutants 
are any more stable than the original. They all have very similar half-lives at 60°C to 
the original xylA.cd2 (around 12 minutes), with the exception of mutant 4 which has a 
reduced half-life of 8 minutes. When the specific activities are compared mutants 3, 4 
and 12 are all similar to each other and to the original enzyme while mutant 5 has an 
apparently decreased specific activity. These values are, however, only a rough guide. 
Specific activities calculated from cell extracts are subject to the influence of other 
factors, for example actual expression levels, and as such a true comparison of specific 
activities can only be made with values obtained from pure protein.
From these characterisation results it can be concluded that these four mutant xylA.cd2 
enzymes do not demonstrate any improvements in stability in comparison to the original 
enzyme.
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6.5 CONCLUSIONS
This chapter has described the use of directed evolution in attempts to develop a mutant 
xylA.cd2 enzyme that displays an improved thermal stability in comparison to the 
original enzyme. A random mutant library of xylA.cd2 clones has been produced, and an 
agar plate-based screening method has been used in an attempt to identify mutants 
demonstrating an increase in thermal stability. Four potentially improved mutants were 
isolated using this screen, but on further characterisation they did not actually appear to 
be any more stable than the original enzyme.
The results obtained in this chapter highlight the need for a much more reliable method 
of screening the random mutant library. It is often said that directed evolution 
experiments are only as successful as the screen used to isolate improved mutants from 
the random mutant library, and this has been demonstrated here. The agar plate screen 
used in this chapter has proved to be unsuccessful in isolating mutants demonstrating a 
true increase in stability, and confirms the need for a much more consistent and 
reproducible method of screening.
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Chapter 7




Random mutagenesis experiments rely crucially on the accuracy of screening methods in 
order to identify variants from a random mutant library that show improvements in the 
desired properties. This has been demonstrated in Chapter 6, where the initial method of 
screening the N. patriciarum xylA.cd2 random mutant library has proved to be 
unreliable in identifying promising mutants demonstrating an increase in stability. The 
aim of this project is to increase the stability of xylA.cd2 whilst retaining its activity at 
physiological temperatures. This means that the directed evolution screening process 
needs to be capable of selecting for two individual properties: increased stability at 
elevated temperatures and maintenance of high activity at physiological temperatures. It 
has been shown that often the activities of thermophilic enzymes at lower temperatures 
are compromised with respect to their mesophilic or psychrophilic homologues 
(Meiering et al., 1992; Shoichet et al., 1995). This has lead to the suggestion that 
enzymes cannot be both highly thermostable and highly active at low temperatures. 
Rather than being due to a mutually exclusive relationship (stability and activity making 
mutually exclusive demands on enzyme flexibility), an explanation for this observed 
trade-off between stability and activity could be simply that natural selection has 
selected for one or the other, but not both properties (Schreiber et a l, 1994). This would 
suggest that it is possible for enzymes to be both thermostable and active at lower 
temperatures, providing that selective pressure is applied for both properties at the same 
time.
96-well plate based systems are commonly used in situations where many samples need 
to be screened quickly and efficiently. The availability of mechanical equipment such as 
automated colony-picking machines and reagent dispensers means that many more 
samples can be screened in a given time than would be physically possible by hand.
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Even without robotic equipment microtitre plates allow efficient organisation of 
samples, and with basic equipment such as multi-channel pipettes many samples can be 
screened easily and proficiently. It is the aim of this section of work to design an 
efficient system that will facilitate the screening of a random mutant library of xylA.cd2 
clones, and thereby permit the identification of variants demonstrating an increased 
stability whilst retaining high levels of activity at lower temperatures. In order to make 
the screen as efficient as possible, consideration has to be given not only to the 
effectiveness of each stage of the screening process, but also to the ease and convenience 
with which the screen may be performed. The basis for development of this screen 
comes from the thermostability screening method used by Giver et al (1998). Their 
method of cell growth and thermostability screening in microtitre plates has been 
adapted for the xylA.cd2 enzyme. All the developmental work described in this chapter 
has been carried out on pUC18.xylA.cd2 clones transformed into E. coli JM109 cells. 
Due to the developmental nature of this section of work, this chapter will be in a slightly 
different format to previous ones, and will focus on each section of the screen 
individually.
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7.2 MATERIALS AND EQUIPMENT
7.2.1 Materials
Lysozyme and Breath-Easy™ breathable membranes (catalogue number Z38,006-9) 
were purchased from Sigma, Poole, Dorset, UK. Thermofast® 96-well PCR plates and 
heatproof adhesive seals were purchased from Abgene, Surrey, UK. Gilson DistriTip 
repeat dispensing syringes were purchased from Anachem, Bedfordshire, UK. Deep- 
well plates and flat-bottomed microtitre plates were purchased from Thermo Life 
Sciences, Hampshire, UK. BugBuster™ protein extraction reagent was purchased from 
Novagen UK, Nottingham, UK (catalogue number 70584-3). All other materials not 
listed here can be found in sections 2.1.1 and 2.3.1.
7.2.2 Equipment
A Gilson Distriman repeat pipette and Finnpipette electronic multi-channel pipettes were 
used to dispense sample aliquots and manipulate micro-cultures. A Grant microplate 
heater, model QBTP, was used initially to heat the 96-well plates. The thermal cycler 
used in subsequent assays was an Eppendorf 96-well Mastercycler. Final absorbance 
values were measured on a SPECTRAmax® PLUS384 microplate reader and 
manipulated using SOFTmax® PRO software.
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7.3 CELL GROWTH
7.3.1 Aim
To successfully grow JM109 pUC18.xylA.cd2 transformants in 96-well plate mini­
cultures.
7.3.2 Method
Initial attempts to grow JM109 pUC18.xylA.cd2 clones in 96-well plate format were 
carried out in 1ml cultures in deep-well plates. This method proved unsuccessful due to 
excessive clumping of the cells during growth. Subsequent attempts to grow JM109 
pUC18.xylA.cd2 clones were based on the method of Giver et al (1998). 200pl of LB 
broth, supplemented with lOOpg/ml ampicillin, was dispensed into all 96 wells of a flat- 
bottomed microtitre plate. Each individual well was inoculated with a single colony of 
JM109 containing the pUC18.xylA.cd2 plasmid using a sterile pipette tip. The plate was 
then covered with a breathable membrane and incubated at 30°C for 24 hours to allow 
cell growth. The breathable membrane is made from polyurethane and is permeable to 
oxygen, carbon dioxide and water vapour. The cultures were incubated with vigorous 
shaking at 320 rpm to ensure good aeration and gas exchange through the membrane. 
After 24 hours the mini-cultures were duplicated by transferring 5jnl of each well into a 
new plate containing fresh medium and ampicillin. The original plates were stored at 
4°C and the duplicate plates were again covered with a breathable membrane and grown 
for an additional 16 hours.
7.3.3 Results and discussion
The initial method proved unsuccessful very early on, with the cells clumping together 
during growth. The 1ml cultures were difficult to manipulate easily and rapidly due to 
their large size. The deep-well plates also proved difficult to seal with a membrane, and 
as such cross-contamination could not be ruled out.
The subsequent method was much more successful, both in terms of actual culture 
growth and ease of execution. Using standard 96-well microtitre plates and smaller 
volumes means that the cultures are easy to manipulate using multi-channel pipettes.
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Growing the cultures at a slightly lower temperature eliminated the clumping problem, 
and sub-culturing for a second time seemed to even out the growth generally over all the 
wells so that the cell density (estimated by reading the absorbance of the cultures at 
600nm) was fairly uniform over the entire plate. The breathable membranes were 
effective at sealing individual wells while still allowing the necessary gas exchange for 
cell growth. Cross contamination between wells was eliminated using the smaller culture 
volumes in standard microtitre plates. This was demonstrated by dispensing media to all 
wells of a plate but only inoculating a selection with single colonies. After incubation at 
30°C for 24 hours there was only growth visible in the wells that had been inoculated 
with a single colony.
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7.4 LYSIS OF CELL CULTURES
7.4.1 Aim
To develop a successful method of lysing the 200(4,1 mini-cultures of JM109 cells 
containing the pUC18.xylA.cd2 plasmid, so that the xylA.cd2 enzyme can be released 
and subsequently assayed for activity.
A set of experiments was performed to determine which method, from a selection of 
commonly used cell lysis methods, would be most suited to lysing the mini-cultures in 
situ in the 96-well microtitre plates. In addition to the effectiveness of lysis, each method 
was assessed for ease and convenience of use. The effectiveness of each method was 
determined by assaying the culture lysate for xylanase activity using a scaled-down 
version of the standard DNS assay described in section 2.3.2.
7.4.2 Method





These methods were compared to cultures assayed for xylanase activity without any 
method of cell lysis. The protocol is outlined below:
4 plates containing replicas of the same twelve 200pl mini-cultures of JM109 harbouring 
the pUC18.xylA.cd2 plasmid were treated as follows: Plate 1 was treated with a 
lOmg/ml stock of lysozyme (isolated from chicken egg white)( 1(4,1 per lOOpl of culture 
was added to each well to give a final concentration of lOOpg/ml) and incubated at room 
temperature for 2 hours; plate 2 was stored at -20°C overnight to lyse the cell cultures by 
freeze-thawing; plate 3 was treated with 40(4,1 of BugBuster™ (a commercially available 
detergent-based protein extraction reagent that perforates the E. coli cell wall to liberate 
the soluble protein) per well and incubated at room temperature for 15 minutes 
(according to manufacturer’s instructions); plate 4 cultures were lysed by sonication 
(cultures subjected to 30s burst at 8-10 microns, peak to peak).
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After lysis each culture was assayed for xylanase activity as follows. The standard DNS 
assay was scaled down 5-fold so that the whole assay could be performed in 96-well 
plates. 20pl of the lysed cell cultures were transferred to a 96-well plate and incubated 
with 80pl of 0.2% soluble xylan for 15 minutes at 37°C. The assay was terminated by 
the addition of lOOpl of DNS reagent and the plates were incubated at 100°C for 20 
minutes, followed by 10 minutes on ice. The absorbance of each sample was read in a 
microplate reader at 575nm.
7.4.3 Assessment of results
METHOD
% ACTIVITY 
(in comparison to no lysis)
No lysis 100 ±5.5
Lysozyme 145 ± 5.6
Freeze-thawing 125 ±4.4
BugBuster™ 113 ± 8.1
Sonication 138 ±10.1
Table 7.1 Comparison of xylanase activity after the various lysis methods tested
Activity is expressed as percent activity observed in the cultures assayed after no method o f lysis 
(where ‘no lysis’ activity is 100%). Values given are mean ± standard error o f 12 assays.
Table 7.1 summarises the lysis experiment results, and shows the mean and standard 
error of 12 samples assayed after the various lysis methods. It can be seen that the 
increase in activity seen after the various methods of lysis is not that large, with an 
average maximum increase of only 45% seen when lysozyme is used. The 
pUC18.xylA.cd2 clone expresses high levels of the highly active xylA.cd2 protein, 
which are detectable without actually lysing the cells. This is also visible when the 
Congo Red overlay assay is used to detect xylanase activity in E. coli cells streaked out 
on agar plates: these cells exhibit activity yet they are not broken open during the course 
of the assay. For the purpose of lysing random mutant xylA.cd2 cell cultures in the 96- 
well plate screen, the aim is to release as much of the enzyme as possible so that the
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maximum amount of activity can be detected when the mutants are screened for activity 
and stability.
The above results suggest that using lysozyme has been the most effective way of lysing 
the cells, giving an increase in activity of just under 50%. In more detail, the method of 
lysis was as follows: 1 pi of a lOmg/ml stock of lysozyme was added per IOOjliI of cell 
culture, giving a final concentration of lOOpg/ml. After addition of lysozyme the wells 
were thoroughly mixed using a pipette to ensure even distribution of the lysozyme 
throughout the cell culture, and then the mixed cultures were incubated at room 
temperature for 2 hours with vigorous shaking at 320rpm, before being assayed for 
xylanase activity.
The other methods of lysis used varied in their success. Sonication showed an average 
increase in activity of 38%, only a few percent lower than lysozyme. Sonication, 
however, was the most difficult and time-consuming method to perform, with each well 
having to be sonicated individually, and it also had the largest error associated with it. 
There is a drop in increased activity seen between sonication and freeze-thawing, with 
freeze-thawing only showing a 25% average increase in activity over the ‘no lysis’ 
control. BugBuster™, the final method to be tested, was the least successful, showing an 
average increase in activity of only 13%. This method also had quite a large standard 
error associated with it.
The above results clearly suggest that lysozyme is the most effective method of lysing 
mini-cultures in 96-well plates. In addition to being effective at lysing the cells it was a 
simple method to employ, confirming that it would be ideal for the random mutant 
library screening system; the lysozyme was distributed into individual wells using a 
repeat dispenser, then the wells were mixed by pipetting the culture up and down with a 
multi-channel electronic pipette. The plates were then simply incubated with shaking at 
room temperature for 2 hours before being assayed.
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7.4.4 Optimisation of lysis using lysozyme
Having determined that using lysozyme is the most effective way to lyse mini-cultures 
in 96-well plates, the method was optimised further in order to obtain as great an 
increase as possible in the activity seen in comparison to control cultures that have not 
been lysed.
Lysis of the mini-cultures was observed using a final lysozyme concentration of 
lOOpg/ml, and with an increased concentration of 250pg/ml at both room temperature 
and 37°C for varying incubation times. After incubation the samples were assayed for 
xylanase activity as described above.










No lysis 100 100 100 100
lhr incubation 108 145 101 111
2hr incubation 139 227 92 115
4hr incubation 161 196 79 101
Table 7.2 Comparison of xylanase activity after lysis of cell cultures with lysozyme 
for varying times and at varying temperatures
Activity is expressed as percent activity observed in the cultures assayed after no method o f lysis 
(where ‘no lysis’ activity is 100%). Values given are the mean of duplicate assays.
Table 7.2 summarises the attempts to increase the amount of activity seen in cell cultures 
after lysis by varying the original lysozyme method conditions. It can be seen that 
increasing the concentration of lysozyme used from lOOpg/ml to 250pg/ml made a 
significant difference at room temperature. After only a one hour incubation the activity 
had increased by almost 50%, equivalent to the increase seen after 2 hours incubation 
with 100pg/ml lysozyme. Another large increase was seen after 2 hours incubation, 
where over a 100% increase from the no lysis control was observed. After 4 hours
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incubation with lOOpg/ml lysozyme the activity was still increasing, and showed a 61% 
increase over the no lysis control. 4 hours incubation with 250pg/ml lysozyme showed a 
decrease in activity compared to the 2 hours value, but the activity remained 
significantly higher than after 4 hours with lOOpg/ml.
Incubation at 37°C was not as successful as at room temperature, with both lysozyme 
concentrations used. The maximum amount of activity observed at 37°C was after 2 
hours incubation with 250jug/ml lysozyme, but this only showed an increase of 15% 
above the no lysis control. A possible explanation for the decrease in activity seen after 
incubation at 37°C could be that the xylA.cd2 enzyme is being degraded by proteolysis. 
Intra-cellular proteases released as the cells are lysed could be responsible for breaking 
down some of the expressed xylA.cd2, and as a result a lower activity is observed. This 
would help to explain why less activity is seen at 37°C, as the proteases would be more 
active at this temperature.
7.4.6 Final culture lysis conditions
The results of these above experiments clearly demonstrate that in order to obtain the 
maximum amount of xylanase activity from random mutant xylA.cd2 mini-cultures the 
best way to lyse the cells is to use an increased concentration of 250pg/ml lysozyme, 
and to incubate the cultures at room temperature for 2 hours with vigorous shaking at 
320 rpm.
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7.5 OPTIMISATION OF XYLANASE ACTIVITY ASSAY
7.5.1 Aim
To optimise the conditions of the scaled down DNS assay in terms of lysate volume, 
amount of substrate and assay incubation time to ensure that the initial rate of reaction is 
measured.
Initially the 96-well plate assays were performed in flat-bottomed plates and the 
incubation steps were carried out on a micro-plate heater. As the assay optimisation 
progressed it became clear that this method was inaccurate and was compromising the 
precision essential for this screen. The improved method places samples to be assayed in 
96-well PCR plates, and uses a 96-well thermal cycler for accurate incubation at any of 
the given temperatures. The problems associated with using the micro-plate heater will 
be discussed later.
7.5.2 Standard Curve
With each set of assays performed in 96-well plate format a standard curve was run in 
parallel. This was achieved using standard solutions of D(+)xylose in a scaled down 
version of the original method (section 2.3.2). Stock solutions ranging from 0.2 to 
1 mg/ml were made and lOOpl of each of these were transferred to a 96-well plate along 
with lOOpl of DNS reagent. The plate was sealed before being heated at 100°C for 20 
minutes to develop the colour. lOOpl of the standard solutions were transferred to a new 
plate to be read for absorbance at 575nm. Figure 7.1 shows a sample standard curve, 
with each point representing the mean of triplicate samples.
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Figure 7.1 A typical standard curve obtained using 96-well plate assay format
7.5.3 Lysate volume, amount of substrate and assay incubation time
Previous studies on the original xylA.cd2 clone (Chapter 3) have shown that the 
expressed protein is highly active, and that it is necessary to make a large dilution in 
order to ensure measuring the initial rate of reaction when assaying the enzyme. It is 
necessary to make sure that the initial rate of reaction for the activity of random mutants 
is being measured in this 96-well plate screen, as this will ensure that any differences in 
activity before and after heat inactivation are as clear as possible to identity. Assays 
were performed with varying amounts of undiluted lysate, then with dilutions of lysate, 
for varying times to determine the best dilution and time combination that would ensure 
that the initial rate of reaction was being measured. The concentration of substrate was 
varied from the original 0.2% soluble xylan used in the standard assays in an attempt to 
increase the absorbance values obtained at 575nm after the 96-well plate assays; as large 
an absorbance as possible at 575nm will again help to make differences in activity as 
clear as possible to identify. The incubation time of the assays in 96-well plate format 
was also studied so that with the given conditions of lysate dilution and substrate amount 
it was certain that the initial rate of reaction was being measured. These studies and their 
results are reported below in chronological order.
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7.5.3.1 Undiluted lysate
The culture lysates were assayed for activity as described in section 7.4.2: 20pl of lysate 
was incubated with 80jli1 of 0.2% soluble xylan for 15 minutes at 37°C, then IOjj.1 DNS 
reagent was added and the samples heated for 20 minutes at 100°C to develop the 
colour. To initially determine the activity of xylA.cd2 in the culture lysates they were 
assayed undiluted. A comparison of the activity seen in 20pl of lysate and 5 pi lysate 
(made up to 20pl with buffer) showed that the same amount of activity was visible in 
both, which suggested that both reactions were reaching completion over the 15 minutes 
of incubation at 37°C.
A time-course study using 5 pi of the undiluted lysate showed that after 4 minutes the 
final absorbance seen at 575nm was the same as that seen after 15 minutes. These results 
all illustrated that, as expected, the expressed xylA.cd2 in the culture lysates was highly 
active, and in order to be sure of measuring the initial rate of the reaction the lysates 
would need to be diluted.
7.5.3.2 Diluted lysate 
• Experiment 1
An assay was performed using varying volumes of a 20-fold dilution of culture lysate. 
The assay used the standard conditions of 15 minutes at 37°C and 0.2% soluble xylan 
substrate and is performed in a flat-bottomed 96-well plate on a micro-plate heater.
Figure 7.2 shows the results of this assay in graphical form. A linear relationship 
between observed activity and lysate volume, which is indicative of the measurement of 
initial rates, was observed only up to lOpl of added lysate. Therefore, if a 20-fold 
dilution of the culture lysate is to be used in the screen then a volume less than lOjul is 
necessary.
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Figure 7.2 Study of xylA.cd2 activity against lysate volume for a 20-fold dilution of cell 
lysate
Each point represents the mean of 3 individual wells.
• Experiment 2
The above experiment was repeated using further dilutions of the cell lysates. In addition 
to a 20-fold dilution, 50-fold and 100-fold dilutions were also made and studied. Again 
the assays were performed using the standard conditions described above. Figure 7.3 
graphically represents these assay results, and it can be clearly seen that the results using 
a 100-fold dilution most closely represent a straight line.
Final lysate conditions chosen from these results are lO^ il of a 100-fold dilution of 
cell lysate.
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Figure 7.3 Study of xylA.cd2 activity against lysate volume for different cell lysate 
dilutions
Black line represents 20-fold dilution; red line represents 50-fold dilution; blue line represents 
100-fold dilution. Each point represents the mean of 3 individual wells.
7.5.3.3 100-fold lysate dilution: assay incubation time study
Using the new dilution conditions for measuring activity in the cell lysates, a time- 
course study was carried out to determine the most appropriate incubation time for the 
assays to ensure initial rates are being measured. 100-fold dilutions of the cell lysates 
were made, and the assay was allowed to proceed for varying times up to 15 minutes. 
0.2% soluble xylan was used as the substrate, and the assays were again performed in a 
96-well flat-bottomed plate on a micro-plate heater.
The results of these assays, illustrated in Figure 7.4, clearly show that assaying for 
xylA.cd2 activity over 15 minutes using lOpl of a 100-fold dilution of lysate does not 
measure the initial rate of the reaction. Figure 7.4 shows that the curve begins to level 
off after 5 minutes, indicating that if I O jlxI  of a 100-fold lysate dilution is used as the 
standard conditions for screening then the incubation time for the assays needs to be 
reduced.
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Figure 7.4 Study of xylA.cd2 activity against time for IOjjJ of a 100-fold dilution of 
culture lysate
Each point represents the mean of 2 individual wells.
It can be seen in Figure 7.4 that there is a visible lag in activity after the first minute o f  
activity. This is most likely due to a delay in heating the reaction mixture to 37°C by the 
micro-plate reader. If the reaction only just reaches 37°C by the time it is terminated by 
the addition o f DNS reagent then very little activity will be observed. This problem will 
be discussed in more detail later in this chapter.
Final assay incubation time chosen from these results is 8 minutes.
7.5.3.4 Varying substrate amount
Although the conditions o f the assay are ensuring that the initial rate o f reaction is being 
measured, the absorbance values measured at 575nm are quite low. Low absorbance 
values may make it more difficult to distinguish between variations seen in the random 
mutants, and to determine whether the variations are actual differences between the 
mutant and original xylA.cd2, or whether they are insignificant errors within the 
screening process. If the absorbance values can be increased this will help to eliminate
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the possibility of overlooking promising mutants by amplifying the differences in their 
activity and stability.
Using the standard conditions so far of lOjul of a 100-fold dilution of lysate in an 8- 
minute assay, the percentage of soluble xylan used as substrate was varied and the 
activity was measured.
Figure 7.5 illustrates the effect of altering substrate concentration over the period of an 
8-minute assay. It can be seen that increasing the percentage of soluble xylan used does 
increase the absorbance values obtained; a 3-fold increase from the 0.2% values is seen 
with 0.6% soluble xylan, but overall the increase in absorbance values is not that large.
This series of assays was repeated over 15 minutes. Although previously 15 minutes was 
shown to be outside the linear range of the assay with 0.2% soluble xylan substrate, if 
the overall absorbance can be increased using a higher percentage substrate over a 
longer assay then a step back can be taken and the amount of lysate can be altered such 
that the assay falls back into the linear range. Figure 7.6 represents these assay results, 
and demonstrates that a higher absorbance can be obtained using a longer assay and 
higher percentage substrate.
Final substrate percentage chosen from these results is 0.6%. Using this result the 
assay of activity against time needs to be repeated, using 0.6% soluble xylan to see if a 
15-minute assay incubation time is outside the initial rate of reaction. If this is the case 
then altering the lysate volume may allow the assay to come back into the linear range 
while still retaining the higher absorbance values.
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Figure 7.5 Study of xylA.cd2 activity against percentage of soluble xylan substrate for 
an 8-minute assay
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Figure 7.6 Study of xylA.cd2 activity against percentage of soluble xylan substrate for 
a 15-minute assay
Study used lOpl of a 100-fold dilution of culture lysate. Each point represents the mean of 3 
individual wells.
138
Chapter 7: Development of 96-well plate screening system
7.5.3.5 Assay incubation time study: 0.6% soluble xylan, 100-fold lysate dilution 
Using the new substrate amount of 0.6%, a time-course study was performed to
determine the longest possible incubation time for the assay that would still allow the
initial rate of reaction to be measured. The standard lysate conditions of lOpl of a 100-
fold dilution were used in the time-course assays.
Figure 7.7 illustrates these results, and it can be seen that with the new percent substrate 
the assay is almost linear, with the curve beginning to level off after 15 minutes. There is 
a lag in activity visible after the first 2 minutes of the assay, and this is again most likely 
due to the samples not getting up to the correct temperature during the course of the 
assay.
Final assay incubation time based on these results is 10 minutes. There is now a need 
repeat the assays of activity against lysate volume to see whether decreasing the volume 
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Figure 7.7 Study of xylA.cd2 activity against time
Study used lOpl of a 100-fold dilution of lysate and 0.6% soluble xylan substrate. Each point 
represents the mean of 3 individual wells.
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7.53.6 Lysate volume study: 100-fold lysate dilution, 0.6% soluble xylan substrate, 15- 
minute assay
Using the now standard conditions of 0.6% soluble xylan substrate, 15-minute assay and 
100-fold dilution of culture lysate, assays were performed that varied the volume of 
diluted lysate. The substrate and incubation time being used allow greater absorbance 
values to be observed, but as shown in the above section 15 minutes is outside the linear 
range of the assay. Reducing the volume of lysate slightly may help to ensure that the 
initial rate of reaction is being measured, while still allowing larger absorbance values to 
be measured.
Figure 7.8 represents the results of varying the 100-fold diluted lysate volume in the 
assay. It shows that if the lysate volume is reduced by just 2pi, to 8pl, then the assay 
comes into the linear range and the initial rate is being measured.
In order to reduce possible sources of error within this 96-well plate screen the number 
of steps requiring pipetting small volumes of liquid should really be kept to a minimum. 
Using 8pl of a 100-fold dilution of culture lysate requires 3 different pipetting stages: 
one to dispense the buffer and lysate to make the 100-fold dilution; one to transfer 8pl of 
the dilution to the assay plate; and one to add 12jnl of buffer to the 8pl of lysate so that 
the final volume of the enzyme fraction of the assay is 20pl. This can be reduced to 
only 2 stages by increasing the volume of lysate used, but using a more dilute lysate. 8pi 
of a 100-fold dilution is equivalent to using 20pl of a 250-fold dilution. This way, only 2 
pipetting stages are required: one to make the dilution and one to transfer the 20pl to the 
assay plate. Using this different lysate dilution will eliminate a step where error could be 
introduced into the screen, and so will help to keep the screen as accurate as possible. A 
final study needs to be performed using these new dilution amounts to be certain that the 
assay is still measuring the initial rate of the reaction.
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Figure 7.8 Study of xylA.cd2 activity (shown as absorbance at 575nm) against 100-fold 
diluted lysate volume
Study used 0.6% soluble xylan substrate over a 15-minute assay.
7.5.3.7 Final assay incubation time study: 250-fold lysate dilution, 0.6% soluble xylan 
substrate
A final time-course study was performed using the new lysate amount of 20pl of a 250- 
fold dilution, along with the standard 0.6% soluble xylan substrate, to confirm that 15 
minutes is still within the linear range of the reaction.
Figure 7.9 represents these results and shows that 15 minutes is actually too long, as the 
straight-line portion of the graph has begun to level off after 12 minutes.
From these results the final assay conditions have been chosen as 20pl of a 250-fold 
dilution of culture lysate, with 80pl of 0.6% soluble xylan substrate over a 10- 
minute assay.
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Figure 7.9 Study of xylA.cd2 activity (shown as absorbance at 575nm) against time
Study used 20jil of a 250-fold lysate dilution and 0.6% soluble xylan substrate.
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7.6 ASSESSMENT OF THERMAL STABILITY
7.6.1 Aim
To develop a successful heat inactivation step that will allow the differentiation of 
random mutants showing an increase in stability and/or activity from those whose 
characteristics have remained the same as the original xylA.cd2.
The idea behind this section of the screening process is to determine the activity of 
individual xylA.cd2 random mutants both before and after a heat inactivation step. 
Using the method of Giver et al. (1998), the stability of each mutant will then be 




S represents the stability of each mutant
At is the residual activity of each mutant, determined by activity assay at 37°C after
heat inactivation, and is expressed as absorbance units at 575nm/10 minute assay 
Ai is the initial activity of each mutant, determined by activity assay at 37°C, and is
expressed as absorbance units at 575nm/10 minute assay
A method needs to be developed that incorporates the standard assay conditions 
determined in the above section with a heat incubation step so that sufficient loss of 
activity is seen. Again, all of the optimisation work described in this section has been 
carried out on pUC18.xylA.cd2 clones transformed into E. coli JM109 cells. It is 
intended to use the information obtained with the original xylA.cd2 enzyme to set 
selection criteria that will be applied to the randomly mutated enzymes.
It is known from studies of the original xylA.cd2 enzyme described in Chapter 3 that 
60°C is a crucial temperature in terms of the stability of the enzyme. 60°C is just above 
the optimum temperature for activity of the enzyme, and beyond this temperature
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inactivation is rapid. This would seem an ideal temperature around which to base the 
heat inactivation step, as any mutants with improved stability should be easily detectable 
at this temperature (as is shown with the site-directed mutant of xylA.cd2, described in 
Chapter 5).
7.6.2 Heat Inactivation: 65°C, micro-plate heater
Initial attempts to determine an appropriate temperature and incubation time for the heat 
inactivation step were performed in 96-well flat-bottomed plates on the micro-plate 
heater. Given the lag in activity already observed (thought to be due to the samples not 
immediately reaching the correct temperature), 65°C was chosen over 60°C for the 
initial heat inactivation studies. 250-fold dilutions of the culture lysates were made, and 
20jul were transferred to a separate plate for the initial activity assay. The remaining 
230pl of diluted lysate was heated at 65°C and 20pl samples were taken out at various 
time points and placed for 5 minutes in a second plate, which had been pre-chilled on ice 
to stop the inactivation, before being assayed for residual activity.
This method of heat inactivation proved to be somewhat unsuccessful. Figure 7.10 
shows the results of this experiment, and it can be clearly seen that, while there is some 
sort of inactivation taking place, the method is not very accurate. It can be roughly 
estimated that approximately 50% of activity is lost over 15 minutes. Duplicate 
experiments were run in tandem, and the results of both are shown in Figure 7.10. It is 
expected that the results of this experiment should represent an inactivation curve when 
plotted as in Figure 7.10. The duplicate points are not as similar as would be hoped for 
two identical experiments on separate dilutions of the same culture lysate. These 
problems suggest that there has not been uniform heating across the plate during the heat 
inactivation step.
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Figure 7.10 Heat inactivation study at 65°C using a micro-plate heater
Duplicate points are shown for each time point. The study used standard assay conditions of 
250-fold lysate dilution, 0.6% soluble xylan substrate over 10 minutes. Activity is expressed as 
percent of maximum activity (observed at 0 minutes).
7.6.3 Problems with micro-plate heater
Throughout these optimisation experiments there have been noticeable problems with 
the incubation steps, both in the heat inactivation and the various assay steps. It has been 
apparent that the micro-plate heater has not been efficient at heating the samples being 
studied in the 96-well plates, and as a result the final absorbance values for the 
individual wells have not been as precise as they could have been. The most common 
problems observed are outlined below:
■ Uneven heating seen across the whole plate. This is most noticable after the 
heat inactivation step but presumably is occurring during all incubations. The 
effect is mainly due to the fact that the 96-well flat-bottomed plates do not 
actually sit flat on the heating block of the micro-plate heater.
■ At the higher assay incubation temperature the flat-bottomed plates appear to 
warp over time, again leading to uneven heating across the whole plate.
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■ The seals used on the plates are not very effective, and at the higher 
incubation temperatures there is visible leakage and evaporation from 
individual wells.
It is essential for any screening process that all the individual stages of the screen are as 
uniform and reproducible as possible, and the introduction of possible sources of error is 
kept to a minimum. This is particularly important in a screen like this one, which relies 
on the measurement of small differences in activity to distinguish between random 
mutants that show an increased stability and/or activity, and those whose characteristics 
are the same as the original xylA.cd2. The equipment used to manipulate the culture 
lysates and transfer reagents to and from 96-well plates is all as precise as possible in 
terms of delivering accurate volumes: electronic multi-channel pipettes with volume 
handling tips ranging from lpl to 500pl have been used. The only areas of the screen to 
be lacking in accuracy and precision are the heating steps.
So far these optimisation experiments have been carried out on cultures of original 
xylA.cd2, and the results obtained have been sufficient to draw conclusions about each 
separate optimisation experiment. Now that the assay conditions have been optimised, 
the real core of the screen needs to be developed; that is, determining the heat 
inactivation step such that random mutants with an increase in stability will stand out 
from those whose properties have remained the same as the original enzyme. For this 
part of the screen it is vital that the heating process is accurate and precise, and that each 
individual well within a 96-well plate receives the same treatment with regards to timed 
incubation at a given temperature. It was felt that the only way to achieve this with any 
degree of certainty was to change the apparatus used to heat the 96-well plates. 
Therefore, it was decided that the heat inactivation step, and all the assay steps, would 
now be performed on a 96-well thermal cycler. A thermal cycler is designed to deliver 
uniform heat, and 96-well PCR plates are designed for efficient heat transfer between 
the machine and the liquid within the individual wells. In addition, the thermal cycler 
has a ‘hot-top’ lid, which will serve to eliminate the evaporation problem seen with the 
original method.
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7.6.4 Heat inactivation: 65°C, 96-well thermal cycler
The heat inactivation time-course experiment described above was repeated, the only 
difference being the equipment used to carry out the heat steps for both the inactivation 
and assay. As before, 250-fold dilutions of the culture lysates were made, 20pl were 
transferred out for the initial activity assay and the rest was heated at 65°C for varying 
times before being assayed for residual activity. The results of this experiment (not 
shown) clearly demonstrate that the heat inactivation step is now actually being carried 
out at the incorrect temperature; 65°C is much too high and all the activity is lost within 
10 minutes.
7.6.5 Heat inactivation: 60°C, 96-well thermal cycler
The heat inactivation time-course experiment was repeated exactly as before, the only 
difference being that the inactivation was performed at 60°C rather than at 65°C. These 
results, illustrated in Figure 7.11, show clear inactivation and much improvement in the 
correlation between duplicate samples. This inactivation profile suggests that 
approximately 40% of activity is lost over 10 minutes.
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Figure 7.11 Heat inactivation study at 60°C using a 96-well thermal cycler
Duplicate points are shown for each time point. Study used standard assay conditions. Data are 
shown as In (% activity) against incubation time (% activity being calculated as a percent of 
maximum activity, seen at time 0). Line of best fit shown is calculated by linear regression.
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7.6.6 Heat inactivation: 60°C, 96-well thermal cycler, inactivating assay volume 
only
The aim of these optimisation experiments has been to determine the best way of 
screening random mutants of xylA.cd2 in the most accurate and precise way possible. 
As discussed previously, reducing the number of stages within the screen will help to 
reduce the number of places where errors could be introduced. It was for this reason that 
it was decided to repeat the heat inactivation study using just the 20pl of diluted lysate 
required for the assay.
The new method was as follows: 250-fold dilutions of the culture lysates were made, 
then using a multi-channel pipette on repeat dispense mode 20pl of the dilutions were 
transferred to 2 new plates. The first plate was assayed for initial activity at 37°C, and 
the second plate was heated at 60°C for 10 minutes before being placed immediately in 
an ice/water bath for 5 minutes, and then assayed for residual activity at 37°C. This 
method was easier to perform in terms of lysate manipulation and ease of handling of the 
96-well plates. It was possible to perform the inactivation step with such a small volume 
of lysate as the heated lid of the 96-well thermal cycler prevented any evaporation.
The results of this study however showed no activity in any of the wells after heating at 
60°C. This was most likely due to the fact that the 20pl of diluted lysate reached 60°C 
almost immediately, and as a result 10 minutes completely inactivated the enzyme. This 
suggests that the earlier method of heating all the remaining diluted lysate (after 20pl 
had been removed for the initial activity assay) was not actually that effective at heating 
the lysate up to 60°C, and in actual fact the lysate dilutions were not up to 60°C for the 
full period of the assay. One final experiment now needs to be performed, and the heat 
inactivation time-course study repeated using only 20pl of the diluted lysates to 
determine an appropriate incubation time for heat inactivation.
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7.6.7 Final heat inactivation study: 60°C time-course study with 20pl of diluted 
lysate only
The final heat inactivation study was a time-course study performed on only 20pl of the 
diluted lysates at 60°C. Figure 7.12 shows the results of this study. The inactivation 
profile shows that when heating only 20 j l i 1 of lysate approximately 40% of activity is lost 
over only 3 minutes.
From these results the final heat inactivation conditions have been chosen as 3 
minutes incubation at 60°C of 20pl of 250-fold diluted culture lysates, followed by 
immediate incubation in an ice/water bath for 5 minutes, then 5 minutes at room 
temperature before being assayed for residual activity at 37°C.
4.5
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Figure 7.12 Heat inactivation study at 60°C using a 96-well thermal cycler and 20p.l of 
diluted culture lysate only
Duplicate points are shown for each time point. The study used standard assay conditions. Data 
are shown as In (% activity) against incubation time (% activity being calculated as a percent of 
maximum activity, seen at time 0). Line of best fit shown is calculated by linear regression.
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7.7 FINAL TEST: USING OPTIMISED CONDITIONS IN AN ASSAY 
SITUATION
As a final confirmation that the developed 96-well plate screen is as consistent, 
reproducible and efficient as possible a final test assay was carried out using the original 
xylA.cd2 enzyme. A whole 96-well plate was inoculated with single colonies of E. coli 
containing the pUC18.cd2 plasmid construct, and the mini-cultures were grown and 
lysed using the now standard conditions, outlined in sections 7.3 and 7.4 above. The 
whole plate of lysates was then subjected to thermal stability screening and assay using 
the final conditions described in sections 7.5 and 7.6.
Figure 7.13 is a plot of stability, represented as Ar/Ai, against initial activity, Ai. This 
figure demonstrates the range over which values for the original xylA.cd2 can fall. 
Plotting the data obtained from the screening of true mutants on the same graph will help 
to visualise those that fall outside the ‘normal’ range of activities and stabilities for the 
original enzyme. This will aid the identification of mutants displaying improvements in 
stability and/or activity. Table 7.3 summarises the data obtained from this final study.
Initial activity, Ai
MEAN VALUE 
± STANDARD DEVIATION 
0.835 ±0.128
Residual activity, Ar 0.410 ±0.130
Stability, Ar/Ai 0.479 ±0.074
Table 7.3 Summary of the activity va! ues obtained from the final test of the 96-well
plate random mutant library screening system
Activity values shown are mean ± standard deviation obtained from 96 individual cell cultures.
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Figure 7.13 Graph showing stability against initial activity for 96 individual xylA.cd2 
cultures
151
Chapter 7: Development of 96-well plate screening system
7.8 SUMMARY: OPTIMISED PROTOCOL AND SELECTION CRITERIA
The final optimised protocol for screening the xylA.cd2 random mutant library is as
follows:
Growth of cell cultures
■ Transformants demonstrating xylanase activity on RBB-xylan agar plates will be 
picked into individual wells of a 96-well plate, with each well containing 200jul of 
LB with lOOpg/ml ampicillin.
■ Cultures will be covered with a breathable membrane grown for 24 hours at 30°C 
with shaking at 320rpm.
■ 5pi of each culture will be transferred to a new plate containing 200pl fresh LB with 
ampicillin and grown for a further 16 hours.
Lysis of cell cultures
■ 5pi of a lOmg/ml stock of lysozyme will be dispensed into each well, and the wells 
mixed thoroughly with a multi-channel pipette.
■ The cultures will be incubated at room temperature for 2 hours, with shaking at 
320rpm.
Determination of xylanase activity and stability of mutants at 60°C
■ Each lysate will be diluted 250-fold in PC buffer.
■ 20pl aliquots will be transferred to 2 separate 96-well PCR plates: one plate will be 
assayed directly for activity at 37°C (initial activity, Ai); the other plate will be 
assayed for residual activity (Ar) after a heat inactivation step at 60°C.
■ The heat inactivation step will be performed by covering the plate with a heat-proof 
seal and incubating at 60°C for 3 minutes in a 96-well thermal cycler, followed 
immediately by incubation on ice for 5 minutes, then incubation at room temperature 
for 5 minutes.
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■ Both plates will be assayed for activity (either initial or residual) by dispensing 80pl 
of a 0.6% soluble xylan solution into each well, covering with a heatproof seal and 
incubating the plates at 37°C in a 96-well thermal cycler.
■ After 10 minutes the assay will be terminated by the addition of lOOjul DNS reagent. 
The reagent colour will be developed by incubation at 100°C for 20 minutes in a 96- 
well thermal cycler, followed immediately by incubation on ice for 10 minutes, then 
10 minutes at room temperature.
■ lOOjal of each sample will be transferred to a flat-bottomed 96-well plate and the 
absorbance of the plate read at 575nm.
Assessment of thermal stability of mutants
■ The ratio of residual to initial activity (Ar/Ai) will be calculated for all the mutants
and will be plotted on a graph of Ar/Ai against Ai. Mutant ratio values will be
compared to the original xylA.cd2 characteristics.
■ Mutants displaying less than 20% of the original xylA.cd2 activity will be discarded 
from further study.
■ Mutants displaying residual activity greater than 60% (Ar/Ai value of greater than
0.6) will be put through a second screening process with a longer heat inactivation 
step of 5 minutes at 60°C.
■ Promising mutants will be compared in more detail to the original xylA.cd2 with 
respect to their thermal stability and temperature activity profiles.
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Chapter 8
RANDOM MUTANT LIBRARY SCREENING USING 96-WELL
PLATE SYSTEM
8.1 INTRODUCTION
This chapter will bring together the random mutant library described in Chapter 6 and 
the 96-well plate screening system optimised in Chapter 7. It will describe the use of the 
screening system to study the random mutant library, and will describe the isolation of 
12 mutant enzymes demonstrating an improvement in thermal stability over the original 
xylA.cd2. It will describe the characterisation of three of these 12 mutants, and the 
success of the 96-well plate system, judged by comparing the characteristics of the 
mutant and original enzymes, will be discussed.
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8.2 MATERIALS AND METHODS
All methods used in this chapter not outlined below can be found in Chapters 2,6 and 7.
8.2.1 Materials
All materials used in this section are as outlined in Chapter 2, sections 2.1.1, 2.2.1 and 
2.3.1, Chapter 6, section 6.2.1 and Chapter 7, section 7.2.
8.2.2 Random mutant library screening
The random mutant libraiy was transformed into Epicurian Coli® cells as described in 
section 6.2.3, and the transformants were spread onto LB-agar plates containing 
500pg/ml RBB-xylan in addition to 100pg/ml ampicillin and 40pg/ml X-gal. Colonies 
with a clearing zone around them were picked into 200pl mini-cultures in 96-well plates 
and were grown as described in section 7.8. These mini-cultures were then lysed and 
assayed for activity before and after a heat inactivation step as described in section 7.8.
8.2.3 Further characterisation of improved mutants
Any random mutants displaying a residual activity greater than 60% were put through an 
extended heat inactivation step of 5 minutes at 60°C. Mutants still retaining at least 60% 
of activity after this step were chosen for more detailed studies, and of these any mutants 
showing only a slight decrease in activity between 3 and 5 minutes of inactivation were 
chosen for individual study. Plasmid was prepared from these mutant cultures as 
described in section 2.1.8, and the mutant xylA.cd2 inserts were sequenced to identify 
any mutations in the coding sequence.
8.2.4 Expression and partial purification of mutant xylA.cd2 enzymes
The mutant xylA.cd2 proteins were expressed from 50ml cultures of LB supplemented 
with lOOpg/ml ampicillin as described in section 2.2.5. E. coli strain JM109 cells 
harbouring the mutant plasmid clones were harvested after approximately 16 hours of 
growth. The cells were disrupted by sonication and a crude cell extract was prepared as 
described in section 2.2.5.1.
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8.2.5 Characterisation of mutant xylA.cd2 enzymes
The unfractionated preparations of mutant xylA.cd2 enzymes were characterised in the 
same way as the original xylA.cd2 protein (Chapter 3). Their specific activities were 
determined as outlined in section 3.2.5. Temperature optima for catalytic activity were 
determined for all the enzymes as described in section 3.2.6, and their thermal stabilities 
at 64°C were determined by a thermal inactivation study as described in section 3.2.7.
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8.3 RESULTS
8.3.1 Initial random mutant selection
The random mutant library screened in this section of work is the one produced in 
Chapter 6, whose characteristics are described in section 6.3.1.2. Approximately 40,000 
colonies were initially screened on RBB-xylan agar plates, and of these 960 (ten 96-well 
plates) xylanase-active colonies were picked into mini-cultures and assayed for activity 
and thermal stability.
8.3.2 Identification of stable mutants and further study
Of the 960 mutants picked into 96-well plate cultures and assayed for activity before and 
after a 3 minute heat inactivation step at 60°C, 135 displayed stability (Ar/Ai) greater 
than 60%. Figure 8.1 shows a stability versus initial activity plot for the 960 mutants 
screened, with the original xylA.cd2 data plotted on the same axes for comparison. The 
line on the graph at Ar/Ai=0.6 indicates the cut-off point below which mutants were 
deemed to have the same stability as the original enzyme. Of the 135 mutants above this 
line, 12 demonstrated a stability of at least 0.6 after the extended 5 minute heat 
inactivation step at 60°C. Figure 8.2 shows a stability versus initial activity plot for the 
135 mutants put through the secondary heat inactivation step, with activities after both 
the 3 and 5 minute thermal inactivation steps plotted on the same axes. The data for the 
original enzyme after heat inactivation for 3 minutes is also included in Figure 8.2, to 
give an indication of the relative stability of the mutants in comparison to the original. 
From the calculated stabilities of the 12 mutants, 3 were seen to demonstrate almost the 
same activity after 3 and 5 minutes at 60°C (highlighted on figure 8.2). Based on these 
results these 3 mutants, known as 1-A10, 1-B6 and 2-C10, were selected for further 
individual study.
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Figure 8.1 Stability versus initial activity plot for the 960 random mutants screened 
for activity after 3 minutes at 60°C
Black represents the original xylA.cd2 samples; light blue represents the random mutant 
samples. Ai is the initial activity of each mutant, expressed as absorbance units at 575nm; Ar/Ai 
is the ratio of residual to initial activity of each mutant. The line represents the cut-off point for 
the selection criteria, and is positioned at Ar/Ai=0.6.
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Figure 8.2 Stability versus initial activity plot for the 135 random mutants screened 
for activity after 3 and 5 minutes at 60°C
Black represents the original xylA.cd2 samples after 3 minutes heat inactivation; light blue 
represents the 135 random mutant samples after 3 minutes heat inactivation; red represents the 
135 random mutant samples after 5 minutes heat inactivation. Circles highlight mutants 1-A10,
1-B6 & 2-CIO, all of which retain similar residual activity after both inactivation steps.
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8.3.3 Sequencing of mutants 1-A10,1-B6 & 2-C10
The inserts of the 3 mutant plasmid clones were sequenced using the M l3 universal 
sequencing and reverse primers. One sequencing reaction from each direction allowed 
the full insert sequence to be obtained. Comparison of the mutant sequences to that of 
the original identified PCR-introduced mutations for all 3 mutants, and these are 













1-A10 -5** A G Asp Gly
1-B6 596 C T Ala Val
2-C10
505 A G Thr Ala
596 C T Ala Val
Table 8.1 Summary of mutations identified in the xylA.cd2 coding region of the 3 
random mutant clones
♦The ‘location o f mutation’ column refers to the base number o f the mutation within the 
xylA.cd2 coding region, where the full region is 675 bases. **negative number indicates that the 
mutation is upstream o f the xylA.cd2 coding sequence, in the additional sequence from the lacZ 
gene that is expressed with the xylA.cd2 protein.
8.4.1 Characterisation of mutants 1-A10,1-B6 & 2-C10
In order to further characterise the 3 isolated mutants, the genes were each expressed 
from a 50ml culture and a cell extract was prepared. A cell extract from a culture 
expressing the original xylA.cd2 was also prepared, and was assayed alongside the 3 
mutants so that a comparison could be made between them.
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8.4.1.1 Specific activities
The specific activities of the partially purified mutants and original xylA.cd2 were 
determined, using a 1/20,000 dilution of all the partially purified enzymes in order to 
ensure initial rates were being measured. Table 8.2 summarises the specific activities.
1 ENZYME






Table 8.2 Summary of original and mutant xylA.cd2 enzyme specific activities
8.4.1.2 Temperature optima for activity
The partially purified enzymes were assayed at various temperatures from 18°C to 90°C. 
Figure 8.3 represents these results graphically, and shows the temperature activity 
profile for each of the 3 mutants alongside the original xylA.cd2 profile. As all 3 
mutants demonstrate a similar specific activity to the original, these assay results have 
been represented as a percentage of the maximum activity observed. The maximum 
activity of mutants 1-A10 and 2-C10 was observed at 55°C, the same as the original 
xylA.cd2, but mutant 1-B6 shows a shift in its optimum temperature for activity to 60°C.
8.4.1.3 Thermal stability at 64
Each mutant was heat inactivated over 5 minutes at 64°C, and Figure 8.4 graphically 
represents these results. Table 8.3 summarises the half-lives of each of the 3 mutant 
enzymes, in comparison to the half-life at 60°C of the original xylA.cd2.
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Figure 8.3c
Figure 8.3 Temperature activity curves for 3 mutant xylA.cd2 enzymes
Activities are expressed as a percentage of activity at the optimum (55°C for original, 1-A10 &
2-C10; 60°C for 1-B6). Each point represents the mean of duplicate assays. For all graphs black 
line represents original xylA.cd2; red line represents mutant enzyme.
Figure 8.3a Temperature activity curve for mutant 1-A10
Figure 8.3b Temperature activity curve for mutant 1-B6
Figure 8.3c Temperature activity curve for mutant 2-C10
162










0 2 3 4 51
Time (minutes)
Figure 8.4 Thermal inactivation at 64°C of 3 mutant xylA.cd2 enzymes
Data are shown as In (% activity) against incubation time (% activity being calculated as a 
percent of maximum activity, seen at time 0). Lines of best fit, calculated by linear regression, 
are shown. Black line represents original xylA.cd2; light blue line represents mutant 1-A10; 
green line represents mutant 1-B6; red line represents mutant 2-C10.





Table 8.3 Comparison of half-lives at 64°C of original and mutant xylA.cd2 enzymes
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8.4 DISCUSSION
8.4.1 Library screening and identification of improved mutants
Approximately 40,000 E. coli colonies, transformed with the random mutant library, 
were spread onto RBB-xylan agar plates, and of the xylanase-positive colonies enough 
to fill ten 96-well plates were picked into mini-cultures and screened using the 96-well 
plate system. Using the characteristics displayed by the original xylA.cd2 within the 
plate system (described in detail in Chapter 7), the selection criteria for identifying 
potentially improved mutants were that any mutant demonstrating activity after the heat 
inactivation step of at least 60% of its initial activity would be chosen for further study. 
The screening system identified 135 mutants after the 3-minute heat inactivation that 
retained 60% or more of their initial activity. These 135 were condensed into two new 
plates and subjected to a 5-minute heat inactivation, and of these 135, twelve retained 
60% or more of their initial activity after this 5-minute incubation. Of these 12 there 
were three mutants that did not appear to lose significant activity between the 3 and 5- 
minute inactivation steps. In comparison to the original xylA.cd2, which loses 
approximately 75% of its activity over 5 minutes at 60°C, the data for these 3 mutants 
suggest that they are substantially more stable at 60°C than the original. It is for this 
reason that these 3 were chosen from the 12 for further individual study.
8.4.2 Characterisation of improved mutants
8.4.2.1 Sequence comparison
Sequencing the inserts of the 3 mutants identified mutations in the xylA.cd2 coding 
sequence of 1-B6 and 2-C10, but not in 1-A10. The only obvious change in the sequence 
of 1-A10 is actually 5 bases upstream of the xylA.cd2 coding sequence, in the sequence 
that codes for the extra 12 residues expressed at the N-terminus of the xylA.cd2 protein. 
These residues are from the lacZ protein, and are expressed upstream of the xylA.cd2 
protein due to the way in which is it cloned into the pUC18 vector (described fully in 
section 3.4.1). It was suggested in Chapter 3 that these additional 12 N-terminal residues 
may influence both the activity and stability properties of the xylA.cd2 enzyme, but 
without expressing xylA.cd2 without them it would be difficult to predict with any 
degree of certainty. It would be possible to express the xylA.cd2 protein without the
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additional N-terminal residues by cloning the coding sequence into a different plasmid 
vector, for example pET-3a. There is, however, limited information available on the 
expression of xylA.cd2 without any additional N-terminal residues, and it suggests that 
without these additional residues xylA.cd2 expression is very poor (Hazlewood, 
unpublished data). The sequence results for mutant 1-A10, particularly when viewed 
with the stability data for this enzyme, suggest that these additional residues do have an 
effect on the stabilisation of xylA.cd2 at elevated temperatures.
The sequence mutations identified in the other 2 mutants are within the xylA.cd2 coding 
region. Mutant 1-B6 has a mutation that equates to an alanine to valine substitution in 
the expressed protein (A 199V). Mutant 2-C10 has two amino acid substitutions: a 
threonine to alanine (T169A) and an alanine to valine (A199V). Interestingly, the 
A199V substitution is at the same location in both these mutant enzymes, which may 
suggest that this residue plays an important role in stabilising the enzyme, particularly 
when it has been isolated in two individual mutants. The modelled structure of xylA.cd2 
described in Chapter 4 has been used to suggest possible stabilising mechanisms for 
these amino acid substitutions. The location of the T169A substitution is on a loop in the 
xylA.cd2 structure that was introduced to accommodate an insertion in its sequence in 
comparison to the template enzyme. This makes it more difficult to predict how the 
substitution may be affecting the overall structure, as the location of the loop is not well 
defined. However, if the residues are situated on a loop structure as in the model, it is 
likely that the threonine is on the surface of the protein with its side-chain pointing into 
the hydrophobic core; the same position adopted by the alanine in the model. The 
A199V substitution is situated in a (3-strand. The residue is in the active site cleft but the 
side-chain points into the core of the protein, between a p-sheet, rather than into the 
active site cleft. It has been suggested that perhaps the larger side-chain of valine 
protrudes into a cavity within the core of the enzyme, and this is how it helps to stabilise 
the enzyme at elevated temperatures (a cavity would cause destabilisation at higher 
temperatures, and filling it with a more bulky side-chain may help to stabilise). In 
addition, sequence comparison of xylA.cd2 with the other family 11 xylanases shows 
that most others have either a valine or threonine in this position. These suggestions are
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predictions based on the modelled structure of xylA.cd2, and can only be confirmed if 
the actual crystal structure is solved. Another interesting consideration is that both the 
T169A and A199V substitutions are substitutions for a more hydrophobic residue. The 
structural basis of thermostability in proteins has been extensively reviewed, and 
increased numbers of hydrophobic interactions are frequently cited as factors involved in 
increasing thermostability (Vieille and Zeikus, 2001; Sterner and Liebl, 2001). For 
example, a comparative study of ten different triosephosphate isomerase structures 
identified an increased number of buried hydrophobic residues as one of the major 
factors contributing to the increased thermostability (Maes et a i, 1999). It could be 
considered that these substitutions seen in the mutant xylA.cd2 proteins are contributing 
to an increase in stability by increasing the number of hydrophobic interactions within 
the protein, particularly when comparison to the modelled structure suggests that the 
orientation of these residues is into the core of the enzyme.
8.4.2.2 Thermoactivity and thermostability
The purpose of individually studying apparently improved mutants was to confirm that 
the characteristics they displayed in the screen were indeed true characteristics, and not 
artefacts of some stage of the screen itself. The individual studies of thermoactivity and 
thermostability at 64°C were performed on cell extracts prepared for each enzyme, and 
as previously a cell extract of the original xylA.cd2 was also prepared and assayed in 
parallel for comparison.
All 3 mutants show an increase in stability over the original enzyme at 64°C. XylA.cd2 
inactivates very rapidly at this temperature, with the partially pure preparation having a 
half-life of just less than 1 minute. In contrast, 1-A10, the least stable of the 3 mutants, 
has a half-life of 8 minutes, 1-B6 has a half-life of 28.5 minutes at 64°C, and 2-C10, the 
most stable of the mutants, has a half-life of 36 minutes. These are quite considerable 
increases in stability, and when the amino acid substitutions are considered it may seem 
sensible that 1-A10 demonstrates the smallest increase in stability and 1-C10 the largest. 
1-A10 has a substitution just outside the core xylA.cd2 residues that may be influencing 
the structure of the actual xylA.cd2 protein from an external position. 1-B6 has one
166
Chapter 8: Random mutant library screening using 96-well plate system
internal substitution that is in some way stabilising the enzyme. 2-C10 has two 
substitutions, one potentially on the surface of the protein, and the other buried within 
the core of the enzyme, in the same position as the mutation in 1-B6. The fact that 2- 
C10 has two mutations, and is displaying the greatest increase in stability supports the 
theory that stability can be achieved accumulatively by a combination of effects, rather 
than by a single change within the protein.
Although the specific activities calculated in this chapter do give the impression that 
there is very little difference between the 3 mutants and the original enzyme, these 
specific activities are calculated from activity measurements in a cell extract, rather than 
from purified protein. While these specific activity values do reflect to a certain degree 
the activities of the proteins, there are other factors, such as differences in expression 
levels, which may have some bearing on the actual activity. It is for this reason that a 
true comparison of the specific activities of these mutant proteins with the original 
xylA.cd2 can only be made when the mutants have been purified.
Despite the fact that the specific activity values cannot be relied on 100% to indicate true 
differences between the mutant and original xylA.cd2 proteins, the results of these 
characterisation experiments do indicate that the stability of xylA.cd2 has been 
substantially improved without compromising its catalytic activity.
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8.5 CONCLUSIONS
This chapter has described the identification of three mutants of xylA.cd2 from the 
random mutant library generated in Chapter 6 that demonstrate a considerable 
improvement in thermal stability over the original xylA.cd2 enzyme.
The results of this chapter confirm that the 96-well plate screen developed in Chapter 7 
is a much more reliable and consistent method of screening the random mutant library 
than the original agar plate-based screen used in Chapter 6. It has allowed the rapid 
screening of a large number of random mutant library clones, demonstrating that it 
possesses the properties necessary of a screen that is to study the large numbers of 
random mutants generated in a directed evolution experiment. The screen has been used 
to identify twelve random mutants that display an increase in thermal stability. Of these 
twelve, three show consistent increases in stability when analysed using standard 
methods, verifying that the screen is not only reliable but also accurate enough to screen 
the products of a directed evolution experiment and successfully identify mutants 
demonstrating improvements in the desired property, i.e. thermal stability.
The three mutants characterised in detail demonstrate considerable increases in 
thermostability; the most improved demonstrating a 35-fold increase in stability over the 
original xylA.cd2 at 64°C. Despite the improvements in stability none of the three 
mutants appear to have compromised activity at lower temperatures, an important 
consideration in achieving the aims of this project as a whole. The results of this chapter 
suggest that it is possible for enzymes to be both thermostable and active at lower 
temperatures, providing that selective pressure is applied for both properties at the same 
time.
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Chapter 9 
FINAL CONCLUSIONS AND FUTURE WORK
9.1 FINAL CONCLUSIONS
The aim of this project was to increase the thermal stability of xylanase A from the 
mesophilic anaerobic fungus Neocallimastix patriciarum, whilst retaining its high levels 
of activity at lower temperatures. Two separate mutagenesis techniques have been 
utilised in attempts to achieve this goal: site-directed mutagenesis and directed 
evolution, or random mutagenesis. Both approaches were applied to the second catalytic 
domain of xylanase A (xylA.cd2) only. The site-directed approach involved the 
development of a model three-dimensional structure of xylA.cd2, followed by the design 
and introduction of mutations predicted to increase its thermal stability. In this case a 
disulphide bond was introduced into xylA.cd2. The directed evolution approach 
involved construction of a library of random mutants of xylA.cd2 by subjecting the gene 
encoding xylA.cd2 to a series of error-prone PCR steps in order to introduce random 
mutations. A reliable, consistent and reproducible screen was then developed and used 
to screen this random mutant library in order to identify those mutants displaying an 
improved thermal stability while still retaining high levels of activity at lower 
temperatures.
Chapter 5 describes the introduction into xylA.cd2 of two mutations identified from the 
model structure as being possible targets for increased thermal stability. The mutations 
were designed to introduce a disulphide bond into the enzyme. Characterisation of the 
mutant enzyme with respect to the original xylA.cd2 shows that it is more stable, having 
a greater activation energy for the inactivation process and a half-life at least 2.5 times 
greater than the original enzyme at the temperatures studied (58-64°C). These results 
demonstrate the effectiveness of structure-based design as a tool for making 
improvements in a given enzyme. Given that the mutations were based on a modelled 
structure rather than the actual three-dimensional crystal structure of xylA.cd2, the 
results described in chapter 5 are satisfying: often modelled structures do not accurately
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reflect the detailed structure of a protein and mutations predicted from a modelled 
structure can cause major disruption to the overall stability of an enzyme, and as a result 
dramatically reduce its catalytic efficiency. However, while the introduction of a 
disulphide bond does appear to have contributed to an increase in stability of the 
xylA.cd2 enzyme, the improvement is not that large, particularly in comparison to the 
results obtained using the directed evolution approach. Given that the site-directed 
mutant is still as active as the original enzyme (indicating that its folded, native structure 
has not been affected by the introduction of a disulphide bond) greater improvements to 
its thermal stability could be made by introducing further site-specific mutations. Other 
improvements based on the structural model suggested in Chapter 4 include the 
introduction of a surface aromatic cluster, and the introduction of a greater number of 
ionic interactions. Another option for improving the thermostability of the site-directed 
mutant is to use it as a template for directed evolution. The process of directed evolution 
is accumulative, with the small changes in a given property identified at each round of 
mutagenesis contributing to the overall improvement seen in the final mutant. With its 
already improved thermal stability, the site-directed mutant represents a good base for 
further improvements.
The results of Chapter 6 demonstrate the need for an accurate, reproducible screening 
system with which to analyse the products of a directed evolution experiment. The 
library of random mutants produced by error-prone PCR contains the coding sequence 
for many thousands of enzymes that could potentially possess improvements in the 
characteristic of interest. The three mutants isolated from the 96-well plate screen 
described in Chapter 7 all demonstrate true improvements in thermal stability over the 
original xylA.cd2 enzyme when characterised individually. This validates the reliability 
of the screening system, and supports the theory that directed evolution experiments are 
only as successful as the system by which the random mutant library is screened. The 
three mutants characterised in Chapter 8 would all be good candidates for further rounds 
of directed evolution. Considering that most directed evolution experiments are 
performed over several rounds of mutagenesis and screening, the fact that quite 
considerable improvements have been made in just one round of mutagenesis bodes well
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for further rounds, and suggests that it should be possible using this method to identify a 
final xylA.cd2 mutant demonstrating a substantial increase in stability.
9.2 FUTURE WORK
In addition to improving the site-directed mutant xylA.cd2 and subjecting the three 
improved random mutants to further rounds of directed evolution, as proposed above, 
there are other suggestions for further work that emerge from the results of this project. 
One area where further investigation is required is in the characterisation of the 
remaining nine mutants identified from the random mutant library screen. Chapter 8 
describes the identification of 12 mutants displaying increased thermal stabilities after a 
5 minute incubation at 60°C, but time constraints allowed the individual characterisation 
of only three of these 12. Given the improvements in thermal stability demonstrated by 
the three characterised mutants, it is reasonable to project that the remaining nine 
mutants will also demonstrate increased thermostability.
All 12 improved mutants could be used as templates for further rounds of error-prone 
PCR and screening, A sensible suggestion may also be to use DNA shuffling technology 
to recombine these improved mutants, with the aim of identifying a single mutant 
containing combinations of mutations that impart an even greater thermostability. This 
single mutant could then be used as a template for more rounds of random mutagenesis, 
recombination and screening.
The aim of this project was to increase the thermal stability of xylA.cd2 whilst retaining 
its high levels of activity at lower temperatures. The mutants obtained in this study, 
particularly those identified by the directed evolution approach, are notably more stable 
than the original xylA.cd2 enzyme yet still retain good activity at lower temperatures. 
Their thermal stability, however, is not yet appropriate enough for use in the intended 
industrial application. The results of this study more than demonstrate the effectiveness 
of the methods employed at increasing thermal stability, and it is my opinion that further 
rounds of mutagenesis and/or recombination and screening would fulfil the aims of
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developing an enzyme with significantly improved thermal stability that retains its high 
activity at lower temperatures.
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APPENDIX




REFERENCE SEQUENCE (5’ - 3 ’) 1
Primer l a Forward Section 3.2.2 CAA GGA TCC AAA GTT TAC TGT CGG TAA
T
Primer 2b Reverse Section 3.2.2 ACG GGA TCC GGC AGA CTA GGC TGG ACT 
AGA ACC CTTTGG
Primer 3C Forward Section 5.2.2 CAT ATT ACT GTC TCA TGT CAC TTT AAG 
GAATG
Primer 4° Forward Section 5.2.2 GA AAA ATG GTA ACC TGT GAT GGA GCT 
CAA
Primer 5 Forward Section 6.2.2 CCT CTT CGC TAT TAC GCC AGC TGG
Primer 6 Reverse Section 6.2.2 CGA CAG GTT TCC CGA CTG GAA AGC
a Bold type indicates the position of a BamHI restriction site; arrow indicates the start of 
the cd2 coding region
b Bold type indicates the position of a BamHI restriction site; bold italic type indicates 
the introduced stop codon 
0 Bold type indicates the introduced mutations
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